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Abstract
The insulin-like growth factor (IGF) family has been identified as having a key role 
in regulating follicular growth in mammals. IGFs have been shown to act as survival 
factors that stimulate somatic cell proliferation and differentiation, as well as being 
involved in the final stages of oocyte maturation. Insulin-like growth factor binding 
proteins (IGFBPs) regulate the availability of IGFs as they can sequester 
extracellular IGFs and hence reduce their bioavailability. The aims of this thesis were 
to use a serum-free culture system to investigate the role of the IGF system during 
early bovine follicular development. The study focused on investigating the actions 
and regulation of IGF in three key stages of follicle growth. These key stages were: 
primordial follicle initiation, the transition from preantral to early antral stages and 
early antral follicle growth.
To begin with, this study looked at the effect of IGF-I on primordial initiation and 
preantral follicle growth and oocyte health, in the presence or absence of androgen. 
Androgens can have a direct action via androgen receptors (AR), but it has also been 
suggested that androgens may have an indirect action by influencing the actions of 
IGF-I through its IGF receptors. No effects of IGF-I on primordial follicle initiation 
or activated follicle growth were evident, but IGF-I that was not regulated by 
IGFBPs was found to have a negative effect on the oocyte health of follicles after 6 
days of culture. Hence, during the early stages of follicle development regulation of 
the bioavailability of IGF is crucial to maintain the health of the oocyte. AR 
immunoreactivity was found in the oocyte and granulosa cells of bovine preantral 
and antral follicles. Supplementation of culture medium with androstenedione, either 
on its own or in combination with IGF-I, also failed to affect follicle activation and 
growth. So the detrimental effect of IGF-I on oocyte health was not altered by the 
presence of androstenedione.
Previous in vitro preantral follicle culture studies have demonstrated a positive effect 
of IGF-I on follicle growth but a negative effect on oocyte size and granulosa 
differentiation. In the present study a 6 day culture of bovine early antral follicles in
the presence of IGF-I was found to stimulate both follicle proliferation in the early 
stages of development and differentiation at all developmental stages, as exhibited by 
oestradiol production. Furthermore, these effects were found to occur in a dose and 
stage dependent manner. Additionally, oocyte health was improved by the addition 
of recombinant IGF-I in the more mature antral follicles. These results highlight the 
importance of follicle developmental stage when deciding the best in vitro culture 
conditions.
It is important to investigate the mechanisms involved in regulating the expression of 
IGFBPs at different stages of follicle growth, as changes in their expression will 
affect the bioavailability of IGF to its receptors. IGFBP-2 mRNA and protein were 
shown to be expressed in the oocyte and granulosa cells, but not theca cells, of early 
antral follicles. In addition, IGF-I was found to influence the expression of IGFBP-2 
in granulosa cells and oocytes of the largest size range of early antral follicles. A 
decrease in IGFBP-2 immunoreactivity was observed when follicles were cultured in 
the absence or in a low dose of IGF-I compared to follicles cultured in a high dose of 
IGF-I. These results suggest that IGF-I may regulate the expression of IGFBP-2 
through a negative feedback mechanism, which again is stage dependent.
The biological actions of IGF depend in part on the ability of specific proteases to 
break down the IGF/IGFBP complex. The secretion of proteases capable of 
degrading IGFBP-2 by different bovine follicular compartments was identified, and 
the effect of IGF-I or follicle stimulating hormone (FSH) on modulating IGFBP-2 
proteolytic degradation was also investigated. Proteolysis of IGFBP-2 caused by the 
incubation of IGFBP-2 with oocytes was not detected. However, incubation of 
IGFBP-2 with granulosa cells did cause a small level of IGFBP-2 degradation. IGF-I 
and FSH were not found to enhance or inhibit the degradation of IGFBP-2 after 
incubation with bovine oocytes or granulosa cells.
The use of a serum-free culture system in this study has improved our understanding 
of how the complex IGF system is regulated throughout bovine follicular 
development. It has highlighted that the control of IGF availability to a growing
follicle is governed by different levels of regulation, such as the level of expression 
and degree of proteolysis of IGFBPs, which are follicle stage dependent. A fuller 
understanding of the mechanisms that control the access and regulation of local 
growth factors will allow us to move closer to developing an in vitro culture system 
capable of producing large numbers of viable oocytes for use in reproductive 
technologies.
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The main function of the female ovary is to support the differentiation and release of 
a mature oocyte, which can then be successfully fertilised and ensure the survival of 
the species. In mammalian ovaries the individual follicle consists of an oocyte, 
surrounded by granulosa cells and an outer layer of theca cells. These follicles must 
develop through primordial, primary and secondary stages before reaching the 
preovulatory stage, and subsequently being ovulated (Figure 1.1). The fate of each 
follicle is dependent on the integration of both extra-ovarian signals, such as 
gonadotrophins, and intra-follicular factors, such as locally produced growth factors 
(Webb et al. 2003). These signals and factors determine which follicles will go on to 
be ovulated or undergo atretic degeneration. The pool of oocytes in the mammalian 
ovary is generally regarded as becoming fixed early in life, and by the time a female 
has reached puberty she may have less than 20% of the original number of 
primordial follicles left (Faddy et al. 1987). This represents a huge loss of genetic 
material and has led to the development of technologies to try to utilise or manipulate 
this large supply of immature oocytes. Recent findings suggest that germline stem 
cells may exist and continue to develop in more than the handful of species already 
known to continue to produce germ cells throughout life (Johnson et al. 2004; Telfer 
2004). However, even if this is the case, we do not know if these germ cells are 
viable, or whether they form part of the pool of primordial follicles from which 
growing follicles are selected throughout the life of the female. At present, the 
mechanisms that regulate the gradual initiation of growth of ovarian follicles from 
the primordial pool are poorly understood. By improving our knowledge of the 
signals that initiate follicular growth in mammals, and of the conditions necessary for 
sustained early follicle development in vitro, improvements in all aspects of fertility 
can be made. The similarity of bovine and primate ovaries makes cattle excellent 
models for humans, as well as important models in themselves because of their 
agricultural importance (Fortune et al. 1999). The ultimate goal of studies on follicle 
growth in vitro is to develop conditions that will sustain follicular development to the 

























Morphology and progression of events during follicular development in mammals
Primordial follicles (a) are embedded in stromal tissue and consist of flattened granulosa cells that 
enclose a primary oocyte at the dictyate stage with a germinal vesicle (nucleus). After initiation of 
growth, granulosa cells become cuboidal in shape and begin to proliferate. A theca layer forms and the 
oocyte grows and secretes the zona pellucida; the follicle is now termed a preantral follicle (b). The 
production of coalescing fluid drops within the avascular granulosa layer signals the start of antral 
stages of growth (c). As the follicular antrum fully expands, the oocyte is left surrounded by a distinct 
layer of granulosa cells known as the cumulus oophorus. Finally, the oocyte is ovulated (d), leaving 
behind the follicle shell now termed a corpus luteum (e).
The use of assisted reproductive techniques such as superovulation, in vitro 
maturation and fertilisation, and artificial insemination has increased in recent years 
and had a beneficial impact in improving reproductive performance of many species. 
However, the safety of reproductive technologies must be fully investigated before 
being widely applied. In cattle, reproductive efficiency can be described as a
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measure of the ability of a cow to become pregnant and produce viable offspring. 
The average dairy cow in the UK has an optimum calving interval that is dependent 
to a varying extent on milk yield and season of calving. This financial loss is caused 
by factors such as loss in milk yield, cost of replacing culled cows, decreased calf 
sales per cow and an increase in herd depreciation costs. The average calving interval 
of the UK dairy herd is 395 days, which represents an annual loss of up to £90 per 
cow, so there is much to be gained from improving the reproductive performance in 
the dairy herd (Peters and Ball 1995).
Superovulation procedures (which involve bombarding the ovaries with elevated 
concentrations of gonadotrophins) can increase the number of oocytes, but the 
response is highly variable, both between and within animals. The numbers of 
fertilisable oocytes decline with successive treatments, and even when fertilisation is 
achieved a substantial percentage of the subsequent embryos are lost due to poor 
oocyte quality prior to conception (Telfer et al. 1999). In domestic species there has 
been only limited success with in vitro maturation (IVM) of oocytes recovered from 
antral follicles by superovulation, possibly due to the follicles being increasingly 
heterogeneous. The oocytes may therefore already be developmentally compromised. 
It has been recognised for some time that the best means to increase the capability 
and success of assisted reproduction programmes is to use oocytes from immature 
follicles for IVM. Oocytes contained within the hundreds of thousands of primordial 
and preantral follicles within the ovaries of any individual animal are thought to be a 
more homogeneous and useful source. The use of new technologies to increase the 
yield of oocytes and improve female fecundity therefore assumes high priority for 
research and development.
Although a great deal of research has been focused on methods for growing more 
developed large preantral follicles in vitro, little is known about the conditions 
necessary to sustain and stimulate the earliest and smallest growing primordial 
follicles. The ideal culture system would accelerate oocyte/follicle development but 
still allow key factors to be expressed in the normal sequence without the need for 
the development of large antral cavities. To fully understand follicle development
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and advance technology, it is important for us to identify cellular markers of somatic 
cell differentiation and oocyte development. These markers need to be able to be 
related to normal in vivo development, and hence signal the health and viability or 
death of a follicle.
1.2 Follicular formation and follicle growth
The growth of a follicle from the initiation of the primordial stage to the time of 
ovulation is a dynamic process, which involves a complex system to ensure the 
oocyte is fully matured and ready for its subsequent fertilisation after it is released 
from the Graafian follicles at ovulation (Figure 1.2). Follicle growth is characterised 
by different phases of growth and differentiation, and complex interactions between 
the gonads, pituitary and the reproductive tract. Each of these components must 
interact and work together to coordinate the proper sequence of events that lead to 
oocyte maturation.
1.2.1 Follicular formation
Follicle formation in mammals is the developmental process by which individual 
oocytes assemble into primordial follicles within the ovary. At the first stage of 
development, the germ cells stop dividing mitotically and form associations with 
small numbers of pre-granulosa cells to form primordial follicles (Telfer et al. 1988). 
The germ cell enters meiosis and is now referred to as an oocyte. Meiosis only 
proceeds to the diplotene stage of prophase before it is arrested (Peters 1969). 
Primordial follicles constitute a store of germ cells in the postnatal ovary and their 
numbers vary with species and age, but in the cow and sheep they number between 
two and three million (Erickson 1966; Gosden and Telfer 1987a; 1987b). The exact 
timing of follicle formation is species-specific; in rodents, the assembly of follicles is 
precisely coordinated and occurs during the first few days after birth (Kezele et al. 
2002a). In contrast, the formation of follicles in domestic animals and primates 
occurs during fetal life. Furthermore, some follicles begin to leave the resting pool 
while others are still being formed; hence, follicles are formed over a much longer 
period of time than in rodents and in a less synchronous manner (Fortune et al. 2000; 
2003). Factors regulating the crucial process of primordial follicle formation are
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largely unknown. However, a gene that has been implicated in regulation of 
folliculogenesis is Factor in the germline alpha (Figld) (Bayne et al. 2004; Soyal et 
al. 2000). Knockout analysis in the mouse has shown that Figla, a germ-cell specific 
basic helix-loop-helix transcription factor, is required for oocyte survival and the 
formation of primordial follicles (Dean 2002; Soyal et al. 2000). Additionally, a 
number of factors have been implicated in the survival of primordial germ cells and 
the regulation of germ cell proliferation during the crucial period of development 
leading up to primordial follicle formation. These include activin (Martins da Silva et 
al. 2004), kit ligand and its receptor c-kit (Godin et al. 1991; Klinger and De Felici 
2002; Manova et al. 1993; Robinson et al. 2001), bone morphogenetic protein-4 
(BMP-4) (Fujiwara et al 2001), Wnt-4 (Vainio et al. 1999) and neurotrophins 
(Anderson et al. 2002; Dissen et al. 1995; Ojeda et al. 2000; Spears et al. 2003).
1.2.2 Initiation and early follicle growth
Primordial follicles do not proliferate and therefore represent a female's total 
reproductive potential, as they are the only source from which groups of ovulable 
follicles will be recruited for growth throughout life. These follicles remain quiescent 
until they are triggered by an unknown signal to enter a growing phase. Initially, 
granulosa cells become cuboidal in shape and begin to express markers of cell 
proliferation, such as proliferating cell nuclear antigen (PCNA) (Wandji et al. 1996; 
1997). The oocyte starts to grow (Arendsen and Groen-Klevant 1980; Braw-Tal and 
Yossefi 1997; Cahill and Mauleon 1981; Lintern-Moore and Moore 1979) and 
granulosa cells begin to proliferate to form layers around the oocyte. The exact 
mechanisms responsible for primordial follicle activation, and the mechanisms that 
permit some of the dormant follicles to initiate growth as soon as the primordial 
follicle store is established - while the rest of the follicles remain dormant for 
months or years - remain to be fully elucidated (Picton 2001). Unknown stimulatory 
factors may be responsible for initiating growth, or alternatively initial recruitment 
may be due to a release from inhibitory stimuli that maintain the follicles in a resting 
state (McGee and Hsueh 2000). FoxoSa (FKHRL1), a member of the FOXO 
subfamily of forkhead transcription factors, has been implicated in the regulation of 
follicle activation. Foxo3a"" ovaries were shown to contain elevated numbers of early
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growing follicles that resulted in the progression of increased numbers of follicles to 
more advanced stages of follicular development and premature ovarian failure 
(Castrillon et al. 2003). A number of candidate molecules have been suggested for 
paracrine/autocrine control of*primordial development. These include anti-mullerian 
hormone (AMH) (Durlinger et al. 1999; 2002), interactions between c-kit and stem 
cell factor (kit ligand) (Huang et al. 1993; Yoshida et al. 1997), and a range of 
growth factors, including growth differentiating factor-9 (GDF-9) (Dong et al. 1996; 
Elvin et al. 1999a; 1999b) and bone morphogenic protein-15 (BMP-15) (Dube et al 
1998), but there is no conclusive proof of their involvement. However, 
gonadotrophins [follicle-stimulating hormone (FSH) and luteinising hormone (LH)] 
do not appear to be essential for early follicle growth because, in their absence, 
follicles can still develop to the early antral stage (Awotwi et al. 1984; Gong et al. 
1996).
1.2.3 Preantral to antral follicle development
A preantral follicle is characterised by a primary oocyte, surrounded by a zona 
pellucida and at least one full layer of cuboidal granulosa cells. During preantral 
stages the oocyte increases rapidly in volume (Eppig 1994; Schultz and Wassarman 
1977), granulosa cells multiply to form several layers, and thecal cells - which are 
recruited from the surrounding interstitial stromal cells - come to lie on the basement 
membrane surrounding the granulosa cells (Braw-Tal and Yossefi 1997; Hirshfield 
1991b). The early stages of follicle growth are the most crucial for oocyte 
development as it is during these stages that many of the proteins essential for further 
development, both before and after ovulation, are produced. The oocyte's diameter 
increases rapidly during preantral stages of follicle growth due to an increase in 
protein content (Schultz and Wassarman 1977) and accumulation of resources 
essential for maturation, fertilisation and pre-implantation embryo development 
(Eppig 1994). Oocytes from preantral follicles are unable to resume meiosis, but it is 
during this phase that they are synthesizing molecules essential for the resumption of 
meiosis (Bachvarova et al. 1985).
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Figure 1.2
Schematical diagram of the developing follicle and growth rates of bovine oocytes
and follicles in vivo
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1.2.4 Final stages of follicle growth and ovulation
Once the follicle reaches a species-specific size (~200um for mammalian follicles) 
granulosa cells start to secrete glycoproteins, which coalesce to form a fluid-filled 
space called an antrum within the granulosa cell layers (Gosden and Telfer 1987b; 
Hirshfield 199la; Lussier et al. 1987). This fluid is termed follicular fluid and its 
composition varies considerably. The formation of the fluid-filled cavity marks the 
beginning of the antral stage of development. At this stage, the follicles become 
acutely dependent on gonadotrophins for further growth and development (Nayudu 
and Osborn 1992). The antral follicle - which precedes the final Graafian follicle 
(spherical vesicle from which the ovum is released on ovulation) - has three somatic 
cell compartments that surround the oocyte. These are the differentiated interstitial 
cells (theca cells), mural granulosa cells and cumulus granulosa cells. The theca cells 
are vascularised and can be found external to the basal membrane; they express 
luteinising hormone (LH) receptors. The mural and cumulus granulosa cells are all 
avascular and express follicle stimulating hormone (FSH) receptors. Mural granulosa 
cells are located on the inner side of the basal membrane, and as the follicle grows 
they also begin to express LH-receptors. Cumulus cells are also on the inner side of 
the basal membrane but separated from the mural cells by the antral cavity. These 
cells do not express LH-receptors, and at ovulation leave the follicle with the oocyte 
as a mucified complex. The maintenance of cumulus granulosa cell contact with the 
oocyte through gap junctions is essential, as the oocyte is dependent on the contact 
for a supply of nutrients for further development. Granulosa cell contact also holds 
the oocyte in arrest at the dictyate stage of development until the follicle has reached 
the appropriate developmental stage, at which point ovulation occurs (Eppig and 
Downs 1984; Eppig 1991b; Wert and Larsen 1989).
Follicles that have developed to the antral stage may undergo one of two possible 
fates. One is to continue to increase in size and become a Graafian follicle, which 
when stimulated by a LH surge will rupture to release the ovum for fertilisation; this 
process is termed ovulation. The preovulatory follicle undergoes three major changes 
as ovulation approaches. Firstly, the oocyte resumes meiosis and hence fully matures 
from a primary to a secondary oocyte. Secondly, there is dissociation of the cumulus
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granulosa cells from the granulosa layer; and lastly, the external follicular wall thins 
and then ruptures (Espey 1967; 1980; Thibault and Levasseur 1988).
However, many antral follicles spontaneously cease to grow and begin to regress or 
degenerate, a process known as atresia. The mechanism by which follicles are 
selected for ovulation or atresia is not yet clearly understood. The development of an 
antrum precedes the occurrence of widespread atresia in the antral follicle 
population, and as a result of this selection process the vast majority (>99%) of 
primordial follicles fail to ovulate. This large loss of female germ cells represents a 
massive wastage of oocytes that could potentially be rescued if developed in vitro 
(Telferetal. 1999).
1.2.5 Oocvte growth and maturation
The limited knowledge on the regulation of oocyte formation, the different steps of 
folliculogenesis and the required conditions for oocytes to undergo proper growth, 
differentiation and maturation are major causes of the failure in obtaining viable 
offspring from in vitro cultured early oocytes from domestic species and humans 
(Van den and Zhao 2005). The growth of the oocyte and accompanying somatic cells 
from initiation to the final preovulatory stages is a lengthy process, taking around six 
months in sheep (Cahill and Mauleon 1980) and cattle (Lussier et al 1987). The 
majority of this time (about four months) is spent in the preantral stages of 
development, which is the time when the greatest increase in oocyte mass is 
achieved. During this stage the oocyte enters its extensive growth phase, the 
surrounding granulosa cells become more proliferative and a theca layer develops 
around the granulosa from interstitial stroma cells.
For normal fertilisation and embryonic development to proceed, the oocyte must 
acquire the ability to resume meiosis. Oocytes from immature follicles are unable to 
resume meiosis (Iwamatsu and Yanagimachi 1975). However, by the time the 
follicles have reached the antral stages of development the oocytes of most species 
have acquired the ability to resume meiosis (Mattioli and Barboni 1998; Telfer et al. 
1999). It is thought the ability of an oocyte to be competent (to be able to resume
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nuclear maturation and to undergo fertilisation and cell cleavage) is related to its 
size. In rodents it was found that oocytes less than 80fj,m in diameter were unable to 
complete maturation (Iwamatsu and Yanagimachi 1975). In larger species such as 
the pig and cow, meiotic competence is acquired in two steps. Oocytes of 100|j,m in 
diameter can resume meiosis but do not progress beyond Metaphase I, whereas 
oocytes of HO^im can progress and complete meiotic maturation to Metaphase II 
(Fair et al. 1995; Hirao et al. 1994; Hyttel et al. 1997; Motlik and Fulka 1986). 
Therefore, it appears that the ability of an oocyte to complete meiotic maturation is 
related to the size of the oocyte and hence the stage of follicle development. Oocytes 
have to grow to become competent and during this increase in volume, oocytes also 
have to differentiate. A complex cytoplasmic organisation is required dependent on 
both the production of new gene products and organelles, and the modification and 
redistribution of existing ones (Picton et al. 2003). Together with a huge rise in RNA 
and protein synthesis, the numbers of ribosomes, mitochondria and other cell 
organelles increase enormously in growing oocytes. The accumulation of numerous 
scattered membrane-bound vesicles, glycogen granules, protein, lipid droplets and 
multivesicular bodies is indicative for storage and molecular transport across the 
oocyte membrane. Many organelles transform in appearance and disperse towards 
the periphery of the oocyte (Van den and Zhao 2005). One of the most crucial 
changes during the growth phase of an oocyte is its secretion of a glycoprotein 
membrane, the zona pellucida, which forms a protective coat around the oocyte. The 
zona proteins are essential for normal follicle development and their expression 
requires transcription factor Fig-oc (Soyal et al. 2000). The granulosa cells become 
coupled with one another and also form gap junctions on the oolemma with the 
oocyte via processes passing through the developing zona pellucida (Anderson and 
Albertini 1976). The gap junctions facilitate a two-directional communication and 
allow transfer of nutrients, metabolic precursors, informational molecules (such as 
hormones, neurotrophins and growth factors) and inhibitory and stimulatory meiotic 
signals. By the use of this mechanism the growing oocyte can actively promote 
growth and differentiation of the somatic cells, while conversely the granulosa cells 
are able to ensure continued growth and differentiation of the oocyte (Van den and 
Zhao 2005). During oocyte growth and maturation signalling factors are exchanged
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between the oocyte and its surrounding granulosa cells. The oocyte conducts the time 
of follicular development by controlling granulosa cell proliferation and 
differentiation, which leads to increased responsiveness to gonadotrophins, theca cell 
differentiation, cumulus expansion and in the end rupture of the follicular wall 
(Buccione et al. 1990a; 1990b; Erickson and Shimasaki 2000; Salustri et al. 1990; Su 
et al. 2002; 2003; Vanderhyden et al. 1990; 1992; Vanderhyden and Tonary 1995). 
In turn, the granulosa cells are indispensable for oocyte growth, differentiation, 
nuclear meiotic state, cytoplasmic maturation and genomic transcriptional activity 
(Brower and Schultz 1982; Buccione et al 1990a; Cecconi et al. 1991; De La and 
Eppig 2001; Eppig 1979; Matzuk et al. 2002; Tsafriri and Channing 1975; Van den 
and Zhao 2005).
In early bovine antral follicles, oocytes reach a diameter of 120jj,m and at this stage 
acquires competence to resume meiosis, which is associated with almost completely 
inactivated nuclear transcription activity of the oocyte (Hyttel et al. 2001). The 
competence of an oocyte to resume and complete meiosis and, after fertilisation, to 
develop into a blastocyst is significantly increased during follicular dominance and 
particularly during luteolysis through a process called oocyte capacitation, whereby 
the nuclear envelope becomes undulated and the nucleolar remnant displays a 
vacuole of increasing size. After termination of oocyte transcription, the oocyte does 
not enter quiescence but prepares itself for a possible continued development as an 
embryo after fertilisation (Van den and Zhao 2005). So in growing and dominant 
follicles, oocytes remain arrested at the diplotene stages of the meiotic prophase, 
until resumption of meiosis (in fully grown, meiotically competent oocytes from 
dominant follicles) is triggered by the preovulatory LH surge. During the period 
between the LH surge and ovulation, the oocyte undergoes a series of marked 
changes not only in the nucleus but also in the cytoplasm, the process termed as 
oocyte maturation. Nuclear maturation last about 24 hours in the cow and comprises 
of several steps (including germinal vesicle breakdown (GVBD) and formation of the 
first polar body), before the oocyte arrest at Mil until fertilisation (Van den and Zhao 
2005). Since no LH receptors have been detected in oocytes it is likely that the signal 
that triggers oocyte maturation originates from their surrounding somatic cells (Peng
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et al. 1991). Maturation promoting factor (MPF) is a protein that has been highlight 
as being responsible for the onset of oocyte maturation as its activation precedes or 
occurs cocomittantly with GVBD (Gordo et al. 2001). In vitro maturation of 
immature oocytes from antral follicles is more rapid than maturing oocyte from 
earlier stages, but oocyte at this stage are less abundant in mammalian ovaries. 
Hence, the ability to grow, mature and fertilise oocytes successfully from the most 
abundant follicle stage in the ovary (primordial follicles) would dramatically increase 
the reproductive potential of mammalian species.
1.2.6 Follicular growth in cattle
Follicle formation in cattle begins during fetal development and occurs over a long 
period of time, so that some follicles are activated and leave the resting pool before 
other follicles have been formed (Fortune et al. 2000). Follicular development in 
cattle is a lengthy process taking around six months from initiation of the growth of 
primordial follicles until development of a preovulatory follicle (Figure 1.3). The 
majority of this time (around four months) is spent in the preantral stages of 
development (Lussier et al. 1987).
1.:.2-6.1.The.pestrus.cxc!e
In the non-pregnant cow, ovulation occurs at approximately 21-day intervals. For a 
short period of time before ovulation, the cow normally exhibits oestrous behaviour 
or sexual receptivity when she will attract and accept the attention of a bull. 
Consequently, there is a close relationship between ovarian and behavioural events, 
ensuring that the female is sexually receptive at the fertile period. The cow is a 
polyoestrous animal; therefore once oestrous cycles are established they continue 
indefinitely unless interrupted by pregnancy (Peters and Ball 1995).
Ovarian follicular growth in cattle occurs in waves, usually involving either two or 
three waves per oestrus cycle (Figure 1.3). These waves are initiated by a rise in 
circulating FSH for 1-2 days. This rise in FSH triggers the start of each new wave, 
before gradually declining again (Adams et al 1992; Ginther et al. 1997). The 
follicular waves are first detectable as a group of 4-5mm follicles on approximately
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days 0 and 10 for two-wave interovulatory intervals, and on approximately days 0, 9 
and 16 for three-wave intervals. Each wave involves the synchronous emergence of 
a cohort of follicles that begin to grow at a similar rate until one follicle becomes 
dominant and the remainder become subordinates. The dominant follicle is identified 
retrospectively as the largest follicle of a wave and may become ovulatory or 
anovulatory (first wave in two-wave cycles and first two waves in three-wave 
cycles). Subordinates regress after a short growing phase. The mechanism by which 
a dominant follicle is selected and continues to grow, while the subordinates regress, 
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Figure 1.3
Bovine follicular growth and oestrus cycle
Follicular development in cattle is a lengthy process with the majority of this time spent in the 
preantral stages of development. Cohorts of follicles are triggered to grow; however, most are destined 
to undergo atresia unless rescued by survival factors. The recruited follicles continue to grow and 
mature to the antral stage where they need to be capable of responding to gonadotrophins (FSH and 
LH). Follicles that can respond to gonadotrophins will be selected to develop further and hence escape 
atresia. Only a few follicles are capable of coping with the decline in FSH levels and subsequently all 
but one follicle, the dominant follicle, will undergo apoptosis. The dominant follicle goes on to be 
ovulated, as it is able to maintain a significantly greater level of growth than the subordinate follicles. 
Two or three waves of follicular development occur sequentially during the bovine oestrus cycle. 
Following repeated cycles of follicle growth and atresia or ovulation, the follicle reserve becomes 




In mammalian species the vast majority of ovarian follicles, ranging between 70- 
99.9%, will be eliminated before reaching ovulation (Erickson 1966). Hence, it is the 
norm for a follicle to die rather than to ovulate. The process by which a follicle is 
eliminated before reaching ovulation is follicle atresia. Ovarian follicular 
degeneration or atresia is a hormonally controlled apoptotic process, whereby 
degenerating follicles are eliminated in a coordinated fashion (Hsueh et al. 1994; 
Kaipia and Hsueh 1997; Markstrom et al. 2002).
Follicles die by the process of apoptosis, which is characterised morphologically by 
detachment of an individual cell from its neighbours, cytoplasmic collapse and cell 
shrinkage (anoikis), condensation of chromatin and its redistribution to the nuclear 
perimeter (pyknosis), and the pinching-off (budding) of small spherical bits of 
plasma (Kaipia and Hsueh 1997; Majno and Joris 1995; Martimbeau and Tilly 1997; 
Tilly et al. 1991; Wyllie et al. 1980). Physiological cell death (programmed cell 
death, apoptosis) differs from that of pathological cell death (necrosis) as it is an 
active process of gene-directed cellular self-destruction (Tilly et al. 1991; Wyllie et 
al. 1980). During apoptotic cell death cleavage of the internucleosomal linker DNA 
of the nucleus into multiples of 185-200 base pairs occurs under the regulated action 
of Ca2+/Mg2+ dependent endonucleases (Martimbeau and Tilly 1997). Under many 
conditions, adenosine triphosphate (ATP) generation is needed for the proper 
execution of physiological cell death, and thus mitochondrial integrity is generally 
preserved until the final moments preceding cellular dissolution (Martimbeau and 
Tilly 1997).
The stimuli that trigger the onset of physiological cell death are varied and include 
both biological (absence or presence of hormones) and pharmacological (irradiation 
or geotoxicants) agents (Eastman 1993). Gonadotrophins (Braw and Tsafriri 1980; 
Chun et al. 1994; 1996; Kaipia and Hsueh 1997; Markstrom et al. 2002), epidermal 
growth factor (EOF) (Tilly et al. 1992), transforming growth factor-cc (TGFoc) (Tilly 
et al. 1992), basic fibroblast growth factor (bFGF) (Tilly et al. 1992), insulin-like 
growth factor-I (IGF-I) (Chun et al. 1994), interleukin-lp (IL-lp) (Chun et al. 1995)
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and oestrogens (Billig et al. 1993) have all been identified as follicle survival factors 
capable of suppressing apoptotic DNA fragmentation. By contrast, androgens (Billig 
et al. 1993), interleukin-6 (IL-6) (Kaipia and Hsueh 1997), tumour necrosis factor-oc 
(TNF-a) (Kaipia et al. 1996), gonadotrophin-releasing hormone (GnRH) (Billig et 
al. 1994) and free radicals (Tilly and Tilly 1995) are potential apoptosis inducing 
factors.
The regulation of follicular atresia is stage-specific (Markstrom et al. 2002). 
Preantral follicles, although known to be responsive to gonadotrophins, are able to 
grow to the antral stage without gonadotrophin support (Hirshfield 199la). However, 
in culture preantral follicles have been found to undergo spontaneous apoptosis 
indicating their dependence on survival signals (Kaipia and Hsueh 1997). Therefore, 
it is likely that intraovarian regulation is of greater importance at this stage of follicle 
growth. Follicle cell apoptosis occurs at all stages of follicle development, but the 
antral transition is the 'bottleneck' for developing follicles (Kaipia and Hsueh 1997). 
At this stage, exposure to FSH seems to be required for their escape from atresia and 
development to the ovulatory stage, while other factors such as IGF-I and IL-lp have 
a less pronounced rescuing effect (Hsueh et al. 1994; Kaipia and Hsueh 1997).
1.4 In vivo studies
In vivo studies using ovariectomy (removal of one or both ovaries) and 
hypophysectomy (removal of the pituitary gland) techniques have been useful for 
identifying the function of gonadotrophins (Chiras and Greenwald 1978a; 1978b; 
Dufour et al 1979; Nakano et al. 1975). In addition, the use of ultrasound to track 
follicles has proved to be helpful in clarifying the changes in follicle diameter, timing 
and number of waves per cycle (Adams et al. 1994; Savio et al. 1988; Sirois and 
Fortune 1988). However, in vivo techniques are limiting as they fail to allow 
individual follicle morphology and health to be analysed; furthermore, it can be hard 
to see true effects due to the presence of so many factors. Follicular steroidogenesis 
involves numerous enzymes, and a change in the activity of any one may affect 
precursor supply to another. In addition, many trophic hormones (hormones 
influencing the activity of endocrine glands and growth) and paracrine factors
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influence steroid synthesis, which in turn further increases the difficulty in 
deciphering the actions of specific hormones.
1.5 In vitro studies
Culture systems provide a well-controlled environment for physiological studies of 
individual follicles as well as thin cortical strips containing mostly primordial 
follicles. Systems using serum-free culture medium are preferred as they reduce the 
numerous undefined components found in serum, which is essential for revealing the 
function of specific factor(s). These methods allow us to analyse somatic cell and 
oocyte development and function. They can also provide an insight into how the 
oocyte interacts with the somatic cells, as these interactions are critical for normal 
development of the oocyte and follicle unit. Techniques for the culture of ovaries 
have been described now for almost 70 years. Early in vitro techniques used the 
culture of whole ovaries (Martinovitch 1938), but whilst this type of culture 
preserves normal tissue interactions, it is severely limited in that long-term 
maintenance of organ explants is difficult. While it is possible to maintain the 
cortical regions of the ovary to some extent, the inner medulla region is subject to 
anoxia, depletion of nutrients and accumulation of metabolites leading to necrosis 
(Thomas et al. 2003b). Due to these limitations and because of the time required for 
full follicular development (especially in larger species), the culture of adult ovaries 
is not seen as a viable way to grow and mature oocytes from immature follicles 
(Eppig and Schroeder 1989; Schroeder and Eppig 1989). Over the past decade, 
several culture systems have been developed that can produce large numbers of 
developmentally competent oocytes from immature murine follicles. Eppig and 
O'Brien (1996; 2003) successfully showed that complete development of mouse 
oocytes in vitro from the primordial follicle stage through to the birth of live young is 
possible. This amazing achievement depended on a two-step procedure involving 
organ culture for the follicles to begin growing, followed by the isolation of the 
growing follicles because organ culture could not sustain full development. By 
comparison, for domestic animals and humans, the technology is still far from 
successful due to a variety of reasons including difficulty of follicle isolation, longer 
period required for follicular growth, and in the case of humans, difficultly in
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obtaining a sufficient amount of quality material (containing high numbers of 
follicles).
1.5.1 Primordial follicle culture
Primordial follicles represent the most abundant population of oocytes in the ovary at 
any age (Gosden and Telfer 1987a). The isolation of primordial follicles for culture 
can be achieved by proteolytic enzyme digestion of ovaries (Greenwald and Moor 
1989). However, enzymatic techniques lead to degeneration of the basement 
membrane, which can result in detachment of granulosa cells and denudation of the 
oocyte (Telfer et al. 1999). When follicle integrity is lost, so is the developmental 
potential of the follicle (Buccione et al. 1990a); therefore, an alternative method to 
obtain primordial follicles has been to culture small strips of fetal ovarian cortex, as 
these are almost entirely composed of primordial follicles (Braw-Tal and Yossefi 
1997; Fortune et al. 1998). Wandji et al. showed that primordial follicles are capable 
of initiating in cultured bovine (1996) and baboon (1997) ovarian cortical sections. 
Furthermore, in vitro culture of human primordial and primary follicles within slices 
of ovarian tissue has shown follicles initiating, developing to secondary follicles and 
occasionally to early antral follicles (Hovatta et al. 1997; 1999; Louhio et al. 2000; 
Wright et al. 1999). However, complete development of oocytes from the primordial 
stage has only been achieved in the mouse (Eppig and O'Brien 1996; O'Brien et al. 
2003). Initially, this involved organ culture, and once the follicles had begun to grow 
they were isolated for subsequent follicle culture and in vitro oocyte maturation 
(IVM).
1.5.2 Preantral follicle culture
Several methods for isolating preantral follicles from ovaries (Cortvrindt and Smitz 
2001; Smitz and Cortvrindt 2002) have been developed: these include tissue 
degradation by the use of proteolytic enzymes or collagenase (less damaging to cell 
membranes) (Eppig and Schroeder 1989; Grob 1964; Roy and Greenwald 1985; 
1996; Telfer and Watson 2000; Torrance et al. 1989) and manual isolation (Abir et 
al. 1997; McCaffery et al 2000; Nayudu and Osborn 1992; Ralph et al 1995). 
Enzymatic dissociation procedures can produce high yields of follicles in a shorter
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time compared to manual dissection techniques, but manual dissection maintains 
follicle integrity as an intact theca layer and basement membrane are retained. The 
viability of rodent culture systems has been demonstrated by the production of live 
offspring from in vitro grown oocyte-granulosa cell complexes (OGC) from mouse 
preantral follicles (Eppig and Schroeder 1989), the culture of whole preantral 
follicles (Spears et al. 1994), and the two-step procedure of primordial follicle 
initiation, subsequent follicle isolation and IVM (Eppig and O'Brien 1996; O'Brien et 
al. 2003).
Unfortunately, the isolation and culture techniques from rodent species cannot be 
readily applied to small bovine follicles due to ovaries from cows being less densely 
packed with follicles and of a more fibrous nature. They also have a protracted 
period of follicular growth, and as the follicles increase in size problems of nutrient 
restriction and insufficient gas and waste exchange arise (Thomas et al. 2003b). 
Furthermore, problems of limited technology, the long generation interval of cattle, 
and the fundamental lack of knowledge of early stages of follicular development are 
major obstacles, which have meant that in vitro maturation has had little success. 
However, progress has been made in developing techniques that have so far managed 
to produce the in vitro development of ovine (Cecconi et al 1999; Thomas et al 
2002) and bovine (Gutierrez et al. 2000; Hulshof et al. 1995; Itoh et al. 2002; 
McCaffery et al. 2000; Ralph et al. 1995; Saha et al. 2000) preantral follicles, with 
some developing to the antral stage. Although no oocytes from bovine or ovine in 
vitro grown preantral follicles have been successfully fertilised, porcine follicles 
have been shown to develop to the antral stage in vitro, produce oocytes capable of 
resuming meiosis (Hirao et al. 1994) and then undergo fertilisation and embryonic 
development (Wu et al 2001). These studies have established a framework for 
similar methods to be applied in human and other domestic species. Both mechanical 
(Abir et al. 1997) and enzymatic (Roy and Treacy 1993; Roy and Terada 1999) 
isolation techniques have been applied to human preantral follicles. Unfortunately, 
long-term culture of these follicles has met with little success. Late preantral follicles 
have been maintained in culture for a period of a few weeks, but maintaining a 
healthy oocyte has proved to be problematic (Abir et al 1997).
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1.5.3 Antral follicle culture
Bovine early antral follicles (0.5-0.7mm) cultured for 16 days in serum-free media 
have been shown to maintain their three-dimensional structures and have 
morphologically normal oocytes (Senbon and Miyano 2002). However, due to their 
large size and problems with accumulation of waste products in the culture media, 
the culture of antral follicles is disappointing. Furthermore, compared to preantral 
follicles they are much less abundant in number and also have a high possibility of 
being developmentally compromised at the time of dissection. Therefore, at this 
stage of development, instead of culturing the whole follicle, work has focused 
around the removal of the oocyte-granulosa cell complex (OGC) from antral follicles 
for subsequent oocyte maturation in vitro.
1.5.4 Oocvte culture
It is clear that throughout follicular growth the interaction of the oocyte with its 
somatic cells is fundamental to providing the germ cell with nutrients and growth 
regulators that are crucial for normal development (Eppig 199la; 2001; Hunter et al. 
1976). The ability to mimic the full period of growth of a follicle is an ambitious 
task, so the creation of a culture environment that supports oocyte-granulosa cell 
interactions would be beneficial; one such technique is in vitro growth (IVG) of 
immature follicles followed by in vitro maturation (IVM) of the oocytes. IVG 
involves the in vitro culture of immature follicles to a time when the oocyte can be 
collected for subsequent IVM before fertilisation and embryo transfer (Picton 2002; 
Picton et al. 2003). hi rodents, IVG/IVM procedures have produced live young 
(Eppig and Schroeder 1989; Eppig and O'Brien 1996; Roy and Greenwald 1989; 
Spears et al. 1994). However, the use of such techniques in larger mammalian 
species is problematic due to a longer growth phase, larger follicles and the fact that 
if the oocytes are recovered from antral follicles for IVM, they are more likely to be 
developmentally compromised (Telfer et al. 2000). Over the past decade many 
publications using IVM techniques have indicated a variety of factors that could play 
a role in improving in vitro oocyte competence rates (Sirard 2001). These include 
follicle size (Lonergan et al. 1994; Pavlok et al. 1992), ovarian stimulation with FSH 
(Sirard 2001) and culture conditions (Sirard et al. 1998); and with a further
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understanding of how the follicle induces competence, these conditions and follicular 
signals can be attempted to be re-created in vitro. At present, oocytes aspirated from 
the antral follicles of domestic species are more commonly used in studies aimed at 
developing improved culture media and techniques for growing in vitro fertilised 
bovine embryos to the blastocyst stage (Hansel 2003; Lim and Hansel 1996). In 
humans, some live births have resulted from the maturation and fertilisation of 
immature human oocytes (Barnes et al. 1996; Cha et al. 1991; Cha and Chian 1998; 
Jaroudi et al 1999). In an attempt to improve IVM success rates in the future, 
methods and techniques for in vitro growth (IVG) of immature follicles (primordial 
and preantral) from human and domestic species are being developed in an attempt to 
produce large sources of viable oocytes for subsequent IVM procedures (Telfer et al. 
2000).
1.5.5 Benefits and problems associated with different in vitro culture systems 
All systems aim to provide an environment which sustains follicular growth. Rodents 
are excellent models for pioneering technologies as the time period for full follicle 
growth is short in comparison to domestic species and humans. However, 
intermediate species are required to test the feasibility for human application. Serum 
can be added to cultures as it provides a rich environment for in vitro follicular 
development. However, it introduces many unknown elements to the system 
therefore; serum-free systems are preferred.
Cortical strip cultures allow us to look at the initiation of follicle growth (Braw-Tal 
and Yossefi 1997; Derrar et al. 2000; Fortune et al. 1998; Wandji et al. 1996), as 
primordial follicles, which are hard to isolate on there own, have better survival rates 
when cultured within cortical strips as follicle integrity is not lost (Greenwald and 
Moor 1989; Telfer et al. 1999). To isolate primordial follicles from the adult sheep 
and cow ovary, a prolonged incubation of several hours is necessary because of the 
fibrous nature of the ovary. This method leads to a great deal of cellular damage and 
is therefore not suitable for isolating follicles for culture (Telfer et al. 1999). Small 
isolated of pieces of ovarian cortex have high densities of primordial follicles and are 
hence a more productive way to culture primordial follicles. This culture system also
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allows us to study follicle interactions, as paracrine interactions are maintained 
however, this system is not well defined as each strip is heterogeneous as it is 
influenced by follicles at different stages of development present throughout the 
strip; it is difficult to track an individual follicles growth and can only be used for 
follicles at early stages of development.
Culture of isolated follicle provides an environment whereby addition of factors can 
be controlled and their action on follicle growth and health can be studied. 
Furthermore, particular developmental characteristics can be related to subsequent 
reproductive performance of the gamete, thereby defining normal follicular 
development more accurately (Thomas et al. 2003b). Individual follicle culture 
provides a well controlled environment where a single follicle can be tracked. 
Follicles can be isolated by the use of enzymes (Eppig and Schroeder 1989; Grob 
1964; Roy and Greenwald 1985; 1996; Telfer and Watson 2000; Torrance et al. 
1989) or by mechanical isolation with needles (Abir et al. 1997; McCaffery et al. 
2000; Nayudu and Osborn 1992; Ralph et al. 1995). Enzymes allow large numbers of 
follicle to be isolated in a short period of time but, there are problems with enzymes 
causing degradation of the basement membrane. Microdissection, on the other hand, 
maintains the three-dimensional structure of the follicles but is very time consuming 
(Thomas et al. 2003b). Oocyte-granulosa cell complexes (OGC) can be isolated from 
preantral follicles by the use of enzymes to provide an important tool for the study of 
oocyte development as well as for analysis of follicular development and function. In 
mouse follicles, degradation of the theca cell layer and the basement membrane by 
collagenase results in OGC, and these have been cultured to produce oocytes that 
have grown and acquired developmental competence (Eppig and Schroeder 1989). 
This system appears to be the best for producing oocytes but it lacks other 
components of the follicle such as theca and antral cavity, however, the viability of 
the rodent system using whole mouse follicles has been demonstrated by the 
production of live young (Spears et al. 1994).
The use of manual dissection to retrieve individual follicles maintains a theca layer 
and an intact basement membrane therefore, follicle integrity is maintained, which is
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important for the examination of interfollicular effects and steroidogenesis. This 
system maintains the three-dimensional organization of cells, and the interactions of 
the various follicular cell types which is critical for normal cellular development 
however, follicle-follicle interactions are lost and in large species (such as cattle and 
humans) when follicles reach a large size there can be problems of insufficient waste 
and gas exchange.
The culture of oocyte-cumulus complexes (OCC) from antral follicles allows later 
stages of oocyte development to be studied (Picton 2002; Fair et al. 2002) when in 
vitro culture of the whole follicular unit is prohibited due to problems with 
accumulation of waste products in the culture media. Large numbers of OCC can be 
easily and cheaply attained by the aspiration of antral follicles. The in vitro culture of 
OCC allows investigation of factors influencing oocyte maturation and fertilisation, 
bearing in the mind that the three-dimensional structure of the follicular unit is lost 
and oocytes aspirated from antral follicles may already be developmentally 
compromised (Telfer et al. 1999).
1.6 Oestrogen biosynthesis
Oestrogens are well-known endocrine and intrafollicular autocrine mitogenic 
compounds (Tonetta and diZerega 1989). In mammals, these steroids are generally 
synthesised in granulosa cells of antral follicles, but in sows and women this also 
occurs in the theca cells (Van den Hurk et al. 1997). Oestradiol synergises with FSH 
to enhance granulosa cell proliferation and antrum formation in large preantral 
follicles in the rat (Tonetta and diZerega 1989) and pigs (Hirao et al. 1994). By 
contrast, however, oestradiol does not affect the proliferative activity of bovine 
granulosa cells, but it has been shown to enhance their size in cultured bovine 
primary and small secondary follicles (Hulshof 1995).
In monovular species, the preovulatory follicle is responsible for inducing oestrus 
and the ovulatory LH surge, which it does by increasing the secretion of the steroid 
oestradiol (Silva and Price 2000). Thus the ability for a follicle to synthesise 
oestradiol is essential for a normal, healthy follicle to develop. The main oestrogens
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produced in the ovary are oestradiol 17(3 and oestrone. Oestradiol is produced by an 
interaction between the steroidogenic granulosa and theca cells under the regulation 
of FSH and LH. Oestrogen biosynthesis is achieved by a two-cell, two- 
gonadotrophin mechanism, with granulosa cells being the major site of conversion of 
androgens to oestrogens (Hillier et al. 1994) (Figure 1.4). To provide the granulosa 
cells with androstenedione [the preferred substrate in cattle (Silva and Price 2000)] - 
which is then converted to oestrogen - acetate and cholesterol are converted to 
androgens within the vascularised theca cells by the rate limiting enzyme cytochrome 
P450 17alpha-hydroxylase (P450ci 7) (Hillier et al. 1994; Sasano et al. 1989). This 
conversion is regulated and greatly stimulated by LH (Erickson et al. 1985).
Granulosa cells are incapable of producing androgens. However, when the avascular 
mural granulosa cells are provided with exogenous androgens produced by the theca 
cells they readily aromatise them to oestrogens under the stimulation of FSH. This 
process involves the conversion of androstenedione into oestrone by cytochrome 
P450 aromatase complex (P450arom) (Simpson et al. 1994). Oestrone is then 
converted to oestradiol by the enzyme 17p-hydroxysteroid dehydrogenase (17PHSD) 
(Silva and Price 2000).
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The 2-cell, 2-gonadotrphin mechanism for follicular oestrogen biosynthesis
Androgen synthesis occurs in the theca cells and is regulated by LH. Cholesterol is converted into 
androgens under the regulation of LH. These androgens are then diffused into the granulosa cells, 
where P450arom aromatises them into oestrogens in response to FSH.
Oestrogens stimulate further oestrogen output by binding to receptors in the 
granulosa cells, which are then stimulated to proliferate and also to synthesize yet 
more oestrogen receptors (Hillier et al. 1994). Steroidogenesis has been shown to be 
enhanced by other factors such as insulin and insulin-like growth factor-I (IGF-I) 
(Bergh et al. 1991; Campbell et al. 1998; Cara and Rosenfield 1988; Spicer et al. 
1993; Stewart et al. 1995; Zhao et al. 1998), either working alone or in synergy with 
gonadotrophins. The production of oestradiol increases as the follicle develops, 
which means large antral follicles secrete much greater amounts of oestradiol than 
small antral follicles (Smith et al. 1996). Therefore, measuring the amount of 
oestradiol being secreted can give a good estimation of the oestrogenic capability of 
a follicle and can indicate if the follicle is healthy. A decrease in oestradiol synthesis 
is one of the early signs of follicle atresia (Guilbault et al. 1993). Peak follicular
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oestradiol concentrations are generally obtained during the growth phase of the 
dominant follicle, and then oestradiol concentrations decrease considerably as the 
follicle reaches its maximum diameter (Badinga et al. 1992; Price et al. 1995).
1.7 Endocrine control
The anterior pituitary gland is known to secrete the protein hormones follicle 
stimulating hormone (FSH) and luteinising hormone (LH), both of which have a 
critical influence on the reproductive system. The synthesis and secretion of both 
FSH and LH is controlled by gonadotrophin releasing hormone (GnRH), which is a 
member of a large family of peptides and is produced in the hypothalamus (Austin 
and Short 1972). FSH and LH are involved in endocrine control of follicle 
development, mainly by regulating the expression of the P450 steroidogenic enzymes 
necessary for ovarian steroidogenesis (Hillier et al. 1994). FSH is the key hormone 
stimulating the emergence of waves of follicles, and its decline is associated with the 
selection of a dominant follicle, which then becomes dependent on LH for its final 
fate when concentrations of FSH are minimal (Roche 1996). The early stages of 
follicle growth can occur in the absence of gonadotrophins (Dufour et al. 1979); 
however, the later stages of preantral and early antral development are primarily 
regulated by gonadotrophins. FSH is an essential survival hormone for the 
prevention of atresia of antral follicles (Chun et al. 1996; Hirshfield 1991a; Hsueh et 
al. 1994). It is vital for the formation of the antral cavity (Nayudu and Osborn 1992) 
in mouse ovarian follicles cultured in vitro and is also involved in the proliferation 
and differentiation of granulosa cells (rodent: Roy and Greenwald 1989; Tonetta and 
diZerega 1989; cattle: Hulshof et al. 1995; Ralph et al. 1995; pig: Hirao et al. 1994; 
Morbeck et al. 1993; sheep: Newton et al. 1999; human: Roy and Treacy 1993) and 
in the maturation of the oocyte prior to ovulation (Durinzi et al. 1997; Eppig and 
Schroeder 1989; Gilchrist et al. 1997; Guler et al 2000; Schramm and Bavister 
1994).
Although early follicle development has been shown to occur independently of 
gonadotrophins (Dufour et al. 1979), the presence of FSH binding sites/receptors in 
granulosa cells of humans (Zheng et al. 1996), cattle (Wandji et al. 1992), sheep
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(Eckery et al. 1997) and rats (Monniaux and de Reviers 1989) supports a 
physiological role for FSH during early stages of follicle growth. Furthermore, recent 
findings have shown FSH can affect the rate of development of preantral follicles in 
mice (Mizunuma et al. 1999), rats (McGee et al. 1997), humans (Wright et al. 1999) 
and sheep (Campbell et al. 2004).
1.8 Intraovarian control
Although follicular development is primarily regulated by gonadotrophins, other 
factors have been shown to alter follicular growth patterns. A range of follicular 
growth factors are now known to be involved in the regulation of follicular growth. 
Factors such as basic fibroblast growth factor (bFGF) (Nilsson et al. 2001) and nerve 
growth factor (NGF) (Dissen et al. 2001) have been associated with inducing 
primordial follicle development and activating follicle growth, while anti-miillerian 
hormone (AMH) inhibits initiation of primordial follicle growth (Durlinger et al. 
1999; 2002). Leukemia inhibitory factor (LIF) (Nilsson et al. 2002) has also been 
shown to promote the primordial to primary follicle transition, while vascular 
endothelial growth factor (VEGF) (Danforth et al. 2003) and mullerian inhibitory 
substance (MIS) (McGee et al. 2001) have been reported to stimulate preantral 
follicle growth. Yet another factor implemented in modulating early stages of follicle 
development is epidermal growth factor (EGF) (Roy 1993; 1999). 
The transforming growth factor-0 (TGF-0) superfamily comprises a range of 
proteins, including members of the activin-inhibin system, with the potential to act as 
intraovarian regulators (Armstrong and Webb 1997). Activin suppresses androgen 
output by the theca cells but stimulates the granulosa cells to develop aromatising 
capacity. Inhibin, on the other hand, stimulates androgen output and moderates 
aromatising capacity. Local feedback loops may function within individual follicles 
involving a sequential change of inhibins, activins and their binding proteins, which 
ultimately determines the different fates of the selected and unselected follicles that 
develop in the same systemic environment of gonadotrophins and growth hormone 
(Roche 1996). Therefore, the interaction of a complex range of intrafollicular, extra- 
and intraovarian signals determines the ultimate fate of the follicle. It has become 
apparent that the insulin-like growth factor (IGF) system plays a central role in these
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interactions, regulating both the proliferative and steroidogenic responses of thecal 
and granulosa cells to gonadotrophins (Armstrong et al. 1998).
1.9 Regulation by oocyte-specific factors
It is well known that granulosa cells can regulate oocyte meiosis by direct transfer of 
meiosis-arresting signals through gap junctions (Tsafriri and Charming 1975). 
However, evidence is now rapidly accumulating that oocytes themselves can 
profoundly influence the development and function of a growing follicle. Oocytes 
are now thought to play an essential role in controlling their own development by 
regulating the function of oocyte-associated granulosa cells (Buccione et al. 1990a; 
1990b). Data supporting this view has shown that oocytes promote granulosa cell 
proliferation (Vanderhyden et al. 1990; 1992) and alter steroid production 
(Vanderhyden and Tonary 1995). Furthermore, the oocyte has been found to be 
essential in stimulating hyaluronic acid synthesis by the cumulus granulosa cells 
(Salustri et al. 1990), resulting in the morphological process of cumulus expansion 
(Buccione et al. 1990a; 1990b). This stimulation of hyaluronic acid synthesis is 
brought about by the production of the oocyte-secreted enabling factor, which is 
thought to be made up of one or more oocyte-secreted paracrine factor(s) (Eppig et 
al. 1993; Vanderhyden et al. 1990). The TGF-0 superfamily consists of secreted 
peptide growth factors that are known to be important in a variety of developmental 
events during ovarian follicle development (Knight and Glister 2003). Three 
members of the TGF-0 superfamily are known to be expressed by oocytes: these are 
growth differentiation factor-9 (GDF-9), bone morphogenetic protein-15 [BMP-15 
(also known as GDF-9B)] and bone morphogenetic protein-6 (BMP-6) (Aaltonen et 
al. 1999; Bodensteiner et al. 1999; Elvin et al. 2000; Jaatinen et al. 1999; McGrath et 
al. 1995;McNattyefa/. 2001).
Dong et al. (1996) uncovered the family member of the TGF-P superfamily called 
GDF-9. This oocyte-secreted factor has been found to be obligatory for proper 
follicle growth and fertility in mice. Ovaries from GDF-9-deficient female mice 
demonstrated that primordial and primary one-layer follicles will form; however, 
there is a block in follicular development beyond the primary one-layer follicle stage
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that leads to complete infertility. GDF-9 is now known to be expressed in rodent, 
human (McGrath et al. 1995) and ruminant (Bodensteiner et al. 1999) oocytes, and 
in the porcine oocyte and cumulus cells (Prochazka et al. 2002; 2004). Further in 
vitro studies have so far shown that GDF-9 can promote kit ligand mRNA expression 
(Nilsson and Skinner 2002) and stimulate rat theca cell androgen biosynthesis 
(Solovyeva et al. 2000), as well as promote the growth, development and survival of 
human follicles at early stages of growth (Hreinsson et al. 2002). Furthermore, the 
effects of GDF-9 on mice granulosa cells change with the progression of their 
development (Latham et al. 2004).
In contrast to the effects of GDF-9 gene knockout in mice, the deletion of the BMP- 
15 or -6 gene in mice had little or no effects on follicle development and fertility 
(Solloway et al. 1998). However, a naturally occurring mutation in BMP-15 causes a 
striking effect on the fertility of the Inverdale and Hanna lines of sheep (Galloway et 
al 2000).
Yet another factor known to be expressed in murine and ovine oocytes is the tyrosine 
kinase receptor c-kit, with its ligand (kit ligand) being found in the granulosa cells 
(Motro and Bernstein 1993; Clark et al. 1996; Tisdall et al. 1997). Inhibition of the 
interaction between KL and c-kit prevents the transformation of murine primordial 
follicles to primary follicles (Huang et al. 1993; Yoshida et al. 1997). The interaction 
of this ligand with its receptor also appears to be important after initiation of follicle 
growth, as oocyte growth was found to accelerate in murine preantral follicles when 
cultured in the presence of KL (Packer et al. 1994). Further to the factors discussed 
above, oocytes may secrete many proteins during their development whose 
functions, at the present time, remain unknown (Eppig et al. 2002).
1.10 Insulin-like growth factor system
The insulin-like growth factor (IGF) ligands, IGF-I and IGF-II, were first purified 
and sequenced in 1978 (Rinderknecht and Humbel 1978a; 1978b). Following this 
purification, extensive research has been carried out on these peptides and the other 
constituents of the IGF family. The findings of Adashi et al. (1985), findings were
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published on the role of IGFs as intraovarian regulators of granulosa cell growth and 
function. Since this journal, the accumulation of information on the involvement of 
the IGF system in the ovary has increased rapidly. The structures of the components 
of the IGF family have now been described, and an understanding of the regulation 
and function of these peptides and proteins in the ovary has begun to emerge.
1.10.1 The insulin-like growth factor family
The IGF autocrine/paracrine system is a complex family made up of the IGF peptides 
(IGF-I and IGF-II), specific IGF receptors (type-I and type-II) in their target cells, a 
family of proteins called insulin-like growth factor binding proteins (IGFBP) that 
regulate the availability of the IGFs to their target cells, and IGFBP proteases 
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Figure 1.5
The insulin-like growth factor (IGF) system
The IGF system consists of two IGF ligands I and II, insulin-like growth factor binding proteins 
(IGFBPs) of which there are at least six known, two IGF receptors (type I and type II) and the IGFBP 
proteases. The ligands bind to the receptors to exert an action on the cell. Their bioavailability can be 
regulated by their interaction with the IGFBPs; when an IGF is bound to an IGFBP it cannot exert an 
action. However, the IGF/IGFBP complex can be broken down by the action of proteases that cleave 
the IGFBP and hence release the IGF. Under certain conditions both IGF ligands can interact with the 
insulin receptor to mediate their action.
IGF-I and IGF-II, which are structurally similar to insulin, are two highly 
homologous, low molecular weight hormone peptides that promote cellular mitosis 
and differentiation (Giudice 1992). The IGFs are single chain polypeptides that 
contain three intrachain disulphide bonds. The IGFs are known to be important 
mitogens that affect cell growth and metabolism. As well as endocrine effects
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exerted by circulating IGFs, locally produced IGFs exert paracrine, as well as 
autocrine, effects on cell proliferation (Hammond et al. 1991; Hwa et al. 1999).
The IGFs (IGF-I and -II) facilitate their actions by binding with their specific cell 
surface membrane receptors. Both of them can also, under certain conditions, interact 
with the insulin receptor (Hwa et al. 1999) at lower affinity. IGF-I preferentially 
interacts with IGF-I receptor and the same is also true for IGF-II and the IGF-II 
receptor. The type I IGF receptor has, in most tissues, a higher affinity for IGF-I 
compared to IGF-II, and it binds insulin with moderate affinity (Giudice 1992). The 
type I IGF receptor and the insulin receptor are glycoproteins that are tetramers, 
consisting of two a-subunits and two p-subunits, which are linked by interchain 
disulphide bonds (Ullrich et al. 1986). The a-subunit is extracellular and contains the 
ligand-binding domain, whereas the p-subunit has a hydrophobic domain that 
traverses the cell membrane, contains an ATP binding site and ligand-activated 
tyrosine kinase activity, as well as sites for auto phosphorylation. The type II IGF 
receptor has a high affinity for IGF-II, a lower affinity for IGF-I and does not bind 
insulin. Its structure differs from that of the type I IGF receptor and the insulin 
receptor in that it is a single chain glycoprotein, with ninety percent of its linear 
structure being extracellular (Giudice 1992). The Type II IGF receptor primarily 
binds IGF-II, but also serves as a receptor for mannose-6-phosphate-containing 
ligands (Hwa et al 1999).
In many biological fluids, such as serum, amniotic fluid and other body fluids, the 
IGFs are usually found bound to IGFBPs. The IGFBPs constitute a heterogeneous 
group of at least six distinct proteins (Figure 1.6) capable of binding IGFs with 
affinities in the 10" 10 to 10"9 M range (Adashi 1998; Hwa et al. 1999; Spicer and 
Echtemkamp 1995). IGFBPs are cysteine-rich proteins sharing high similarity in 
their primary amino acid sequence. They have three recognised domains: the 
conserved N-terminal domain, the highly variable mid-region, and the conserved C- 
terminal. The N- and C-terminus have been shown to be necessary for high affinity 
binding of the IGFs, with the loss of the C-terminus significantly reducing the ability 
of the IGFBP to interact with IGFs. There are two distinct classes of IGF binding
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proteins: these consist of the low-affinity (IGFBP related proteins and IGFBP 
proteolytic fragments) and the high affinity IGF binders (IGFBPs 1-6) (Hwa et al. 
1999). A number of factors have been identified in regulating IGFBP serum levels, 
including nutritional status. (Zapf et al. 1989), peptide hormones, proteases and 
chronological age (Donahue et al. 1990).
1.10.2 Action of IGF and IGFBPs in the ovary
Components of the IGF system have been identified as being expressed and 
regulated in ovaries of many mammalian species; this strongly supports a central role 
for the IGF system in ovarian follicular development. Furthermore, IGFs affect 
biosynthetic processes in granulosa and theca cells and have an influence on mitotic 
activity in the granulosa cells (Giudice 1992; Poretsky et al. 1999). The IGF system 
plays a key role in ovarian function: an absolute requirement for IGF-I has been 
highlighted in experiments using IGF-I knock-out mice that were sterile (Baker et al. 
1996). Igfl null mice have impaired granulosa cell proliferation and follicular growth 
(Kadakia et al. 2001). IGF-I has been shown to have a role in both proliferation and 
differentiation of cattle (Spicer et al 1993; Stewart et al. 1995), sheep (Campbell et 
al. 1998; Monniaux and Pisselet 1992), pig (Kolodziejczyk et al. 2003) and human 
(Bergh et al. 1991; Zhao et al. 1998) granulosa and theca cells in vitro. In the early 
stages of follicle growth, IGF-I has been found to act as a survival factor (Louhio et 
al. 2000; Wandji et al. 1998) and to stimulate follicular growth (Gutierrez et al. 
2000; Itoh et al. 2002). IGF-I is important in the antral stages of follicle 
development, where it is involved in the regulation of follicle growth, stimulation of 
somatic cell proliferation and oestrogen, as well as progesterone biosynthesis 
(Armstrong and Webb 1997; Monniaux and Pisselet 1992; Spicer et al. 1993). 
Nuclear maturation in the oocytes of cattle (Lorenzo et al. 1994) and pigs (Sirotkin et 
al. 2000) has been shown to be enhanced by IGF-I; however, addition of IGF-I was 
not found to improve nuclear or cytoplasmic maturation of sheep oocytes (Guler et 
al. 2000).
It has been shown that IGFBPs can act to modulate IGF actions in both a positive 
and negative manner. IGFBPs have higher affinities for IGFs than do the IGF-I and
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-II receptors (Jones and Clemmons 1995); therefore, IGF bioavailability can be 
regulated by the IGFBPs sequestering extracellular IGFs and hence reduce the 
number of 'free' IGFs available for specific cell surface receptors. This in turn 
inhibits any mitogenic actions of the IGFs (Jones and Clemmons 1995). Varying 
binding proteins can regulate IGF actions differently, while the same binding protein 
can have an IGF-inhibiting or potentiating role under different conditions (Andress 
and Birnbaum 1992; De Mellow and Baxter 1988; Jones et al. 1993). IGFBPs have 
also been noted to potentiate IGF action. Circulating IGFBPs are believed to prolong 
the half-life of the attached IGFs by protecting them from degradation, while also 
acting as a reservoir (Binoux and Hossenlopp 1988; Blum et al. 1989) to aid 
transportation and a controlled delivery of IGFs to a specific cell of tissue (Giudice 
1992; Jones and Clemmons 1995). IGFBPs can interact with ECM and somatic cell 
membranes by attaching themselves to them. This mechanism acts to regulate both 
IGF and IGFBP action as the maintenance and remodelling of the ECM regulates 
both binding and release of growth factors from the ECM storage sites. Binding of 
IGFBPs to the ECM and cell surface molecules depends on specific amino acids 
motifs within the primary structure of IGFBPs. For example IGFBP-2 contains the 
integrin recognition sequence RGD (arginine-glycine-aspartic acid), hence it can 
bind to integrins on the plasma membranes of granulosa and theca cells (Armstrong 
and Webb 1997). Moreover, it has been suggested that IGFBPs themselves can exert 
specific cellular effects independently of IGFs and their receptors (Wright et al. 
2002).
At certain developmental stages of follicle growth, the relative ratio of IGFs to 
IGFBPs will vary to allow cell-specific growth promoting effects of the IGFs. A 
mechanism by which facilitation of IGF can be increased is through the activity of 
specific IGFBP proteases that degrade the IGF/IGFBP complex (Rajaram et al. 
1997). IGFBP fragments generated by the action of proteases show a marked loss of 
IGF binding (Collett-Solberg and Cohen 1996). Proteolysis of IGFBPs was first 
observed in serum from pregnant women, where it was demonstrated that IGFBP-3 
was proteolytically cleaved to yield a predominant 29-3 OkDa form that was still 
capable of binding IGFs, but with reduced affinity (Giudice et al. 1990; Hossenlopp
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et al. 1990). Indeed, proteolysis of IGFBPs has been detected in follicular fluid from 
ewes (Besnard et al. 1996b), cattle (Spicer et al. 2001), mares (Bridges et al. 2002), 
pigs (Besnard et al. 1997) and humans (Mason et al. 1996). The degree of proteolytic 
degradation differs between various follicular compartments and stages of follicle 
growth.
Regulation of IGFs by the IGFBPs appears to be crucial, especially in early follicle 
growth. This was highlighted when high concentrations of IGF-I were made 
available to bovine follicles and found to have a detrimental effect on primordial 
follicle health (Yang and Fortune 2002) and preantral oocyte health in vitro 
(McCaffery et al. 2000) and in vivo (Armstrong et al. 2001). It appears, therefore, 
that the IGF system plays a vital role in modulating ovarian follicular development 
and steroidogenesis. During early follicle growth, evidence suggests that IGF-I does 
not have an important role to play in either granulosa proliferation or as an enhancer 
of oocyte growth (McCaffery et al. 2000; Armstrong et al. 2001). Levels of IGFBPs 
have been found to be high at this stage and therefore limit the access of IGF-I to its 
specific cell surface receptor. On the other hand, during the later stages of follicle 
growth levels of IGFBPs fall, thus allowing IGF-I to exert its action (Monget and 
Bondy 2000). These results imply that regulation of IGF-I is dependent on the 
developmental stage of the follicle, and that immature follicles have a mechanism 
whereby high levels of IGFBPs protect them from circulating IGFs.
1.10.3 IGF system in ruminants
The expression of mRNA encoding IGF-II in thecal tissue of bovine ovarian follicles 
(Figure 1.6) has been detected (Armstrong and Webb 1997) and a similar spatial 
distribution has been described in sheep (Perks et al. 1995). The expression of 
niRNA encoding IGF-I in ruminants remains controversial. Leeuwenberg et al. 
(1995) detected IGF-I mRNA in ovine granulosal and thecal tissue, and Yuan et al. 
(1998) detected IGF-I mRNA in bovine granulosal cells. By contrast, Perks et al. 
(1995) failed to detect the expression of mRNA encoding IGF-I in ovine follicles. 
Similarly, Armstrong et al. (1998; 2000) failed to detect expression of IGF-I mRNA 
in bovine follicles (Figure 1.6). In the cow it has been shown that IGF-II is the
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principal intrafollicular IGF ligand (Armstrong et al. 2000). IGF-II mRNA is 
expressed in theca cells of bovine follicles at around the time of antrum formation 
(Armstrong et al. 2000), which coincides with the time that theca cells acquire LH 
receptors. Since IGF-I has been shown to increase LH receptor number in bovine 
theca cells (Stewart et al. 1995), it is hypothesised that in vivo, IGF-II takes the place 
of IGF-I and regulates the timing of onset of LH receptor expression in theca cells 
via an autocrine mechanism (Armstrong et al. 2000).
The two major binding proteins produced by the developing bovine follicle, which 
regulate the bioavailability of locally produced IGF-II, are IGFBP-2 and IGFBP-4. 
Expression of mRNAs encoding IGFBP-2 to -5 have been found in bovine follicles 
(Figure 1.6) and expression of IGFBP-2, -4 and -5 in ovine follicles (Armstrong and 
Webb 1997; Armstrong et al. 1998; 2002; Besnard et al. 1996a). IGFBP-2 mRNA 
has been located in granulosa cells from small and medium-sized healthy antral 
follicles (l-8mm in diameter). In comparison to these follicles, the proportion of 
larger healthy (>8mm) antral follicles expressing IGFBP-2 mRNA in their granulosa 
cells was significantly less. IGFBP-4 mRNA expression has been shown to be 
restricted to thecal cells of healthy antral follicles, with no difference in expression 
between small, medium and large follicles (Armstrong et al. 1998). In sheep, the 
expression of mRNA encoding IGFBP-4 and -2 is also restricted to theca and 


































mRNA expression of the components of the IGF family in developing bovine follicles
Schematic representation of the temporal changes in the expression of mRNA encoding components 
of the IGF system during bovine follicular development (Armstrong et al. 2000; 2002; Nuttinck et al. 
2004; Roberts and Echternkamp 2003; Webb et al. 1999; Yuan et al 1998). IGFr represents type I 
IGF receptor, O - oocyte, CG = cumulus granulosa cells, G = granulosa cells and T = theca cells. 
IGF-I* expression remains controversial, with reports both demonstrating its presence (Yuan et al. 
1998) and absence (Armstrong et al. 2000). There is limited data on the expression of type II IGF 
receptor and insulin receptor in the bovine ovary. Type II IGF receptor mRNA and protein has been 
localised within granulosa and theca cells of human antral follicles (el Roeiy et al. 1993; el Roeiy et 
al. 1994); and ovine granulosa cells of atretic follicles and in theca cells of healthy ovine follicles 
(Teissier et al. 1994). Type II IGF receptors have been found to be present in bovine corpora lutea 
membrane, however, a fuller investigation into the expression of type II IGF receptors in cattle awaits 
further study. Insulin receptors are widely distributed throughout ovarian compartments in many 
animal models and humans (Poretsky et al. 1999; Spicer and Echternkamp 1995), and recent 
preliminary unpublished data has shown the expression of insulin receptor mRNA in the oocyte and 
granulosa cells of bovine antral follicles (Armstrong D.G. laboratory, Roslin).
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The decrease in IGFBP-2 concentration in follicular fluid in cows (Armstrong et al. 
1998) and sheep (Besnard et al. 1996a) during late follicular growth was shown to be 
due to a loss of expression of mRNA encoding IGFBP-2 in granulosal cells in 
dominant follicles. Using serum-free bovine granulosa cell cultures, it has been 
shown that FSH can inhibit the expression of mRNA encoding IGFBP-2 (Armstrong 
et al. 1998). Therefore, it appears that a key step in follicular dominance is the FSH- 
dependent inhibition of the expression of mRNA encoding IGFBP-2 in granulosa 
cells. This in turn would increase the available 'free' IGF and hence increase FSH 
responsiveness of the granulosa cells. In contrast to the expression of mRNA 
encoding IGFBP-2 in granulosa cells, the expression of mRNA encoding IGFBP-4 in 
thecal tissue does not change during follicular growth (Armstrong et al. 1998; 
Besnard et al. 1996a). In this case, the decrease in IGFBP-4 concentration in 
follicular fluid during the development of dominance is due to a corresponding 
increase in the activity of a specific IGFBP-4 protease (Besnard et al. 1996a).
The primary regulators of follicular development are the gonadotrophins which act 
through endocrine mechanisms to control follicle growth. However, to account for 
the observations that follicles have different fates even when exposed to the same 
gonadotrophin environment, the concept of infra-ovarian regulation has been 
developed and is now recognised as a major mechanism regulating follicle 
development. A limiting factor to realising the full potential of many new 
reproductive technologies (for example IVF and embryo transfer) is the lack of 
fertile oocytes. The intraovarian IGF system has been highlighted as a key 
mechanism involved in regulating oocyte/follicle development. Furthermore, the 
importance of this system has been highlighted by it's link with the large offspring 
syndrome which has been observed in bovine offspring following transfer of cloned 
embryos (Lazzari et al. 2002; Niemann and Wrenzycki 2000). IGF-II and IGF type II 
receptor are imprinted genes that play important roles in preimplantation 
development and IGF-II expression in bovine cloned embryos has been found to be 
significantly increased. In nuclear transferred embryos incomplete reprogramming of 
the donor cell nucleus leads to the abnormal expression of developmentally 
important genes. However, it is not known whether deviations from the normal
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developmental pattern persist throughout fetal development. By investigating IGFs 
functions, bioavailability and expression patterns throughout follicle growth a more 
comprehensive description of the components of the IGF system required at various 
follicle developmental stages will be provided. The role of IGFBP-2 in early stages 
of follicular development is unknown however it is hypothesised that it could create 
a barrier for the interaction of IGFs with its receptor on the surface of the oocyte and 
granulosa cells. IGFs derived from adjacent antral follicles or from the circulation 
could then bind to IGFBP-2 in the ECM surrounding granulosa cells of immature 
follicles where it would act as an extracellular store of IGFs. The growth factor could 
then be accessed by the oocyte and/or its associated granulosa cells when required. 
The signal to release IGF from the IGF/IGFBP complex would most likely be a 
specific IGFBP-protease (produced either by the granulosa cells and/or oocyte). This 
therefore provides a putative mechanism whereby the oocyte can regulate its own 
exposure, as well as the surrounding granulosa cells, to IGFs and thus control its own 
development as well as the early stages of granulosa cell proliferation and 
differentiation. Therefore, the hypothesis behind this work was that the regulation of 
IGFBP-2 is a major factor controlling early follicle and oocyte development.
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1.11 Aims of research
The overall aims of the research detailed in this thesis were:
1. To investigate the effects of IGF-I on early bovine oocyte and somatic cell 
development and health using a defined serum-free culture system.
2. To analyse temporal and spatial differences in the expression of IGFBPs at 
different stages of follicle development, as a mechanism to regulating IGF 
bioavailability.
3. To identify the proteolytic activity of different bovine follicular 
compartments.
A limiting factor in many reproductive methods is the shortage of fertilisable 
oocytes. As discussed earlier, superovulation is a process that can increase the 
number of oocytes, but the response within and between animals is very variable. 
Methods for in vitro maturation (FVM) of oocytes from antral follicles have been 
developed, but the success rate is low: in a recent study, less than 5% of cow oocytes 
matured in vitro, and developed beyond the 8-cell embryo stage (Chohan and Hunter 
2004). This may be because the oocytes are coming from antral follicles that might 
already be undergoing atresia. It therefore makes sense to grow less developed 
follicles in vitro to a stage where the oocyte can be harvested for subsequent in vitro 
fertilisation (TVF). If we wish reproductive technologies to improve in the near 
future, it is clearly important to continue research using in vitro culture systems as a 
way of gaining a fuller understanding of the regulatory mechanisms governing 
follicular development.
The work documented below set out to investigate the effects of insulin-like growth 
factor-I (IGF-I) on early bovine oocyte and somatic cell development using an in 
vitro serum-free culture system. Chapters 3 and 4 focused on efforts to identify 
changes in the response and health of a growing follicle at different stages of 
development in the presence or absence of IGF-I, thereby providing a fuller 
understanding of the importance of IGF actions throughout early follicular 
development. The health of follicles was assessed by the measurement of oestradiol
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secretion, the degree of pyknosis occurring in the granulosa cells, and analysis of 
oocyte health.
IGF-I bioavailability, and hence actions, are known to be regulated by their 
interactions with IGFBPs. Chapter 5 details work aimed at exploring the effects of 
IGF-I on controlling the expression of IGFBP-2 in maturing follicles. Finally, the 
proteolytic activity of different components of the bovine follicle were investigated 
in Chapter 6 in an attempt to elucidate proteases capable of degrading the 
IGF/IGFBP-2 complex. In Chapter 7 the results of this thesis are summarised and 







2.1 Bovine ovary collection
Bovine ovaries (Figure 2.2, a) obtained from animals <33 months old, from random 
stages of the oestrous cycle were obtained from an abattoir and transported to the 
laboratory. During transit they were maintained at 25-30°C in Ml99 (HEPES 
buffered) medium (GIBCO BRL, Life Technologies Ltd., Paisley, UK), 
supplemented with sodium pyruvate (2mM), glutamine (2mM), Fraction V BSA (cell 
culture tested) (3mg/ml), penicillin G (75(j,g/ml) and streptomycin (SO^ig/ml) (all 
chemicals from Sigma Chemicals, Poole, UK unless otherwise stated). Upon arrival 
at the laboratory, the ovaries were placed under a laminar flow hood, rinsed in 70% 
alcohol and kept warm (37°C) in an incubator.
2.2 Cortical strip and follicle isolation
2.2.1 Dissection medium
Leibovitz's medium (GIBCO BRL, Life Technologies Ltd., Paisley, UK) was used, 
supplemented with sodium pyruvate (2mM), glutamine (2mM), Fraction V BSA 
(3mg/ml), penicillin G (75|ag/ml) and streptomycin (50(ag/ml). Dissection medium 
was heated to 37°C before use. Leibovitz's medium is buffered by phosphates and 
free amino acids and maintains a stable balance at room temperature and protects 
cells from stresses caused by physiological gases present in air.
2.2.2 Isolation of cortical strips from the bovine ovary
Underneath a laminar flow hood, thin transverse slices of ovarian cortex were taken 
using a scalpel (Figure 2.1 and Figure 2.2, b); slices were 1mm wide and 5mm long. 
Slices for subsequent culture were placed in dissection medium and maintained at 
37°C in an incubator prior to culture. Day 0 sections were fixed overnight in either 
Bouin's solution (70% v/v picric acid, 25% v/v formaldehyde, 5% v/v glacial acetic 
acid) or 4% paraformaldehyde (4% v/v paraformaldehyde in dH2O, 0.1M NaOH, 
0.1M Na phosphate pH 7, 4°C) solutions, before being transferred to 70% alcohol for 
a minimum of 24 hours.
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2.2.3 Isolation of early antral follicles
Underneath a laminar flow hood, fine slices (~lmm wide) of ovarian cortex were 
taken using a scalpel and placed in dissection medium and maintained at 37°C. Early 
antral follicles were isolated from the cortical slices under a dissecting microscope 
(Olympus, UK) fitted with a calibrated eyepiece graticule (Graticules Ltd, Kent, UK) 
using 25 G needles (VWR International Ltd., Leics, UK) attached to syringe barrels. 
Approximately 50 follicles were isolated on each dissection day (approximately 2 
follicle/ovary). Follicles of a normal shape, with an intact basement membrane and 
no obvious signs of degeneration, were selected for culture (Figure 2.1). The time 
taken for collection of ovaries from the abattoir to the start of the culture period was 
a maximum of six hours.
2.3 Cortical strip and follicle culture
2.3.1 Culture medium
The serum-free culture system used was originally developed to induce 
differentiation of granulosa and theca cells (Campbell et al. 1996; Gutierrez et al. 
1997) and was subsequently adapted for the culture of bovine preantral follicles 
(Gutierrez et al. 2000; McCaffery et al. 2000; Thomas et al. 2001). McCoy's 5a 
medium with bicarbonate and HEPES (20mM) was used, supplemented with 
Fraction V BSA (0.1%), L-glutamine (3mM), penicillin (lOOIU/ml), streptomycin 
(O.lmg/ml), transferrin (2.5jig/ml), selenium (4ng/ml), androstenedione (10"7 M), 
insulin (lOng/ml) and L-ascorbic acid sodium salt (50pg/ml), all of which were 
obtained from Sigma Chemicals, Poole, UK. Both bicarbonate and HEPES buffer 
systems were used as bicarbonate maintained the most stable balance in the presence 
of 5% CO2 . However, due to the manipulation of the cultures (changing of culture 
medium and measurement of follicles) occurring every day or every second day 
HEPES was present, as it maintains a stable physiological balance at a range of 
temperatures and protects cells from stresses caused by physiological gases present 
in air. Bovine Serum Albumin is commonly used in culture media for nutrient 
transport and also functions to detoxify cell culture by binding to toxic compounds 
and protects the cells from shear forces in agitated cultures. L-glutamine acting as an
45
Chapter 2
energy source and a precursor for DNA and protein synthesis, penicillin and 
streptomycin inhibiting bacterial growth, transferrin which is essential for iron 
transport, selenium which is important in the production of antioxidant enzymes that 
help prevent cellular damage from free radicals, androstenedione as a substrate for 
oestradiol production, insulin which is essential for long term cell growth in culture 
by involvement in stimulation of cell proliferation and cell growth and L-ascorbic 
acid sodium salt acting as an antioxidant (Thomas et al. 2001) were all present in the 
culture medium.
2.3.2 Cortical strip culture
Cortical strips were individually cultured in 4- or 24-well (flat bottomed) plates 
(Nalge Nunc International, Hereford, UK, and Corning Inc., NY, respectively) in 
SOOul of culture medium. Control groups were cultured in culture medium alone, 
while treatment groups were cultured in culture medium supplemented with the 
desired treatments (see the materials and methods of individual experiments). Plates 
were incubated for 3 or 6 days in a sterile humidified air atmosphere with 5% CO2 at 
37°C. Two culture time frames were used as previous work had indicated that the 
presence of IGF-I may have a detrimental effect on primordial initiation (Yang and 
Fortune 2002). Cultures were set up to firstly identify if the presence of IGF-I did 
have a negative effect on primordial activation or early growth and secondly if this 
were the case could the follicles be rescued after 3 or 6 days of culture by the 
removal of IGF-I or addition of another factor. Half of the culture medium was 
replaced, every day, and this conditioned medium was stored at -80°C.
2.3.3 Follicle culture
Follicles were cultured individually in 96-well (V-shaped bottom) plates (Coming 
Inc., NY) in 250|il of culture medium (Figure 2.1). Control groups were cultured in 
culture medium alone, while treatment groups were cultured in culture medium 
supplemented with the desired treatments. Plates were incubated for 2, 4 or 6 days 
(see the materials and methods of individual experiments) in a sterile humidified air 
atmosphere with 5% CC>2 at 37°C. Initially, a 4 day culture was set up to investigate 
if the antral follicles could be maintained with out bursting or undergoing atresia.
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Subsequent cultures were set up for 6 days as follicles appeared to be able to be 
maintained in the culture system successfully for this time frame. In Chapter 5 
follicles were cultured for 2, 4 or 6 days to investigate if the expression of IGFBP-2 
was effected by day and tfeatment with IGF-I. Half of the culture medium was 
replaced every day or every second day (see the materials and methods of individual 
experiments), and this conditioned medium was stored at -80°C. On the same day 
that half of the culture media was replaced with fresh culture medium, follicle 
diameters were measured using a crossed micrometer (basement membrane to 
basement membrane) under the dissection microscope.
Bovine ovary
Cortical strips containing 
immature follicles
Follicles isolated from 
cortical strips by needles 





Follicles selected for 
culture
Figure 2.1
Isolation and culture of bovine follicles
1'i'saa*




2.4 Collection of follicular fluid, mural granulosa cells, oocyte-cumulus 
complexes and denuded oocytes
Bovine ovaries from random stages of the oestrous cycle were obtained from an 
abattoir and transported to «the laboratory (described in 2.1). Upon arrival at the 
laboratory, the ovaries were placed under a laminar flow hood, rinsed in 70% alcohol 
and kept warm (37°C) in an incubator. For each ovary, all visible antral follicles (> 
3mm in diameter) were aspirated using a syringe connected to a 25 G needle (VWR 
International Ltd., Leics, UK). Follicular fluid was pooled in 15ml test tubes, left to 
settle and then the top two-thirds of the follicular fluid was removed and stored at 
-80°C. The remainder was diluted with dissection medium (see 2.2.1 for method) 
before being analysed under a microscope. Oocyte-cumulus complexes (OCCs) 
(Figure 2.2, c) and mural granulosa cells were picked out of the aspirate using a fine 
glass pipette.
To acquire denuded oocytes (Figure 2.2, d), all oocytes were removed from the 
aspirate using a fine glass pipette and then exposed to hyaluronidase (300IU/ml) for 





Representation of a bovine ovary, follicles and oocytes
Representation of a bovine ovary (a), thin bovine ovarian cortical strip containing follicles (b), 





At the end of the culture period, cortical strips or follicles were fixed in either 
Bouin's solution (70% v/v picric acid, 25% v/v formaldehyde, 5% v/v glacial acetic 
acid) or 4% paraformaldehyde (4% v/v paraformaldehyde in dH2O, 0.1M NaOH, 
0.1M Na phosphate pH 7, 4°C) and dehydrated in ethanol. Material only being used 
for haematoxylin and eosin staining was fixed in Bouin's solution, whereas material 
going on for immunocytochemistry or in situ hybridisation was fixed in 4% 
paraformaldehyde solution. Paraformaldehyde was used as a fixative for material 
going on for immunocytochemistry or in situ hybridisation because unlike Bouins, 
the protein cross-links formed can be easily removed by citrate buffer, as this sodium 
citrate solution is designed to break the protein cross-links, therefore easily 
unmasking the antigens within the tissue sections, and this enhancing staining 
intensity of antibodies. Material was fixed for a minimum of 5 hours before being 
placed in 70% ethanol for at least 24 hours. All concentrations of ethanol used for 
processing of follicles had a small amount of eosin (VWR International Ltd, Leics, 
UK) added to aid visualisation of the follicles during processing.
2.5.2 Processing of tissue for microscopic examination
2:.5,2.1.Processing.of samples
Material for histological assessment was dehydrated by a series of changes achieved 
through increasing ethanol concentrations. Absolute alcohol ethanol was replaced 
with cedar wood oil (VWR International Ltd., Leics, UK) for a minimum of 24 
hours. The oil was then cleared from the cortical strips or follicles with toluene (in a 
fume hood) for 30 minutes. Cortical strips or follicles were embedded in paraffin 
wax (VWR International Ltd., Leics, UK) at 60°C, with changes every hour for 4 




The samples were sectioned at 6pm with a microtome (Leica Microsystems, Milton 
Keynes, UK). The sections were then floated out in a water bath at 42°C and 
mounted on Superfrost plus microscope slides (VWR International Ltd., Leics, UK). 
Slides were left to dry overnight at 37°C, before either staining with haematoxylin 
and eosin or being used for immunocytochemistry or in situ hybridisation.
Haematoxylin stains the nucleus purple and eosin stains the cytoplasm pink. Firstly, 
sections are dewaxed in xylene for 15 minutes and taken down through a series of 
ethanol concentrations (absolute to 70% v/v). The staining procedure was as follows 
(for reagent preparations see Dury and Wellington 1976). Bouin's fixative was 
removed from sections by dipping slides in 70% ethanol with lithium carbonate. 
Slides were rinsed in tap water and placed in haematoxylin (5 minutes), rinsed in 
water again and placed in Scott's tap water substitute. Sections were rinsed in tap 
water and placed in Eosin (2minutes, 1 : 1 solution), dipped in tap water and placed in 
potassium alum (VWR International Ltd., Leics, UK) (3 minutes), and rinsed again 
in tap water. The sections were dehydrated through a series of ethanol concentrations 
and placed in xylene. The sections were mounted using DPX mounting medium 
(VWR International Ltd., Leics, UK) and a glass cover slip.
.2:5.2.4. Histojogica! .assessment
Histological measurements and observations were made under the light microscope 
with a crossed micrometer (Graticules Ltd., Kent, UK). The section containing the 
oocyte nucleolus - or if this was absent, the largest cross-section of the oocyte - was 
used for observations and measurements. Oocyte health was analysed according to 
the following criteria: '0' indicating an absent or severely misshapen oocyte with no 
germinal vesicle and obviously degenerate; ' 1 ' indicating a misshapen oocyte; and 
'2' indicating a morphologically normal oocyte with an intact germinal vesicle 
(McCaffery et al. 2000) (Figure 2.3, b and d). Follicles with oocytes graded as 0 or 1 
were grouped together and termed degenerate oocytes. The number of degenerate 
oocytes was then expressed as a percentage of the total oocytes. Oocyte and follicle
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diameters were measured and the oocyte: follicle ratios calculated. Counting the 
number of pyknotic and non-pyknotic granulosa cells present, and then expressing 
them as a mean percentage of pyknotic granulosa cells for each treatment group, 





Histological sections representing healthy and atretic follicles
a = a follicle with a healthy oocyte and granulosa cells, as well as an antrum; b = a healthy oocyte; c - 




2.6.1 Detection of IGFBP-2 immunoreactivity in bovine follicles 
See materials and methods fpr Chapter 5.
2.6.2 Detection of androgen receptor immunoreactivitv in bovine follicles 
See materials and methods for Chapter 3.
2.7 Detection of IGFBP-2 by in situ hybridisation
See materials and methods for Chapter 5.
2.8 Measurement of oestradiol in culture medium using a delayed 
enhancement lanthanide fluorometric immunoassay (DELFIA)
At the end of the culture period, all the conditioned culture medium which had been 
collected every day or every second day (see the material and methods of individual 
experiments) was taken to Roslin Institute were detection of oestradiol by the 
DELFIA procedure as previously described by Thomas et al. (2003 a) was performed 
by Charis Hogg, Karen Troup and Elaine McCullough. Medium from the three 
treatment groups in all size ranges of follicles was analysed for oestradiol content. 
Oestradiol was biotinylated by standard procedures using l?p-oestradiol-3-(O- 
carboxy) methylether and EZ-Link biotin hydrazise (Pierce Warriner UK Ltd). Nunc- 
Immuno Maxisorp 96-well plates were coated with donkey anti-sheep serum by 
incubating overnight at 4°C in the presence of donkey anti-sheep serum (250p.g/ml) 
made up in bicarbonate buffer pH 9.6 (lOOjal/well). The primary antibody was raised 
in sheep against 17f3-oestradiol 6-(o-carboxymethy)-oxime: BSA (Webb et al. 1985). 
Biotinylated oestradiol, follicle conditioned medium, oestradiol standards and a 
1:50,000 dilution of primary antibody, made up in 200jal of assay buffer, were added 
to pre-coated wells of the microtitre plate. The assay buffer consisted of Tris buffer 
(50mmol/l; pH 7.8) supplemented with sodium chloride (150mmol/l), bovine gamma 
globulin (1%, w/v), Tween-20 (0.01%; v/v), thimerosal (0.0008%; w/v) and 
diethylenetriamine-penta-acetic acid (O.lmoles/1). After incubating the plates 
overnight at 4 °C, they were washed (4x) in a wash buffer consisting of Tris buffer
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(50mmol/l; pH 7.8) supplemented with sodium chloride (150mmol/l), Tween-20 
(0.01%; v/v) and thimerosal (0.0008%; w/v), before adding 100|j,l of assay buffer 
containing lOOng/ml europium labelled streptavidin (Perkin-Elmer Life Sciences, 
UK), followed by incubation at room temperature for 1 hour with shaking. The plates 
were washed (4x) in wash buffer before addition of 200^1 of DELFIA enhancement 
solution (Perkin-Elmer Life Sciences) to each well of the microtitre plate, and 
incubated for a further 5 minutes with shaking at room temperature. The plates were 
analysed on a Victor 2 Multilabel Counter (Perkin-Elmer Life Sciences) by time 
resolved fluorimetry. The emission and excitation wavelengths were 615nm and 
340nm respectively, with a time delay of 400(as. The inter- and intra-assay 
coefficients of variation were 13.2 and 9.6% respectively. The minimum detectable 
level was 8.5pg oestradiol per 250jj,l.
2.9 Analysis of IGFBP-2 proteolytic degradation in conditioned media
Immunoblotting and western ligand blotting protocols were adapted from the 
procedures previously described by Monget et al. (2003). To optimise conditions a 
series of electrophoresis of proteins and blotting procedures were carried out using 
the NuPAGE Novex Pre-Cast Gel System (Invitrogen Ltd., Paisley, UK). Initially 
reducing conditions were used which meant that the disulphide bonds within IGFBP- 
2 would be broken down into subunits. However, problems occurred with detection 
of the protein so non-reducing conditions were used as only nonconvalent 
interactions are destroyed using this technique, thus the protein is linearises but the 
basic structure is maintained. Samples were run on gels with various gradients to 
optimise separation of proteins and resolution of the protein bands. Problems with 
excessive background, hence low visualisation of protein bands, were alleviated by 
the use of a range of blocking agents.
2.9.1 Immunoblotting
Recombinant bovine IGFBP-2 (31 kDa) (Ing/ml) (GroPep Limited, Adelaide, 
Australia) and oocyte-cumulus complexes (2.5 oocytes/jal), denuded oocytes (2.5 
oocytes/jj,l), granulosa cells, bovine follicular fluid (positive control), intact IGFBP-2 
alone (negative control) or concentrated conditioned media (see section 6.2.4) (final
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volume lO^il) were incubated for 20 hours at 37°C, in a sterile humidified air 
atmosphere with 5% CC^. 2.5 oocytes/^1 were used as initial studies using 1 
oocyte/jul fail to cleavage IGFBP-2 hence to account for the possibility of a dilution 
effect occurring the concentration of oocytes/nl was increased. The final volume 
used was lOjjl, so 25 oocytes were added. SeeBlue Plus2 Pre-stained Standard 
marker was run to allow easy visualisation of protein molecular weight ranges during 
electrophoresis and evaluation of western transfer efficiency (Invitrogen Ltd., 
Paisley, UK).
Samples were submitted to electrophoresis on a 12% NuPAGE Bis-Trs SDS- 
polyacrylamide gel with NuPAGE MOPS running buffer, under nonreducing 
conditions at 200V for 50 minutes. The gel was then washed in NuPAGE transfer 
buffer for 30 minutes (all NuPAGE items obtained from Invitrogen Ltd., Paisley, 
UK). The proteins were then electrotransferred onto nitrocellulose membranes 
(Hybond ECL, 0.2jj,m pore size) (Amersham Biosciences UK Ltd, Bucks, UK) using 
30V for 1 hour. Nitrocellulose membranes were treated for 2 hours at room 
temperature with TBS (20mM Tris and 137mM NaCl, pH 7.6) containing 10% non- 
fat dry milk (NFDM) and 0.2% Tween-20 to saturate non-specific sites. Thereafter, 
membranes were incubated for 1 hour at 37°C in TBS containing 5% (NFDM), 
0.05% Tween-20, and antibodies against IGFBP-2 (rabbit anti-bovine IGFBP-2 
antiserum, Upstate Biotechnology Incorporated, Lake Placid, NY) (dilution 1/2000) 
(Sigma Chemicals, Poole, UK). Once washed in TBS containing 1% (NFDM) and 
0.2% Tween-20, nitrocellulose filters were incubated for 1 hour at 37°C with a goat 
anti-rabbit IgG antibody coupled with horseradish peroxidase (dilution 1/5000) 
(Sigma Chemicals, Poole, UK). After washing, the signal was revealed by 
chemiluminescence detection (Figure 2.4).
2.9.2 Western ligand blotting
After electrophoresis and electrotransfer of proteins as described in 2.9.1, 
nitrocellulose filters were washed for 2 hours with PBS (1.3M NaCl, 0.07M 
Na2HPO4, 0.03M NaH2PO4 lOx solution diluted tolx before use, pH 7.4) containing 
10% (w/v) BSA and 0.2% (v/v) Tween-20 to saturate non-specific sites. Thereafter,
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membranes were incubated overnight at 4°C in PBS containing 5% (w/v) BSA, 
0.05% (v/v) Tween-20, and biotinylated IGF-II (dilution 1/1250) (IGF-II, Sigma 
Chemicals, Poole, UK and Biotin Protein Labelling Kit, Roche Diagnostics Ltd., 
Lewes, UK). Afterwards, membranes were washed with PBS containing 1% (w/v) 
BSA and 0.2% (v/v) Tween-20 and incubated for 1 hour with extravidin peroxidase 
(Sigma Chemicals, Poole, UK) in PBS containing 0.2% (v/v) Tween-20 (dilution 
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The Effect of IGF-I Either Alone or
Interacting With Androstenedione




3.1 Dosage effect of IGF-I on primordial follicle activation and the early 
development of bovine follicles
3.1.1 Introduction
Despite advances in the understanding of the mechanisms involved in different 
stages of follicle development, the factors regulating initiation and early follicle 
growth remain only partially elucidated. It is generally accepted that primordial 
follicles do not proliferate after birth, so when the follicle pool is exhausted the 
female is considered to be infertile. Therefore, the correct order and completion of 
events that occur during the transition from primordial to primary follicle stages is 
crucial to maintaining female fertility. The primary regulators of follicle growth and 
development have been shown to be the gonadotrophins, FSH and LH; however, the 
early stages of development are gonadotrophin-independent (Awotwi et al. 1984; 
Gong et al. 1996). Therefore, other factors must be responsible for controlling 
follicle growth initiation.
A great deal of discussion has centred on whether initiation is regulated by a release 
from the effects of inhibitory factors or by a stimulatory signal. A variety of factors 
have been implicated in the activation of primordial follicles such as kit ligand (KL) 
(Parrott and Skinner 1999), basic fibroblast growth factor (bFGF) (Nilsson et al. 
2001), bone morphogenetic protein-4 (BMP-4) (Nilsson and Skinner 2003), leukemia 
inhibitory factor (LIF) (Nilsson et al. 2002), insulin (Kezele et al. 2002b) and nerve 
growth factor (NGF) (Dissen et al. 2001). The tyrosine kinase receptor c-kit and its 
ligand, kit ligand, have been localised to oocytes and granulosa cells respectively 
(Motro and Bernstein 1993). KL has been shown to promote initiation and 
progression of follicle development in the rat ovary, as inhibition of KL actions by a 
c-kit antibody (ACK-2) was shown to completely block primordial follicle 
development (Parrott and Skinner 1999). In a similar manner bFGF, BMP-4 and LIF 
were also demonstrated to induce primordial follicle development, while neutralising 
antibodies reduced the proportion of spontaneous developing primordial follicles. 
Furthermore, it was shown that LIF may also interact with KL to increase the 
primordial to primary follicle transition (Nilsson et al. 2001; 2002; Nilsson and
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Skinner 2003). NGF"7' mice have a reduction in the number of primary follicles 
present in their ovaries compared to wild-type ovaries (Dissen et al. 2001). It has 
been suggested that NGF may be important for the initial differentiation of the 
flattened pre-granulosa cells of primordial follicles into the enlarged, cuboidal shape 
that characterises these cells in primary follicles. If this is the case, then NGF is 
crucial during the time period immediately preceding the initiation of follicular 
growth (Dissen et al. 2001). Vascular endothelial growth factor (VEGF), which is a 
key regulator in angiogenesis in the ovary and known to be produced by theca and/or 
granulosa cells, has been shown to significantly stimulate the number of primary and 
secondary follicles in a dose-dependent manner, suggesting an increase in the 
number of primordial follicles being recruited from the primordial pool into the 
growing phase (Danforth et al. 2003). Furthermore, growth differentiating factor-9 
(GDF-9), which is a member of the TGF-P superfamily, has been shown in humans 
(Hreinsson et al 2002), but not other species (Nilsson and Skinner 2002), to 
significantly increase the proportion of primordial follicles initiating growth in 
culture (Hreinsson et al. 2002). Conversely, anti-Mullerian hormone (AMH) [also 
known as miillerian inhibitory substance (MIS)] has been shown to have the opposite 
role, functioning as an inhibitory growth factor in the ovary during early stages of 
follicle growth. Examination of AMH-null mice revealed lower numbers of 
primordial follicles and more growing follicles compared with wild-type litter mates 
(Durlinger et al. 1999). In addition, AMH has been shown to inhibit primordial 
follicle initiation, as mouse ovaries cultured in the presence of AMH were found to 
contain 40% fewer growing follicles when compared with control ovaries (Durlinger 
et al. 2002).
Once follicles have been initiated to grow they can respond to varying levels of 
endocrine, paracrine and autocrine factors. It is well established that gonadotrophins 
(FSH and LH) are not required for the development of preantral follicles but are 
essential for the progression to the antral stages (Awotwi et al. 1984; Gong et al. 
1996). Nevertheless, work has provided evidence that gonadotrophins can affect the 
rate of development of preantral follicles in mice (Mizunuma et al. 1999), rats 
(McGee et al. 1997), humans (Wright et al. 1999) and sheep (Campbell et al. 2004).
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Therefore, although FSH is not essential, under optimum conditions for follicle 
growth it may be beneficial. As early follicular development can be induced in the 
absence of FSH, it is now widely accepted that intraovarian factors are the main 
regulators during these early stages. Activin, an intraovarian factor produced from 
secondary follicles, has been shown to inhibit early follicle growth by causing small 
preantral follicles to remain in a dormant state until a time when activin levels 
decline (Mizunuma et al. 1999). Interestingly, the effect of activin A has been found 
to be developmentally dependent with it having a stimulatory effect on preantral 
follicles from immature mice, yet no effect on follicle growth in preantral follicles 
from adult mice (Yokota et al. 1997). On the other hand, there are many factors that 
have been confirmed as having a stimulatory effect on early and preantral follicle 
development. GDF-9 is an oocyte-derived factor that is important for further follicle 
development and in rat ovaries the progression of early primary (stage 1) follicles to 
stage 2 primary follicles (Nilsson and Skinner 2002). Furthermore, GDF-9 has been 
shown to stimulate preantral follicle growth in mice (Hayashi et al. 1999), and 
improve human follicle viability and promote progression of early follicles to the 
secondary stage (Hreinsson et al. 2002). Recently, VEGF has been found to stimulate 
preantral follicle growth in a time- and dose-dependent manner (Danforth et al. 
2003). Keratinocyte growth factor (KGF), also known as fibroblast growth factor-7, 
is yet another factor that has been discovered to play a role in early stages of follicle 
development. Treatment of rat preantral follicles with KGF promoted their survival, 
growth and differentiation (McGee et al. 1999). MIS (also known as AMH) has been 
shown to inhibit mouse primordial follicle initiation (Durlinger et al. 2002). 
However, when rat preantral follicles were cultured in the presence of MIS, it was 
found to enhance the effects of FSH both on follicle diameter and cell number 
(McGee et al. 2001). Interestingly, MIS was not found to have an effect on preantral 
follicle cell differentiation (McGee et al. 2001).
The extracellular matrix (ECM) exerts stringent control over cell differentiation, 
either by inducing specific signals via integrins or by modifying cell responsiveness 
to growth factors and hormones (Giancotti 1997). Hence, growth factors that are 
ligands that bind to the ECM must interact with components of the ECM; this
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interaction will in turn have an effect on cell growth, differentiation and survival. 
The transition of a mouse follicle from a primary to a multi-layer stage has been 
shown to be enhanced by the interaction of activin A with the ECM component 
laminin, yet suppressed by the interaction of activin A with another ECM 
component, collagen (Oktay et al. 2000).
Insulin-like growth factor-I (IGF-I) knock-out mice exhibit a block in follicle 
development at the early antral stage (Baker et al. 1996) suggesting that IGF-I is 
expendable for primordial initiation and preantral growth. In vitro culture of rat 
ovaries (Kezele et al. 2002b) and bovine cortical strips (Derrar et al. 2000; Yang and 
Fortune 2002) showed that IGF-I did not promote the primordial to primary follicle 
transition, further supporting the view that IGF does not play a stimulatory role in the 
early stages of follicle development. In addition, in the culture system used by Yang 
and Fortune (2002) IGF-I was found to have a dose-dependent negative effect on 
bovine primordial follicle activation and health. However, studies have detected IGF- 
I binding in bovine preantral follicles (Wandji et al. 1992), and identified type I IGF 
receptor in oocytes, granulosa and theca cells as being present from the preantral 
stage in bovine follicles (Armstrong et al. 2002). IGF receptors are also known to be 
present in the oocytes and granulosa cells from the primordial stage, as well as in 
theca cells from the preantral stage in human follicles (Qu et al. 2000). The 
percentage of follicles in the primary stage of development was shown to increase 
when human ovarian cortex was cultured for two weeks in the presence of IGF-I and 
IGF-II (Louhio et al. 2000). Additionally, IGF-I has been found to have a beneficial 
effect on preantral follicle development in rats (Zhao et al. 2001) and cattle 
(Gutierrez et al. 2000; Itoh et al. 2002). Thus, these findings indicate that the IGF 
system is still a potential candidate for regulating follicle initiation and/or early 
follicle growth.
The aim of the following experiment was to investigate the importance of IGF-I in 
regulating follicle initiation and/or early follicle growth in the bovine ovary, by 
culturing bovine ovarian cortical strips in the presence of IGF-I. In addition to just 
investigating the effects of IGF-I during early follicle development, thorough
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analysis was carried out to account for discrepancies often observed when comparing 
different studies on primordial follicle initiation. A problem associated with studying 
follicle activation is that the criteria used to classify follicles to a particular 
developmental stage often vary between studies or are unclear. The values obtained 
can then be analysed by looking at percentage or total numbers, which further add to 
the confusion when comparing between studies. Therefore, in this current study a 
clear method for classification has been set out and the data has been analysed by 
comparing both percentage and total numbers of follicles.
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3.1.2 Materials and methods
3:1^2 : l.CprticiaJ..strip.jsolatipn..and. culture
Cortical strips were isolated from bovine ovaries and cultured individually for 3 or 6
days, as described in Chapter 2.
3..1..2.2 Treatments
Culture medium (control) was prepared as described in 2.3.1, but no androstenedione 
was added to the McCoy's culture medium. Androstenedione was removed from the 
culture medium as studies carried out on ovine preantral follicles had indicated that 
although androstenedione was found to increase follicular differentiation it decreases 
oocyte survival. It was hypothesised that androstenedione present in the culture 
medium may have been over-stimulating the immature follicles and thus causing 
deleterious effects on oocyte development (Thomas et al. 2002). Although IGF-II is 
the principal intrafollicular IGF ligand in cattle (Armstrong et al. 2000), IGF-I was 
used to allow comparison with previous studies and because it has been hypothesis 
that in vivo IGF-II will have similar effects as IGF-I in vitro (Armstrong et al. 2000). 
Human recombinant IGF-I (HR IGF-I), which does bind to IGFBPs, was purchased 
from Sigma Chemicals, Poole, UK. Two doses of HR IGF-I were used, a low dose of 
lOng/ml and a high dose of lOOng/ml. The low dose of lOng/ml represented a 
physiological dose that would be able to bind to the IGFBPs and would therefore be 
regulated by the level of IGFBPs present. The high dose of lOOng/ml, on the other 
hand, would swamp the IGFBPs present, allowing IGF-I to bypass any regulatory 
mechanism of the IGFBPs and hence bind freely to IGF receptors. The analogue 
Long R3 IGF-I (LR3 IGF-I), which does not bind to binding proteins, was purchased 
from Sigma Chemicals, Poole, UK. LR3 IGF-I will, therefore, bypass any IGFBP 




Treatment groups and 'n' numbers were as follows ('n' number values represent the 
number of bovine cortical strips cultured for each treatment group for 3 and 6 day 
cultures respectively):






















Follicles were measured and characterized with reference and modifications to the 
Braw-Tal and Yossefi (1997) and McNatty et al. (1999) classification of small 
bovine and ovine follicles respectively.
Primordial 
(Type 1)
I (all flattened) <40
Transitory 
(Type la*)
1 (one cuboidal) <30
Transitory 
(Type 1 a)





1-2 (all cuboidal) 10-40 <50 40-80 35
Small preantral 
(Type 3)
41-100 <70 81-130 100
Large preantral 
(Type 4)
4-6 101-250 <90 131-250 100
Small antral 
(Type 5)
>6 >250 <90 250-500 100
Table 3.1.2
Classification and characterisation of small bovine follicles
In this classification system for small bovine follicles (Table 3.1.2), the follicles are classified as types 
1-5. Type 1 refers to primordial follicles (oocyte surrounded by flattened granulosa cells); type la* 
refers to transitory follicles (oocyte surrounded by flattened granulosa cells and one cuboidal 
granulosa cell); type la refers to transitory follicles at a later stage of growth than la* follicles (oocyte 
surrounded by a mixture of flattened and cuboidal granulosa cells); type 2 are primary follicles 
(oocyte surrounded by one or two layers of cuboidal granulosa cells); type 3 are known as small 
preantral follicles (three layers of granulosa cells); type 4 are large preantral follicles (four or more 
layers of granulosa cells); and type 5 are small antral follicles (more than five layers of granulosa cells 






Histological representation of bovine follicles at different stages of development
In this classification system for small bovine follicles, the follicles are classified as types 1-5. 
Type 1 = primordial follicle, type la* = transitory follicle, type la = transitory follicle at a later stage 
of growth than la* follicle, type 2 = primary follicle, type 3 = small preantral follicle, 




Cortical strips were fixed in paraformaldehyde, processed for histology and mounted 
on slides at the end of the culture period, as described in Chapter 2. Samples were 
sectioned at 6jjm, and every fifth section was analysed throughout the whole of each 
cortical strip. The total number of follicles present was counted on each section. To 
avoid double counting, only follicles with a visible nucleolus were counted. Follicles 
were classed by their developmental stage (see Table 3.1.2 and Figure 3.1.1), and 
oocyte health [growing (type la* onwards) follicles only] was analysed by grading 
the oocyte of each follicle as unhealthy (a degenerate germinal vesicle and/or 
misshapen oocyte) or healthy (a morphologically normal oocyte with an intact 
germinal vesicle). Primordial oocyte health was not analysed in this current study as 
the culture system caused wholesale activation. Therefore, after culture most strips 
had very few or no primordial follicles left, which meant a valid investigation on the 
effects of IGF-I on primordial oocyte health could not be carried out.
3.1.5 Statistical analysis
The mean percentage of follicles at each stage of development per cortical strip and 
the mean number of follicles per cortical strip for each treatment group were 
calculated for the following developmental stage categories: non-growing (type 1), 
growing (type la* and la) and advanced (type 2 onwards). The data set was 
normally distributed in accordance with the Anderson-Darling test, variances were 
homogeneous and treatment groups were randomly assigned, therefore, a powerful 
parametric test could be used to analysis samples. ANOVA and t-tests were used as 
they are both very robust statistical tests. Mean percentages of follicles per cortical 
strip and the mean number of follicles per cortical strip were compared between 
experimental groups using one-way ANOVA, with subsequent two-sample t-tests to 
allow for individual comparisons between groups.
The difference between treatment groups in the mean percentages of degenerate 
oocytes per cortical strip, within the growing follicles, was compared using one-way 
































Effect of IGF-I on primordial follicle initiation and early follicle development after 33 
days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 3 days of culture.
Values are the mean percentage or number of follicles per cortical strip per treatment group ± SEM
for 4 cultures.
Day 0 = |___| (n=12), Control = _ (n= 6), 5ng/ml LR3 IGF-I = <n=6).
!Ong/mlHRIGF-I = (n=6) and lOOng/ml HR IGF-I =| (n=6).
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In all treatment groups there was a significant decrease in the mean percentage and 
mean number of follicles per cortical strip compared to Day 0, within the non- 
growing developmental stage category (p<0.05) (Figure 3.1.2). However, there was 
no significant difference in the growing population between any of the treatment 
groups. This therefore indicates that the primordial follicles are not growing to the 





















Non-growing Growing Advanced 
Follicle developmental stage
Non-growing Growing Advanced 
Follicle developmental stage
Figure 3.1.3
Effect of IGF-I on primordial follicle initiation and early follicle development after 6> 
days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 6 days of culture.
Values are the mean percentage or number of follicles per cortical strip per treatment group + SEM
for 6 cultures.
I (n=!2), Control =DayO =
lOng/mlHRIGF-I =
<n= 6), 5ng/ml LR3 IGF-I = (n-6),
(n=6) and lOOng/ml HR IGF-I =[ (n=6).
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In all treatment groups there was a significant decrease in the mean percentage 
(p<0.05) and the mean number (p<0.01) of follicles per cortical strip compared to 
Day 0, within the non-growing developmental stage category (Figure 3.1.3). A 
significant difference in the mean number of follicles per cortical strip was found 
between treatment groups in the growing developmental stage category when 
compared using ANOVA (p<0.05) (Figure 3.1.3). However, when subsequent two- 
sample t-tests were carried out (which is a more stringent test than ANOVA) to 
identify individual comparisons between groups, no two groups were significantly 
different with a p value of < 0.05. However, comparisons between Day 0 and LR3 
IGF-I and control and LR3 IGF-I both revealed p values of 0.06. Hence, there was no 
overall significant difference in the mean percentage or mean number of follicles per 
cortical strip between treatment groups in the growing and advanced follicle 
developmental stage categories. This would seem to indicate that primordial follicles 
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Figure 3.1.4
Effect of IGF-I on oocyte health after 3 and 6 days of culture
Oocyte health of follicles in pieces of bovine ovarian cortex after 3 and 6 days of culture. 
Values are the mean percentage of degenerate oocytes per cortical strip per treatment group ± SEM 
for 4 cultures (3 days) and 6 cultures (6 days). Day 0, n=12, Control, n= 6, 5ng/ml LR3 IGF-I, n=6, 
lOng/ml HR IGF-I, n=6 and lOOng/ml HR IGF-I, n=6.
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No significant differences were detected in the mean percentage of oocyte 
degeneration between any of the treatment groups after three days of culture. After 
six days, the level of oocyte degeneration was significantly lower in control and 
lOng/ml HRIGF-I treatment groups, but higher in the presence of 5ng/ml LR3 IGF-I 




Regulation of early follicle development is less well understood than the later stages. 
It has been highlighted that IGF-I is of critical importance during follicular 
development as the follicles oflgfl null mice arrest at the late preantral/early antral 
stage and fail to respond to gonadotrophins (Baker et al. 1996; Zhou et al, 1997). 
This result implies that IGF-I is not required until later stages of follicular 
development. However, the identification of the presence of the type I IGF receptor 
from the preantral stage in bovine follicles (Armstrong et al. 2002) and the 
primordial stages in human follicles (Qu et al. 2000) suggests the possibility of IGF 
playing a role in earlier stages of follicle growth.
The effects of IGFs have been shown to be dependent on the presence or absence of 
IGFBPs (Jones and Clemmons 1995); when an IGF is bound to an IGFBP it is 
inhibited from exerting its actions. Cortical strip cultures were set up to investigate 
the effects of IGF-I on early follicle development over time, and when the 
bioavailability of IGF was and was not regulated by the IGFBPs. This present study 
confirms the results of others studies (Braw-Tal and Yossefi 1997; Derrar et al. 
2000; Wandji et al. 1996), that the culture of bovine cortical slices causes massive 
primordial follicle initiation, as shown by the significant decrease in primordial 
follicles present after culture. Furthermore, it can be seen that the final outcome of 
the present study is not affected by the method of analysis, as both analyses of the 
mean percentage and the mean number of follicles per cortical strip resulted in the 
same conclusions. However, histological examination of the uncultured strips 
showed that the mean percentage (23.5 ± 2.6 %) and mean number (6 ± 1.5) of 
primordial follicles per cortical strip were much lower than those observed in 
previous work on bovine cortical strips, namely 70.1 ± 3.5 % primordial follicles and 
21 ± 5 primordial follicles per section (Derrar et al. 2000; Wandji et al. 1996). This 
discrepancy in values could be due to the fact that material used in the current study 
to look at primordial follicle activation came from mature heifers compared to the 
fetal tissue used in other studies (Derrar et al. 2000; Wandji et al. 1996). A greater 
total number of primordial follicles would be expected to be present in the fetal 
material when compared to the material taken from the ovaries of reproductively
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mature cattle. In addition, in the present study it was observed that unlike in previous 
studies on bovine cortical strips (Derrar et al. 2000; Wandji et al. 1996) no 
significant increase in primary follicles was found after culture. Derrar et al. (2000) 
and Wandji et al. (1996) surprisingly found a dramatic increase in the number of 
primary follicles after only two days of culture. These results show an incredible 
acceleration in follicle growth, as the development of a primordial follicle to the 
early stages of growing in vivo is a protracted process. The failure to detect an 
increase in growing follicles after three and six days of culture in the present study 
suggests that the primordial follicles present were undergoing atresia and therefore 
not developing on to the primary stage. On the other hand, these results may indicate 
that, unlike in the fetal material, not enough follicles were present to allow the 
dramatic increase in follicles reaching the primary developmental stage to be seen. 
Thus, if primordial follicle numbers are truly as low as observed in the data presented 
here then these results may imply that the primordial follicle supply could run out 
sooner than expected and so support the notion that follicular renewal may occur in 
the postnatal mammalian ovary (Johnson et al. 2004).
Previous work has shown that when human ovarian cortex was cultured in medium 
supplemented with IGFs there was an increase in the percentage of follicles in the 
primary stage (Louhio et al. 2000). To date, bovine primordial follicles have not 
been shown to have functional receptors for IGF-I, so it is not known whether they 
can react to this factor (Armstrong et al. 2002; Wandji et al. 1992). Furthermore, no 
positive effects of IGF have been shown on activation or development of activated 
follicles in cultured bovine cortical pieces (Derrar et al. 2000; Kezele et al. 2002b; 
Yang and Fortune 2002). Results from this current study are in agreement with these 
findings as no significant increase in follicle initiation or progression to more 
advanced stages of follicle development were observed in any of the treatment 
groups in both the three and six day cultures. The results further support the view 
that IGF-I is not essential until later in development (Baker et al. 1996), and that 
IGF-I has differential effects on follicle development that are dependent on the 
developmental stage of the growing follicle. In addition, unlike the experiments 
carried out by Yang and Fortune (2002) the present study failed to observe the
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negative effects of IGF-I found on primordial follicle activation. However, the failure 
to see any effect of IGF-I could be due again to the fact that previous studies (Derrar 
et al. 2000; Yang and Fortune 2002) used fetal material while in the present study 
cortical strips were taken from reproductively mature heifers. The total number of 
primordial follicles present may therefore not have been adequate for a true effect to 
be seen.
Results from recent work reveal that IGF-I had a dose-dependent negative effect on 
follicle growth and health, with the addition of IGF-I antibody ameliorating these 
harmful effects (Yang and Fortune 2002). By contrast, the morphological health of 
primordial, primary and secondary follicles was not compromised, but was also not 
improved by the presence of IGF-I in studies carried out by Derrar at el. (2000). 
Primordial oocyte health was not analysed in this current study as the culture system 
caused wholesale activation. Therefore, after culture most strips had very few or no 
primordial follicles left, which meant a valid investigation on the effects of IGF-I on 
primordial oocyte health could not be carried out. After three days of culture, the 
oocyte health of growing follicles was not altered by the addition of IGF-I to the 
culture medium when compared to follicles cultured in the absence of IGF-I. 
However, after six days of culture the addition of IGF-I in a non-regulated manner 
(either in the form of 5ng/ml LR3 IGF-I or lOOng/ml HR IGF-I) was found to have a 
deleterious effect on oocyte health. From this we can infer that, as is the case for 
bovine preantral follicles (McCaffery et al. 2000), over exposure of the oocytes to 
IGF-I during very early stages of bovine follicle development is detrimental to 
further in vitro follicle development.
In conclusion, the present data found no effects of IGF-I on primordial follicle 
initiation or activated follicle growth. IGF-I that was not regulated by IGFBPs 
(5ng/ml LR3 IGF-I and lOOng/ml HR IGF-I) was found to have a negative effect on 
the oocyte health of follicles cultured for six days. This suggests that during the early 
stages of follicle development the regulation of the bioavailability of IGF is crucial to 
maintain the health of the oocyte. The fact that IGF-I and IGF-II have been shown to 
play a role in stimulating the progression of early stages of human follicular
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development highlights the importance of identifying species-specific differences in 
the regulation of follicle growth that can be used to develop and improve existing in 
vitro culture systems. Furthermore, it is now clear that the intraovarian mechanisms 
involved in regulating follieular grow are multi-factorial with different factors 
exerting effects both alone and in interaction with other factors. BMP-15 has been 
shown to increase mRNA levels of KL in a dose-dependent manner (Thomas et al. 
2004). Furthermore, the interaction between BMP-15 and KL has been found to play 
a role in regulating granulosa cell mitosis in mice (Otsuka and Shimasaki 2002). 
Hence, further work into not only the role of intraovarian factors alone but also how 
these factors interact with one another is needed to broaden our understanding of the 
pivotal roles of these factors during early follicle development.
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3.2 The effect of the interaction between IGF-I and androgen on 
primordial follicle initiation and early follicle development, and 
detection of androgen receptor immunoreactivity in the bovine ovary
3.2.1 Introduction
The first visible signs of primordial follicle activation and early growth are the 
transformation of granulosa cells from a flattened appearance to a cuboidal shape. 
The primary follicle is made up of an oocyte surrounded by a single layer of cuboidal 
granulosa cells. During this stage the granulosa cells begin to proliferate and form 
multiple layers around the oocyte, thus increasing the follicle diameter. The factors 
involved in follicle initiation and early growth are still unclear. Therefore, if we are 
going to be able to grow follicles in vitro from this very early period of development 
to a stage where the oocyte can be matured, then it is vital that we understand more 
fully the processes involved in follicle activation and early growth.
Follicles must be able to respond to endocrine and paracrine signals throughout 
follicle growth in order to be able to further develop and avoid undergoing atresia. 
Follicular atresia is hormonally controlled apoptosis, which can be stimulated or 
inhibited by various factors (Kaipia and Hsueh 1997). Follicle-stimulating hormone 
(FSH) (Chun et al. 1996; Markstrom et al. 2002) and oestrogen (Billig et al 1993) 
are two factors that have been shown to aid developing follicles in escaping atresia. 
FSH's major role is to increase oestrogen biosynthesis by elevating aromatase 
expression in granulosa cells (Kaipia and Hsueh 1997). Oestrogen is produced by the 
conversion of the steroidogenic precursor, androgen, into oestrogen by the enzyme 
P450arom (Figure 1.4) (Hillier and Tetsuka 1997). Hence, androgens are essential 
during the later stages of development, and their availability can have an indirect 
effect in follicle development. Androgens can also have a direct action via androgen 
receptors (AR). Receptors for androgen have been detected in follicles from mice 
(Cheng et al. 2002), rats (Hirai et al 1994; Szoltys and Slomczynska 2000; Szoltys 
et al. 2003; Tetsuka et al. 1995; Tetsuka and Hillier 1996), pigs (Cardenas and Pope 
2002; Garrett and Guthrie 1996; Slomczynska et al 2001), cattle (Hampton et al. 
2004) humans (Saunders et al. 2000) and primates (Duffy et al 1999; Hild-Petito et
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al. 1991; Hillier et al. 1997; Saunders et al. 2000; Weil et al. 1998). Intense AR 
immuno staining has been found in porcine granulosa cell nuclei of preantral and 
antral follicles, with only weak staining on the nuclei of oocytes and theca cells 
(Cardenas and Pope 2002). In the rat (Tetsuka and Hillier 1996) and primate (Hillier 
et al. 1997; Weil et al. 1998) ovary, AR is also predominantly expressed in granulosa 
cells, with expression being highest in preantral/early antral follicles and gradually 
decreasing as the follicles mature (Tetsuka and Hillier 1997). In the primate ovary, 
AR mRNA is expressed in theca interna and stromal cells, and in granulosa cells to a 
lesser degree (Weil et al. 1999). Specific androgen binding sites have been 
characterised within ovine ovarian follicles and a direct correlation between the level 
of AR expression and follicle diameter has been established. However, a role has not 
yet been elucidated (Campo et al. 1985). AR mRNA expression in the bovine ovary 
was found to be absent in primordial follicles but present in granulosa cells in some 
follicles with 1-1.5 layers of cuboidal granulosa cells, and present in all follicles with 
more than 2 layers of granulosa cells; its expression appeared to increase during early 
follicle development (Hampton et al. 2004).
Studies on the effect of androgens on follicular development have produced 
conflicting results, with some showing androgens stimulating development while 
others indicate inhibitory effects. Treatment of rats with androgen was shown to 
inhibit ovarian follicular development and function (Farookhi 1985), and increase 
apoptosis in the granulosa cells of early antral and preantral follicles. Similarly, 
mouse preantral follicles cultured in the presence of androstenedione were also 
observed to have a significant inhibition in follicular and oestradiol production 
(Almahbobi et al. 1995). Furthermore, androgen was shown to antagonise the anti- 
apoptotic effects of oestrogen (Billig et al. 1993). On the other hand, androgen has 
been shown to stimulate primate primordial follicle development (Vendola et al. 
1999b), to enhance follicular growth and development in mouse antral follicles 
(Murray et al. 1998), and to promote follicular growth and survival of preantral and 
small antral follicles in the primate ovary (Vendola et al. 1998).
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It is now clear that a complex system of cell to cell interactions between the oocyte, 
granulosa cells and surrounding stromal tissue are involved in activation, survival 
and early growth and development of the follicle. Furthermore, the expression and 
production of several ovarian growth factors have been implicated during early 
stages. One such factor is IGF-I, which has previously been shown to be influenced 
directly by androgens. Androgen treatment was found to promote primordial follicle 
initiation and to also result in a 3-fold increase in IGF-I mRNA and 5-fold increase in 
IGF-I receptor mRNA in primate primordial follicle oocytes (Vendola et al. 1999b). 
Similarly, a 3-4-fold increase in IGF-I mRNA in antral follicle granulosa, theca and 
interstitial compartments was induced by the culture of primate ovaries with 
androgens. IGF-I receptor mRNA significantly increased in theca cells, but less so in 
granulosa cells and interstitium in the presence of androgens (Vendola et al. 1999a). 
These results suggest that the actions of IGF-I through its own receptor may be 
influenced by the presence of androgens.
The aim of this present study was to use a cortical strip system to investigate the 
effect of androgen on its own or in the presence of IGF-I on primordial follicle 
initiation and early follicle development. Hence, this study investigated whether 




3.2.2 Materials and methods
3.^?...2..1..Cpi1ic.aJ..sJrjpjs.pJa.tjon.a.n(d.c.uJture
Cortical strips were isolatedrfrom bovine ovaries and cultured individually for 3 or 6
days, as described in Chapter 2.
3:2,2.2 Treatments
Treatment groups were as described in 3.1.2.2, but androstenedione (A4) was added 
to all culture media at a concentration of 10"7 M in all treatment groups, and was 
obtained from Sigma Chemicals, Poole, UK.
Treatment groups and 'n' numbers were as follows ('n' number values represent the 
number of bovine cortical strips cultured for each treatment group for 3 and 6 day 
cultures respectively):
Treatment group 'n' numbers for 3 day 'n' numbers for 6 day
culture culture
ADayO
B Control + A4
C 5ng/ml LR3 IGF-I + A4
D10ng/mlHRIGF-I + A4












Treatment groups and number of replicates
3.2.3 Follicle classification and histoloqical assessment
Cortical strips were fixed in paraformaldehyde, processed for histology and mounted 
on slides at the end of the culture period, as described in Chapter 2. Samples were 
sectioned at 6(im, and every fifth section was analysed throughout the whole of each 
cortical strip. The total number of follicles present was counted on each section. To 
avoid double counting, only follicles with a visible nucleolus were counted. Follicles 
were classed by their developmental stage (see Figures 3.1.1 and 3.1.2), and oocyte 
health [growing (type la* onwards) follicles only] was analysed by grading the
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oocyte of each follicle as unhealthy (a degenerate germinal vesicle and/or misshapen 
oocyte) or healthy (a morphologically normal oocyte with an intact germinal 
vesicle).
3.2.4 Detection of androgen receptor immunoreactivitv in bovine follicles 
Freshly dissected out pieces of bovine ovarian cortex were fixed in 
paraformaldehyde, embedded in paraffin wax and mounted on slides, as described in 
Chapter 2. Sections were dewaxed in xylene and rehydrated from ethanol to water, 
before being washed in PBS (2x5 minutes, Sigma). Androgen retrieval was 
performed by placing sections in 0.01M citrate buffer (1x10 minutes 850W followed 
by 1x10 minutes 600W microwave), and then standing them for 20 minutes at RT. 
Sections were washed in PBS (2x5 minutes), placed in 3% hydrogen peroxide for 15 
minutes and washed (5 minutes, PBS). Sections were placed in normal goat serum 
from a Vectastain rabbit ABC-peroxidase kit (Vector Laboratories, Southgate, UK) 
for 30 minutes at RT, followed by incubation with primary antibody [1 hour at RT, 
1:10 dilution rabbit polyclonal androgen receptor antibody (NCL-ARp)] (Novocastra 
Laboratories, Newcastle Upon Tyne, UK). Negative controls were incubated with 
non-immune rabbit serum instead of androgen receptor antibody. Sections were 
washed (2x5 minutes, PBS) and incubated with a biotinylated secondary antibody 
(Vector Labs, as kit) for 30 minutes at RT and washed (5 minutes, PBS). 
Localisation of antigen was performed by incubation with DAB (Vector Labs, as kit) 
for 5 minutes. Slides were rinsed in tap water, counterstained with haematoxylin (15 
seconds), dehydrated and mounted.
3.2.5 Statistical analysis
The mean percentage of follicles per cortical strip and the mean number of follicles 
per cortical strip for each treatment group were calculated for the following 
developmental stage categories: non-growing (type 1), growing (type la* and la) 
and advanced (type 2 onwards). The data set was normally distributed in accordance 
with the Anderson-Darlmg test, variances were homogeneous and treatment groups 
were randomly assigned, therefore, a powerful parametric test could be used to 
analysis samples. ANOVA and t-tests were used as they are both very robust
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statistical tests. Mean percentage of follicles per cortical strip and the mean number 
of follicles per cortical strip were compared between experimental groups using one­ 
way ANOVA, with subsequent two-sample t-tests to allow for individual 
comparisons between groups.
The difference between treatment groups in the mean percentages of degenerate 
oocytes per strip, within the growing follicles, was compared using one-way 
ANOVA, with subsequent two-sample t-tests to allow for individual comparisons 
between groups.
To clearly investigate if the interaction between androgen and IGF-I plays a role in 
primordial activation and the early stages of follicular development, direct 
comparisons were made between corresponding treatment groups in the presence or 
absence of androstenedione. Mean percentages of follicles per cortical strip and the 
mean number of follicles per cortical strip were compared between corresponding 
treatment groups with or without androstenedione within each follicle developmental 
stage category using one-way ANOVA. Oocyte health was analysed by comparing 
corresponding treatment groups in the presence or absence of androstenedione, when 
no IGF-I was present or when the bioavailability of IGF-I was (lOng/ml HR IGF-I) 
and was not (5ng/ml LR3) being regulated by IGFBPs. Differences in the mean 
percentages of degenerate oocytes per strip, within the growing follicles, were 


















































Non-growing Growing Advanced 
Follicle developmental stage
Figure 3.2.1
Effect of IGF-I in the presence of A4 on primordial follicle initiation and early follicle
development after 3 days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 3 days of culture.
Values are the mean percentage or number of follicles per cortical strip per treatment group + SEM
for 4 cultures.
DayO = (n=!2). Control = (n=6). 5ng/mlLR3 IGF-I = (n=6).
lOng/ml HR IGF-I = (n=6) and lOOng/ml HR IGF-I = | (n=6).
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In all treatment groups there was a significant decrease in the mean percentage of 
follicles per cortical strip compared to Day 0, within the non-growing developmental 
stage category (p<0.05) (Figure 3,2.1). However, there was no significant difference 
in the mean percentage of follicles per strip between treatment groups in the non- 
growing developmental stage category. Furthermore, no differences were detected in 
any of the follicle developmental stage categories in the growing population, 
between any of the treatment groups, again indicating that the primordial follicles are 
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Non-growing Growing Advanced 
Follicle developmental stage
Figure 3.2.2
Effect of IGF-I in the presence of A4 on primordial follicle initiation and early follicle; 
development after 6 days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 6 days of culture.
Values are the mean percentage or number of follicles per cortical strip per treatment group ± SEM
for 6 cultures.
Day 0 = |___| (n= 12). Control = (n=8), 5ng/ml LR3 IGF-I = (n=6),
lOng/ml HR IGF-I = __ (n=9) and l()()ng/ml HR IGF-I = [ (n=6).
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In all treatment groups there was a significant decrease in the mean percentage 
(p<0.05) and the mean number (p<0.01) of follicles per cortical strip compared to 
Day 0, within the non-growing developmental stage category (Figure 3.2.2). 
However, there was no significant difference in the growing population between any 
of the treatment groups, suggesting that the primordial follicles are not surviving.
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Non-growing Growing Advanced 
Follicle developmental stage
  Control 0 Control + A4 
D5ng/ml LR3 IGF-I + A4 BlOng/ml HR IGF-I
  100ng/ml IGF-I n100ng/ml IGF-I + A4
rj5ng/ml LR3 IGF-I
  10ng/ml HR IGF-I + A4
Sj.x days of.c.ul.ture
Non-growing Growing Advanced 
Follicle developmental stage
U Control n Control + A4 
DSng/ml LR3 IGF-I + A4 HlOng/ml HR IGF-I 
  10Ong/m I IG F-l D10Ong/m I IG F-l + A4
DSng/ml LR3 IGF-I 
HlOng/ml HR IGF-I + A4
Figure 3.2.3
Comparison of the effects of the interaction between IGF-I and A4 on the mean 
percentage of follicles at different developmental stages after 3 and 6 days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 3 and 6 days of culture.
Values are the mean percentage of follicles per cortical strip per treatment group ± SEM for 4 cultures
(3 days) and 6 cultures (6 days). For 'n' numbers refer to Figures 3.1.2, 3.1.3, 3.2.1 and 3.2.2.
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No significant difference in the mean percentage of follicles per cortical strip was 
found when corresponding treatment groups, with or without androstenedione within 





Non-growing Growing Advanced 
Follicle developmental stage
D Control n Control + A4 
DSng/ml LR3 IGF-I + A4 nlOng/ml HR IGF-I 
mOOng/ml IGF-I n100ng/ml IGF-I + A4
DSng/ml LR3 IGF-I 
DlOng/ml HR IGF-I + A4
Six days, of.culture
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Non-growing Growing Advanced 
Follicle developmental stage
D Control n Control + A4 
DSng/ml LR3 IGF-I + A4 n10ng/ml HR IGF-I 
mOOng/ml IGF-I n100ng/ml IGF-I + A4
DSng/ml LR3 IGF-I 
DlOng/ml HR IGF-I + A4
Figure 3.2.4
Comparison of the effects of the interaction between IGF-I and A4 on the mean
number of follicles at different developmental stages after 3 and 6 days of culture
Distribution of follicles in pieces of bovine ovarian cortex after 3 and 6 days of culture.
Values are the mean percentage of follicles per cortical strip per treatment group ± SEM for 4 cultures
(3 days) and 6 cultures (6 days). For 'n' numbers refer to Figures 3.1.2, 3.1.3, 3.2.1 and 3.2.2.
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No significant difference in the mean number of follicles per cortical strip was found 
when corresponding treatment groups, with or without androstenedione within each 
follicle developmental stage category, were compared for three and six day cultures 
(Figure 3.2.4).
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No significant differences were detected in the mean percentage of oocyte 
degeneration between any of the treatment groups after three days of culture. After 
six days the level of oocyte degeneration was significantly higher in cortical strips 
cultured in the presence of^ng/ml LR3 IGF-I (p<0.05) when compared to Day 0 and 
control + A4 treatment groups, but not in the presence of lOng/ml HR IGF-I + A4 or 
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rh
Control Control + A4 
Treatment group
5ng/ml LR3 IGF-I 5ng/ml LR3 IGF-I + A4 
Treatment group
10ng/ml HR IGF-I 10ng/ml HR IGF-I + A4 
Treatment group
Figure 3.2.6
Oocyte health in the presence or absence of A4, when no IGF-I was present or when
the bioavailability of IGF-I was and was not being regulated by IGFBPs after 3 days of
culture
Values are the mean percentage of degenerate oocytes per cortical strip per treatment group + SEM. 
Values are the mean percentage of follicles per cortical strip per treatment group ± SEM for 4 
cultures. For 'n' numbers refer to Figures 3.1.4 and 3.2.5.
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There was no significant difference found in the mean percentage of oocyte 
degeneration between any of the treatment groups when corresponding treatment 
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5ng/ml LR3 IGF-I 5ng/ml LR3 IGF-I + A4 
Treatment group
=£=
10ng/ml HR IGF-I + A410ng/ml HR IGF-I
Treatment group
Figure 3.2.7
Oocyte health in the presence or absence of A4, when no IGF-I was present or when
the bioavailability of IGF-I was and was not being regulated by IGFBPs after 6 days of
culture
Values are the mean percentage of degenerate oocytes per cortical strip per treatment group + SEM. 
Values are the mean percentage of follicles per cortical strip per treatment group ± SEM for 6 
cultures. For V numbers refer to Figures 3.1.4 and 3.2.5.
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There was no significant difference found in the mean percentage of oocyte 
degeneration between any of the treatment groups when corresponding treatment 




Androgen receptor immunoreactivity in bovine follicles
Histological sections of bovine ovarian follicles after immunocytochemistry with normal goat serum 
(c and f) or an antibody raised against rabbit androgen receptor (a, b, d and e).
Androgen receptor immunoreactivity was detected in granulosa cells and oocytes of 
preantral and antral follicles in vivo, with no specific staining in theca or stromal 




During the early stage of follicular development in vitro it is crucial to provide the 
growing oocyte and surrounding somatic cells with the correct sequence of factors to 
stimulate granulosa cell proliferation and oocyte growth, without causing 
inappropriate exposure of the oocyte to deleterious factors or stimulating untimely 
somatic cell differentiation. The culture system described in this current study was 
originally developed to induce differentiation of ovine and bovine granulosa cells 
(Campbell et al. 1996; Gutierrez et al. 1997), and was subsequently adapted for the 
culture of bovine preantral follicles (Gutierrez et al. 2000; McCaffery et al. 2000; 
Thomas et al. 2001). Androstenedione was included in the culture media to act as a 
substrate for oestradiol production.
Both androgens (Weil et al. 1999) and IGF-I (Spicer et al. 1993; Monniaux and 
Pisselet 1992) have been reported as promoters of the effects of FSH and hence 
indirectly can play a role in regulating follicular development. Furthermore, 
androgens and IGF-I can exert a direct action via their receptors, which have been 
found to be expressed in rodent (Cheng et al. 2002; Tetsuka et al. 1995; Zhao et al. 
2002), domestic species (Armstrong et al. 2000; Campo et al. 1985; Hampton et al. 
2004, Figure 3.2.11) and primate ovaries (el Roeiy et al. 1993; Hone et al. 1992; 
Weil et al. 1998). Androgen and IGF-I have been shown to promote primordial 
follicle activation (Louhio et al. 2000; Vendola et al 1999b) and enhance follicle 
growth and survival (Gutierrez et al. 2000; Itoh et al. 2002; Murray et al. 1998; 
Vendola et al. 1998; Zhao et al. 2001). However, conversely the culture of fetal 
bovine ovarian cortex in the presence of IGF-I was found to have a dose-dependent 
negative effect on primordial activation and primary follicle growth (Yang and 
Fortune 2002). In addition, Derrar et al. (2000) failed to observe an effect of human 
recombinant IGF-I (lOng/ml) when androstenedione (10"7M) was present on 
primordial follicle initiation, or the relative proportions of primary versus secondary 
follicles in bovine cortical pieces after eight days of culture. In agreement with the 
work carried out by Derrar et al. (2000), the present study found that the addition of 
human recombinant IGF-I and androstenedione, at the same concentrations, to the 
culture medium did not promote primordial, primary or secondary follicle
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development. Furthermore, it was found that the addition of androstenedione with 
varying doses and unregulated IGF-I to the culture system also had no effect on 
follicle development in the non-growing and the two growing follicle developmental 
stages.
Recent work carried out on ovine preantral follicles found that although treatment 
with androstenedione increased oestradiol and testosterone production during culture, 
it had a deleterious effect on oocyte development (Thomas et al. 2002). Furthermore, 
IGF-I was reported recently to have a dose dependent negative effect on bovine 
primordial follicle activation and health (Yang and Fortune 2002) and a negative 
effect on the oocyte health of bovine preantral follicles (McCaffery et al. 2000). IGF- 
I in the presence of androstenedione in this current study was not found to alter the 
percentage of oocyte degeneration observed in cultured cortical strip treatment 
groups after three days of culture. However, after six days of culture the presence of 
5ng/ml LR3 IGF-I significantly increased the percentage of degenerate oocytes in 
growing follicles when compared to cultured treatment groups containing no IGF-I 
or a physiological dose of IGF-I which would be regulated by IGFBPs (lOng/ml HR 
IGF-I). The addition of androstenedione to the culture system either on its own or in 
the presence of IGF-I had no effect on oocyte health.
The use of cortical strip cultures in this study has allowed the effects of IGF-I and 
androgen to be examined. However, as seen in other studies this culture system 
causes wholesale activation of follicles (Braw-Tal and Yossefi 1997; Derrar et al. 
2000; Wandji et al. 1996). This activation does not appear to be normal and is 
probably as a result of the overstimulation by the inappropriate culture conditions. 
Due to this fact, future studies investigating the initiation of primordial follicles and 
early growth of follicles may be more informative if the technique demonstrated by 
Cushman et al. (2002) was used. In this study fetal bovine ovarian cortex that was 
grafted beneath the chorioallantoic membrane (CAM) of 6-day-old chick embryos 
did not exhibited the expected primordial activation and furthermore after removal 
from the CAM into culture primordial follicles decreased in number and primary 
follicles increase in number (Cushman et al. 2002). This model provides a useful tool
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for studying factors involved in activation of primordial follicles, however, this 
system is not well defined and results are still influence by follicles at different 
stages of development present throughout the strip.
In conclusion, results obtained from the present study showed that IGF-I was not 
found to have any positive or negative effects on primordial follicle initiation or on 
the development of activated follicles. The supplementation of the culture medium 
with androstenedione, either on its own or in combination with IGF-I, also failed to 
affect follicle activation and growth. The presence of IGF-I when its bioavailability 
was not regulated by IGFBPs was found to have a detrimental effect on oocyte 
health. Moreover, this result was not altered by the supplementation of the culture 
medium with androstenedione, suggesting that the actions of IGF-I through its 
receptor are not influenced by the presence of androgens. However, it must be 
recognised that androstenedione is an aromatisable androgen, and would therefore 
have been acting as a substrate for oestradiol production in the more developed 
follicles present. Bearing this in mind, and the presence of androgen receptor mRNA 
(Hampton et al. 2004) and immurioreactivity found in bovine follicles in this current 
study (Figure 3.2.8), further work using a non-aromatisable androgen such as 
dihydroxytestosterone (DHT) would allow a clearer investigation into the direct 




The Role of the IGF System During 




4.1 The effect of IGF-I on the health and morphology of bovine antral 
follicles in vitro
4.1.1 Introduction
As previously discussed, the bioavailability of IGFs can be regulated by their 
association with the family of insulin-like growth factor binding proteins (IGFBPs). 
These IGFBPs can sequester extracellular IGFs and hence reduce the level of 'free' 
IGFs available for specific cell surface receptors (Giudice 1992; Hwa et al. 1999). 
This, in turn, inhibits any mitogenic actions of the IGFs. The attenuation of IGF 
actions by the IGFBPs is controlled by complex regulatory mechanisms that vary 
throughout follicular development.
During the growth of a follicle, the level of expression and involvement of different 
components of the IGF system have been shown in the mouse ovary to change with 
the stage of development and the onset of atresia (Wandji et al. 1998). Previous in 
vitro cultures using rat preantral follicles demonstrated that follicle development was 
enhanced, and the morphology of the follicles maintained, when grown in the 
presence of IGF and FSH (Zhao et al. 2001). Furthermore, IGF-I has been shown to 
enhance steroidogenesis in the theca cells of rat antral follicles (Cara and Rosenfield 
1988).
As in rodents, IGF-I has been shown to work synergistically with gonadotrophins to 
promote granulosa and theca cell proliferation and differentiation in domestic species 
such as cattle (Spicer et al. 1993; Stewart et al 1995) and sheep (Monniaux and 
Pisselet 1992; Campbell et al. 1998). The later stages of follicle growth have been 
well documented as being influenced and regulated by components of the IGF 
system (Armstrong and Webb 1997; Lorenzo et al. 1994; Schams et al. 1999). 
However, unlike the later stages of follicle development, the role of the IGF system 
during early follicle growth is only now beginning to be understood.
Expression of IGFs and IGFBPs, and their effects, are species specific. In cattle, type 
I IGF receptor mRNA has been detected in the oocyte, granulosa and theca cells of
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preantral and antral follicles (Armstrong et al. 2000; 2002), whereas IGFBP-2 
mRNA has been detected in the oocyte and granulosa cells of preantral and antral 
bovine follicles (Armstrong et al. 1998; 2002, see Chapter 5 results) (Figure 1.6). 
Studies indicate that the expression and production of IGFBPs in the developing 
follicle are dependent on both the cell type and follicle size, and are regulated by 
IGF-I or -II and gonadotrophins (Schams et al. 1999). Previous in vitro preantral 
follicle culture studies have demonstrated a positive effect of IGF-I supplementation 
of culture medium, as the follicles were able to grow and develop into antral follicles 
(Gutierrez et al. 2000; Itoh et al. 2002). However, examination of preantral follicle 
health showed that direct access of IGF-I to bovine preantral follicles has a negative 
affect on oocyte size and granulosa differentiation at that particular stage of follicular 
growth (McCaffery et al. 2000). Since the health of the oocyte is fundamental, it is 
crucial that the oocyte is not inappropriately exposed to factors that may have a 
detrimental effect and thus have implications for later development.
In many biological systems, the bioavailability and IGF receptor mediated effects of 
IGFs are modulated by IGFBPs. In addition to IGFs exerting an action through their 
own receptors, under certain conditions they can also exert an action via insulin 
receptors (Hwa et al. 1999). Both IGF receptors and binding proteins compete for 
free IGFs. IGFBP-2 is thought to play a role in the regulation of IGF by inhibiting 
the interaction of IGFs with their receptors on the oocyte and/or somatic cells. To 
address this point, the native form of IGF-I (which does bind to IGFBPs), human 
recombinant IGF-I (HR IGF-I) and the synthetic analogue Long R3 IGF-I (LR3 IGF- 
I) (which does not bind to IGFBPs), have been used as supplements for the culture of 
bovine early antral follicles. LR3 IGF-I is known to be more potent than authentic 
IGF-I due to its more than 1000-fold reduced affinity for IGFBPs (Francis et al. 
1992). Therefore, by using LR3 IGF-I as a supplement in culture medium, the 
binding protein regulatory mechanism can be bypassed. LR3 IGF-I has been shown 
to have a stimulatory effect on growth and antrum formation during long-term 
culture of bovine preantral follicles (Gutierrez et al. 1997), but by contrast it has a 
detrimental effect on bovine preantral oocyte health (McCaffery et al 2000). It
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therefore appears that IGF-I may have a differential effect on the oocyte and somatic 
cells at certain stages of follicle growth.
The aim of the following*study was to investigate further the hypothesis that the 
bioavailability of IGF-I is strictly regulated according to developmental stage. This 
was assessed by studying the effects of IGF-I on three size ranges of bovine early 
antral follicle development in vitro. Follicle growth and health were studied and 




4.1.2 Materials and methods
Three separate experiments were carried out to investigate the effects of IGF-I on 
early bovine antral follicles in vitro. Initially, a 4 day culture was set up using one 
dose of LR3 IGF-I and two, doses of HR IGF-I. The second experiment was set up to 
look at the effects of a low and high dose of HR IGF-I on IGFBP-2 expression (see 
Chapter 5). Follicles were cultured for 2, 4 or 6 days. The results showed a 
significant increase in growth and oestradiol production by day 6 of culture in the 
follicles that were cultured in media supplemented with 1 fig/ml HR IGF-I. 
Therefore, to identify whether this effect was brought about by binding of the IGF-I 
solely through the IGF receptors, or via the IGF receptors and the insulin receptors, 
the third experiment used follicles cultured in media supplemented with a low dose 
of LR3 IGF-I for 6 days, as this form of IGF-I would not be able to bind to the 
insulin receptor.
Therefore, the three experiments carried out were:
1) The effect of HR IGF-I and LR3 IGF-I on the health and morphology of 
bovine early antral follicles in a 4 day in vitro culture system.
2) The effect of HR IGF-I in the presence or absence of the IGFBP 
regulatory mechanism.
3) The effect of LR3 IGF-I on the health and morphology of bovine early 
antral follicles in a 6 day in vitro culture system.
1) Early antral follicles in two size ranges (165|j,m-215^m and 216|j,m -280^m) were 
isolated from bovine ovaries and cultured for 4 days, as described in Chapter 2.
2) Early antral follicles in three size ranges (165nm-215|im, 216[im -280nm and 
281^m -380(im) were isolated from bovine ovaries and cultured for 2, 4 or 6 days, as 
described in Chapter 2.
3) Early antral follicles in the size range 165^m-215nm were isolated from bovine 
ovaries and cultured for 6 days, as described in Chapter 2.
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For each experiment, half the medium was replaced every day and the conditioned 
media was analysed for oestradiol production by DELFIA hormone assay, as 
described in Chapter 2.
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4; .1.,2 : 2 Treatments
Culture medium (control) was prepared as described in 2.3.1. Human recombinant 
IGF-I (HR IGF-I), which does bind to IGFBPs, was purchased from Sigma 
Chemicals, Poole, UK. Two doses of HR IGF-I were used, a low dose of lOng/ml 
and a high dose of lu.g/ml. The low dose of lOng/ml represented a physiological 
dose that would be able to bind to the IGFBPs and would therefore be regulated by 
the level of IGFBPs present. The high dose of lu.g/ml, on the other hand, would 
swamp the IGFBPs present, allowing IGF-I to bypass any regulatory mechanism of 
the IGFBPs and hence bind freely to IGF receptors. Under these conditions, it is also 
possible that the IGF-I may be able to bind to the insulin receptors, as well as the 
IGF receptors, to exert an action. The analogue Long R3 IGF-I (LR3 IGF-I), which 
does not bind to binding proteins, was purchased from Sigma Chemicals, Poole, UK. 
LR3 IGF-I will, therefore, bypass any IGFBP regulatory mechanism and go straight 
to the IGF receptors to have an effect on the target cell.







D 5ng/ml LR3 IGF-I
l n' numbers
121 and 106 for the size 
ranges 165-215|j.m and 
216-280|^m respectively.
A Control
B lOng/ml HR IGF-I 
IGF-I
123, 128 and 105 for the 
size ranges 165-215 (j,m, 
216-280^m and 281- 
3 80 urn respectively.
A Control
B 5ng/ml LR3 IGF-I
45, 67 and 21 for the size 
ranges 165-215(am, 216- 
280^m and 281-380um 
respectively.
Table 4.1.1
Treatment groups and number of replicates
Number of replica cultures were 6, 11 and 4 for experiments 1, 2 and 3 respectively.
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4.1.3 Measurement of follicle growth
Follicle diameters were measured every day using a crossed micrometer (basement
membrane to basement membrane) under the dissection microscope.
4.1.4 Measurement of oestradiol production
Medium collected every day was stored at -80°C and later used to detect oestradiol 
production. Detection of oestradiol concentrations in conditioned media was 




Follicles were fixed, processed for histology and mounted on slides at the end of the 
culture period, as described in Chapter 2. Oocyte.-follicle ratios, oocyte health and 
granulosa cell health were all analysed, as described in Chapter 2. Granulosa cell 
health analysis was not carried out for experiment 2, as follicles were not stained 
with haematoxylin and eosin but instead underwent immunocytochemistry for 
IGFBP-2 (see Chapter 5). In experiment 2 only follicles from the 6 day cultures were 
histologically analysed.








D lug/mlHR IGF-I 
E 5ng/ml LR3 IGF-I
'n' numbers
136 and 130 for the size 






48, 43 and 41 for the size 
ranges 165-215u.m, 216- 




C 5ng/ml LR3 IGF-I
56, 78 and 26 for the size 
ranges 165-215p.m, 216- 
280nm and 281-380um 
respectively.
Table 4.1.2




The data set was normally distributed in accordance with the Anderson-Darling test, 
variances were homogeneous and treatment groups were randomly assigned, 
therefore, a powerful parametric test could be used to analysis samples. ANOVA and 
subsequently the multiple comparison test 'Tukeys' was used after a significant 
ANOVA to determine where the significant difference existed among the groups. 
Mean follicle diameters and oestradiol production on day 4 (experiment 1) or day 6 
(experiments 2 and 3) of culture were compared between experimental groups using 
a repeated measures ANOVA (General Linear Model), with subsequent Tukeys tests 
to allow for individual comparisons between groups.
Follicles fixed for histological examination on day 4 (experiment 1) or day 6 
(experiments 2 and 3) were analysed for differences between treatment groups with 
regard to the mean oocyte: follicle ratios and mean percentage of pyknotic granulosa 
cells by one-way ANOVA, with subsequent two-sample t-tests to allow for 
individual comparisons between groups. ANOVA and t-tests were used as they are 
both very robust statistical tests. The difference between treatment groups with 
regard to the number of degenerate oocytes was assessed by a 2-proportions test. The 
2-proportions test was chosen as each group was compared to one another and this 
method tests whether two binomial proportions are significantly different from one 
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Effect of HR IGF-I and LR3 IGF-I on follicle growth
Growth of early antral follicles in 2 size ranges in the following treatment groups: 
Control = • (n=30,26), lOng/ml HR IGF-I = (n=32,27), Ijig/ml HR IGF-I = ± (n=28,26) and 
5ng/ml LR3 IGF-I = (n=31.27). The 'n' numbers are for 165-215nm and 216-280(im size ranges 
respectively. Values are mean ± SEM.
All groups showed a significant increase in size between days 0 and 4 (p<0.01) 
(Figure 4.1.1).
By day 4 there was no significant increase in follicle growth between treatment 
groups in the early antral follicles in all size ranges (Figure 4.1.1).
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Effect of HR IGF-I on follicle growth in the presence or absence of the IGFBP
regulatory mechanism
Growth of early antral follicles in 3 size ranges in the following treatment groups: 
Control = • (n=43,43,35), lOng/ml HR IGF-I = (n=37,47,35) and l^ig/ml HR IGF-I = A 
(n=43,38,35). The 'n' numbers are for 165-215u.m, 216-280^m and 281-380u.m size ranges 
respectively. Values are mean ± SEM. * indicates a significant difference in follicle growth (p<0.05).
All groups showed a significant increase in growth between days 0 and 6 (p<0.01) 
(Figure 4.1.2).
There was a significant increase in follicle growth by day 6 in the early antral 
follicles cultured in media supplemented with Ijlg/ml HR IGF-I in the smallest size 
range (165-215M.m) (p<0.01) (Figure 4.1.2).
Follicles in the size ranges 216-280u,m and 281-380(im did not show a significant 
increase in follicle growth between treatment groups.
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3) The effect of LR3 IGF-I on the health and morphology of bovine early 












Effect of LR3 IGF-I on follicle growth
Growth of early antral follicles in 3 size ranges in the following treatment groups:
Control = • (n=18,27,8), 5ng/ml LR3 IGF-I = (n=27,40,13). The 'n' numbers are for 165-215n.m,
216-280|o.m and 281-380(j.m size ranges respectively. Values are mean ± SEM.
All groups showed a significant increase in growth between days 0 and 6 (p<0.01) 
(Figure 4.1.3).
Follicles in all size ranges did not show a significant increase in follicle growth 
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Effect of HR IGF-I and LR3 IGF-I on oestradiol production
Oestradiol production of early antral follicles in 2 size ranges in the following treatment groups: 
Control = • (n=30,26), lOng/ml HR IGF-I = (n=32,27), lu.g/ml HR IGF-I = L (n=28,26) and 
5ng/ml LR3 IGF-I = (n=31.27). The 'n' numbers are for 165-215u,m and 216-280u.m size ranges 
respectively. Values are mean ± SEM.
All groups showed a significant increase in oestradiol production between days 1 and
4(p<0.01)(Figure4.1.4).
No significant difference in oestradiol production was shown between day 1 and day
4 in any treatment group across all size ranges (Figure 4.1.4).
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Effect of HR IGF-I on oestradiol production in the presence or absence of the IGFBP
regulatory mechanism
Growth of early antral follicles in 3 size ranges in the following treatment groups:
Control = • (n=43,43,35), lOng/ml HR IGF-I = (n=37,47,35) and l|ig/ml HR IGF-I = A
(n=43,38,35). The 'n' numbers are for 165-215|im, 216-280nm and 281-380|am size ranges




All groups showed a significant increase in oestradiol production between days 2 and 
6(p<0.01)(Figure4.1.5).
A significant increase in oestradiol production was shown between day 2 and day 6 
in early antral follicles cultured in the presence of 1 (J,g/ml HR IGF-I, across all size 
ranges [165-215|J,m (p<0.05), 216-280|am and 281-380nm (p<0.01)] (Figure 4.1.5).
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3) The effect of LR3 IGF-I on the health and morphology of bovine early 































Effect of LR3 IGF-I on oestradiol production
Oestradiol production of early antral follicles in 3 size ranges in the following treatment groups: 
Control = • (n=18,27,8), 5ng/ml LR3 IGF-I = * (n=27,40,!3). The V numbers are for 165-215nm, 
216-280|nm and 281-380|am size ranges respectively. Values are mean ± SEM.
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Follicles in the size ranges 165-215^m and 216-280(j,m showed a significant increase 
in oestradiol production between days 0 and 6 (p<0.01). The largest size range (281- 
380jj,m) did not show a significant increase in oestradiol production between days 0 
and 6 (Figure 4.1.6).
Follicles in all size ranges did not show a significant difference in oestradiol 
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Effect of HR IGF-I and LR3 IGF-I on oocyte health
Oocyte health of 2 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=20,25), Control (n=30,25), lOng/ml HR IGF-I (n=31,27), lug/ml HR IGF-I (n=26,26) and 5ng/ml 
LR3 IGF-I (n=29,27). Values are the number of degenerate oocytes displayed as a percentage of the 




All cultured follicles in the smallest size range (165-21 Sum) were found to have a 
significantly higher percentage of degenerate oocytes compared to Day 0 follicles 
(p<0.01) (Figure 4.1.7).
There was no significant difference in the percentage of oocyte degeneration between 
cultured treatment groups in the size range 165-21 Sum (Figure 4.1.7).
In the larger size range of follicles (216-280um) a significant increase in the 
percentage of degenerate oocytes was only found in follicles cultured in media 
supplemented with 5ng/ml LR3 IGF-I compared to the Day 0 treatment group 
(p<0.05) (Figure 4.1.7).
There was no significant difference in the percentage of oocyte degeneration between 













































































































































































































































































































































































































There was no significant difference in the percentage of oocyte degeneration between 
treatment groups in the size ranges 165-21 Sum and 281-380jj,m (Figure 4.1.8).
In the larger size range of follicles (281-380f4,m) a significant increase in the 
percentage of degenerate oocytes was found in follicles cultured in control media 
compared to the Day 0 (p<0.01), lOng/ml HR IGF-I (p<0.01) and l^g/ml HR IGF-I 
(p<0.05) treatment groups (Figure 4.1.8).
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3) The effect of LR3 IGF-I on the health and morphology of bovine early 
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Figure 4.1.9
Effect of LR3 IGF-I on oocyte health
Oocyte health of 3 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=13,13,5) Control (n=18,25,8) and 5ng/ml LR3 IGF-I (25,40,13). Values are the number of 
degenerate oocytes displayed as a percentage of the total oocytes analysed after 6 days of culture. The 
'n' numbers are for 165-215um, 216-280|om and 281-380uin size ranges respectively.
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All cultured follicles in the size ranges 165-215|^m and 216-280fj,m were found to 
have a significantly higher percentage of degenerate oocytes compared to Day 0 
follicles (p<0.01) (Figure 4.1.9).
There was no significant difference in the percentage of oocyte degeneration between 
cultured treatment groups in the size ranges 165-215jam and 216-280jim (Figure 
4.1.9).
In the larger size range of follicles (216-280n,m) no significant difference in the 
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Size range (uim) and treatment group
Figure 4.1.10
Effect of HR IGF-I and LR3 IGF-I on oocyte:follicle ratios
Oocyte:follicle ratios of 2 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=20,25), Control (n=30,25), lOng/ml HR IGF-I (n=31,27), liig/ml HR IGF-I (n=26,26) and 5ng/ml 
LR3 IGF-I (n=29,27). The 'n' numbers are for 165-21 Stun and 216-280u.m size ranges respectively. 
Values are the mean oocyte:follicle ratio per treatment group, within each size range, analysed after 
4 days of culture.
No significant difference in oocyte:follicle ratio was found between treatment groups 
in either of the size ranges (Figure 4.1.10).
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Size range (iim) and treatment group
Figure 4.1.11
Effect of HR IGF-I on oocyteifollicle ratios in the presence or absence of the IGFBP
regulatory mechanism
Oocyte:follicle ratios of 3 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=10,10,9), Control (n=13,10,ll), 1 Ong/ml HR IGF-I (n=10,13,ll) and liig/ml HR IGF-I 
(n=15,10,10). The 'n' numbers are for 165-215^im, 216-280u.m and 281-380um size ranges 
respectively. Values are the mean oocyte:follicle ratio per treatment group, within each size range, 
analysed after 6 days of culture.
No significant difference in oocyte:follicle ratio was found between treatment groups 
in any of the size ranges (Figure 4.1.11).
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3/ The effect of LR3 IGF-I on the health and morphology of bovine early 










































Size range (^m) and treatment group
Figure 4.1.12
Effect of LR3 IGF-I on oocyte:follicle ratios
Oocyte:follicle ratios of 3 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=13,13,5) Control (n=18,25,8) and 5ng/ml LR3 IGF-I (25,40,13). The 'n' numbers are for 165- 
215|o.m, 216-280|o.m and 281-380nm size ranges respectively.
Values are the mean oocyte:follicle ratio per treatment group, within each size range, analysed after 6 
days of culture.
No significant difference in oocyte:follicle ratio was found between treatment groups 
in any of the size ranges (Figure 4.1.12).
130
Chapter 4
M The effect of HR IGF-I and LR3 IGF-I on the health and morphology of 
bovine early antral follicles in a 4 day in vitro culture system.
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Size range (u.m) and treatment group
Figure 4.1.13
Effect of HR IGF-I and LR3 IGF-I on granulosa cell health
Granulosa cell health of 2 size ranges of early antral follicles in the following treatment groups: Day 0 
(n=20,25), Control (n=30,25), lOng/ml HR IGF-I (n=31,27), 1 fig/ml HR IGF-I (n=26,26) and 5ng/ml 
LR3 IGF-I (n=29,27). The 'n' numbers are for 165-215|im and 216-280(j.m size ranges respectively. 
Values are the mean percentage of pyknotic granulosa cells per treatment group, within each size 
range, analysed after 4 days of culture.
No significant difference in the percentage of pyknotic granulosa cells was found 
between treatment groups in any of the size ranges (Figure 4.1.13).
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37 The effect of LR3 IGF-I on the health and morphology of bovine early 
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Size range (|im) and treatment group
Figure 4.1.14
Effect of LR3 IGF-I on granulosa cell health
Granulosa cell health of 3 size ranges of early antral follicles in the following treatment groups: Day 0 
(n= 13,13,5) Control (n= 18,25,8) and 5ng/ml LR3 IGF-I (25,40,13). The 'n' numbers are for 165- 
215(im, 216-280|o.m and 281-380(im size ranges respectively.
Values are the mean percentage of pyknotic granulosa cells per treatment group, within each size 
range, analysed after 6 days of culture.
No significant difference in the percentage of pyknotic granulosa cells was found 




Developing techniques for isolating and culturing the follicles of immature domestic 
species to a stage where they can produce developmentally competent oocytes and 
viable offspring presents an enormous challenge. Culture systems have provided a 
useful tool for elucidating regulatory mechanisms controlling follicle development, 
but progress has been slow. However, bovine preantral follicles have successfully 
been maintained in culture (Hulshof et al. 1995; McCaffery et al. 2000; Saha et al. 
2000; Thomas et al. 2001), with some achieving antrum formation (Gutierrez et al. 
2000; Itoh et al. 2002). Accelerated growth of these immature follicles has been 
achieved by media supplementation with various hormones and growth factors. 
There is evidence of a complete intrafollicular IGF system within bovine preantral 
(Armstrong et al. 2002) and antral (Armstrong et al. 1998; 2000) follicles, which 
implies a role for the IGF system throughout follicle development. Previous work has 
outlined the involvement of IGF-I in follicular development (Giudice 1992). IGF-I 
has not been found to have a stimulatory role in follicle initiation (Derrar et al. 2000; 
Kezele et al. 2002b; Yang and Fortune 2002, see Chapter 3 results). However, 
recombinant IGF-I has been shown to increase bovine preantral follicle and oocyte 
diameter in vitro (Itoh et al. 2002), and LR3 IGF-I has aided the formation of the 
antral cavity (Gutierrez et al. 2000). It is therefore evident that regulation by the 
IGFBPs of IGF-I is crucial for normal oocyte development in preantral follicles 
(McCaffery et al. 2000).
In the present study, varying concentrations and forms of IGF-I have allowed us to 
highlight the importance of IGFBPs in IGF regulation at different follicle 
developmental stages. It has been shown that after six days of culture, the growth of 
follicles at an immature stage of development (165-215jam) is influenced by direct 
access to IGF-I (Ijig/ml HR IGF-I). However, the more mature follicles (216- 
380jjm) are unaffected by the exposure to IGF-I. This suggests that as follicles grow 
they are developing and differentiating to a stage where they can withstand increased 
levels of IGF-I, while immature follicles may undergo inappropriate follicular 
differentiation caused by untimely exposure to IGF-I. Hence, the presence of IGF-I 
may not be appropriate until later stages of development. The culture medium used
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in ths system was not supplemented with FSH, as IGFs are well known to work in 
synergy with gonadotrophins to promote follicular development (Spicer et al. 1993; 
Zhao et al. 2001) and this study wanted to soley investigate the effects of IGF-I on 
bovine follicle development. During the early stages of follicle growth stimulation by 
FSH is not thought to be essential (Dufour et al. 1979) however during antral 
development FSH is vital for the prevention of atresia of antral follicles (Chun et al. 
1996). Hence, although the follicles in the present study were in the early stages of 
antral development, therefore not completely dependent on FSH for further growth 
and development, the addition of FSH to the culture medium may have improved the 
health and response of the follicles to IGF-I.
Small antral follicles (165-215^m) exhibit an increase in follicle growth and 
oestradiol production in the presence of 1 ug/ml IGF-I. Unlike the immature follicles, 
the more developed follicles (size ranges 216-280um and 281-380nm) exhibited no 
increase in follicle growth, but still registered an increase in oestradiol production in 
the presence of a high concentration of IGF-I (l^g/ml HR IGF-I). This implies that 
at this developmental stage the follicles are undergoing rapid differentiation rather 
then proliferation and respond to the presence of IGF-I in a positive way by 
increasing oestradiol production and therefore aiding their chances of escaping 
follicular atresia. The effect of IGF-I has been found, in previous work on bovine 
ovarian function, to be influenced by the differentiated state of the follicle (Spicer et 
al. 1993). IGF-I at a concentration of lOOng/ml was found to inhibit oestradiol 
production by granulosa cells from small antral follicles (l-5mm in diameter), 
whereas oestradiol production was stimulated in granulosa cells from large follicles 
(> 8mm in diameter).
IGF-I interacts primarily with the type I IGF receptor - a homodimer tyrosine kinase 
receptor - exhibiting a high degree of homology with the insulin receptor. The 
insulin receptor (IR) and the insulin-like growth factor-I receptor (IGF-IR) belong to 
the same subfamily of receptor tyrosine kinases. They share a high similarity of 
structure and intracellular signalling events (Dupont and LeRoith 2001). The 
biological actions of IGF-I are predominantly mediated by the type I IGF-I receptor.
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However, IGF-I is also capable of binding with the closely related insulin receptor 
(Hwa et al. 1999), although this interaction is of a lower affinity than that of insulin 
for its own receptor. Under certain circumstances, the insulin receptor may mediate 
some of the biological actions of the IGFs (Hwa et al. 1999; LeRoith 2000). The 
IGF-I receptors would have become overwhelmed with IGF-I when the high dose of 
IGF-I (lug/ml HR IGF-I) was present. Therefore, under these conditions the IGF-I 
may have been able to mediate its actions via the insulin receptors, as well as the 
type I IGF receptor. This would explain the significant stimulatory effect on the 
growth of the early antral follicles in the size range 165-215 jam and the significant 
increase in oestradiol production seen in all size ranges of follicles. By contrast, a 
significant increase in growth was not observed in the follicles grown in media 
supplemented with LR3 IGF-I. A possible reason for this is that although LR3 IGF-I 
would have a direct effect (as it does not bind to IGFBPs), the IGF receptors would 
not become overwhelmed by the LR3 IGF-I due to its low concentration of 5ng/ml. 
Therefore, these conditions would have only allowed the LR3 IGF-I to facilitate its 
actions via the type I IGF receptor and not via the insulin receptor as well.
IGF-I is known to stimulate nuclear maturation of cumulus-enclosed oocytes 
(Lorenzo et al. 1994; Sirotkin et al. 2000) and improves early embryonic 
development (Pawshe et al. 1998; Sirisathien et al. 2003; Sirisathien and Brackett 
2003). In contrast to work carried out on bovine preantral follicles (McCaffery et al. 
2000), IGF-I was not found to have a detrimental effect on oocyte development - in 
fact it was found to be beneficial in maintaining oocyte health once the follicle had 
reached a more mature stage of development (281-380^im). During the development 
of the follicular unit, the oocyte undergoes a progressive series of morphological 
modifications as it grows and proceeds through the different stages of development. 
These structural requirements facilitate the increasing energy and nucleic acid 
synthesis requirements of the developing oocyte and are prerequisite to the oocyte's 
achievement of meiotic and embryo developmental competence (Fair 2003). The 
intrinsic quality of the oocyte is the key factor determining the proportion of oocytes 
that will continue to develop and mature. These experiments demonstrate that when
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designing culture systems it is important to consider the developmental stage of the 
follicular unit as the requirements of the developing follicle are constantly changing.
The role of IGFBP-2 in follicles during early follicle development is unclear. 
However, it is hypothesised that IGFBP-2 present in the early stages of follicle 
growth will bind any IGF arriving from the circulation or adjacent follicle, and 
therefore inhibit the interaction of IGFs and their receptors on the surface of the 
oocyte and granulosa cells (Armstrong et al. 2002). The oocyte and/or its granulosa 
cells could then access the growth factor when required, by releasing proteases to 
cleave the IGF from the IGFBP-2. The knowledge that unregulated IGF-I has a 
detrimental effect on preantral oocyte health (McCaffery et al. 2000), and that when 
you bypass the IGFBP-2 regulatory mechanism in early antral follicles IGF-I can 
stimulate follicle growth and oestradiol production, highlights that the regulation of 
IGF-I bioavailability by IGFBP-2 is follicle stage dependent and crucial in the early 
stages of follicle growth to allow normal follicle and oocyte growth to occur in vitro.
In conclusion, this study has investigated the effects of IGF-I on bovine early antral 
follicle development in a six day, serum-free culture system. It found that the 
stimulatory effects of IGF-I on follicle proliferation and differentiation were dose 
and stage dependent. Furthermore, oocyte health was improved by the addition of 
recombinant IGF-I in the more mature follicles. These results highlight the 
importance of follicle developmental stage when deciding the.best in vitro culture 
conditions. Improved knowledge regarding the regulation of IGFs within follicles 
will have practical significance in terms of developing in vitro growth and 
maturation systems for oocytes and therefore contribute to the development of 
techniques for increasing the availability of oocytes from cattle of high genetic merit 
for subsequent use in embryo transfer procedures.
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4.2 Can the insulin receptor be used by IGF-I to mediate its action on 
early antral bovine follicles?
4.2.1 Introduction
IGF-I and insulin are related structurally and functionally (Rinderknecht and Humbel 
1978b; Spicer and Echternkamp 1995). Similarly, the receptor of IGF-I and insulin 
are also structurally related and both ligands interact with each others receptor's with 
low affinity (Jones and Clemmons 1995). In section 4.1 it was shown that human 
recombinant IGF-I at a concentration of ljj,g/ml can accelerate the growth rate of 
early antral follicles in the size range 165-215^im and significantly increase 
oestradiol production in all of the size ranges (165-380|j,m). However, this effect was 
not seen when follicles were cultured with LR3 IGF-I, which does not bind to 
IGFBPs and can therefore bind directly to the IGF receptors. It was hypothesised that 
when the high dose of HR IGF-I (Ij^g/ml) was present the IGF-I receptors would 
have become overwhelmed with IGF-I. Under these conditions the IGF-I may have 
been able to mediate its actions via the insulin receptors, as well as the type I IGF 
receptor. Conversely, although LR3 IGF-I would have a direct effect (would bind 
directly to the receptors), the IGF receptors would not become overwhelmed by the 
LR3 IGF-I due to its low concentration of 5ng/ml. Therefore, these conditions would 
have only allowed for the LR3 IGF-I to facilitate its actions via the type I IGF 
receptor and not also via the insulin receptor. The following experiment was 
designed to block the insulin receptor in order to determine the effects of IGF-I that 
are mediated through its IGF receptors.
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4.2.2 Materials and methods
4..2.,2..tFpJJj(?je.j.s.o!a1tio.n.a.nd.culture
Early antral follicles (]^>5um-215um) were isolated and cultured for 6 days. Half the 
medium was replaced every second day and the conditioned media was analysed for 
oestradiol production by hormone assay, as described in Chapter 2.
4:2,2.2 Treatments
Culture medium (control) was prepared as described in 2.3.1. Insulin receptor mouse 
monoclonal antibody (Vector Laboratories Inc., Peterborough, UK) was used at a 
1/10 dilution.
Treatment groups were as follows:
Treatment group
A Control (no insulin)
'n' numbers
12
B lOng/ml insulin 12




Treatment groups and number of replicates
No repeat cultures were carried out as results from initial study showed that the 
supplementation of the culture medium with insulin receptor mouse monoclonal 
antibody had no significant effect on growth or oestradiol production suggesting that 
this is not the most appropriate way to analyse whether IGF-I is able to exert a 
stimulatory effect on follicle proliferation and differentiation via the IGF receptors 
alone at this particular stage of follicular development.
4.2.3 Measurement of follicle growth
Every second day follicle diameters were measured using a crossed micrometer
(basement membrane to basement membrane) under the dissection microscope.
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4.2.4 Measurement of oestradiol production
Detection of oestradiol concentrations in conditioned media was determined by
DELFIA, as described in Chapter 2.
4.2.5 Statistical analysis
The data set was normally distributed in accordance with the Andersen-Darling test, 
variances were homogeneous and treatment groups were randomly assigned, 
therefore, a powerful parametric test could be used to analysis samples. ANOVA and 
subsequently the multiple comparison test 'Tukeys' was used after a significant 
ANOVA to determine where the significant difference existed among the groups. 
Mean follicle diameters and oestradiol production on day 6 of culture were compared 
between experimental groups using a repeated measures ANOVA (General Linear 















Follicle growth when follicles were cultured in the presence of insulin, insulin + Insr
antibody or no insulin
Growth of early antral follicles in the following treatment groups:
Control (no insulin) = * (n=12), lOng/ml insulin = • (n=12), and lOng/ml insulin + insulin receptor
antibody = ± (n=12). Values are mean ± SEM.
No significant difference in follicle growth between days 0 and 6 was found in any of 
the treatment groups (Figure 4.2.1).













Oestradiol production when follicles were cultured in the presence of insulin, insulin +
Insr antibody or no insulin
Oestradiol production of early antral follicles in the following treatment groups:
Control (no insulin) = « (n=12), lOng/ml insulin = • (n=12), and lOng/ml insulin + insulin receptor
antibody = A (n=12). Values are mean ± SEM.
All groups showed a significant increase in oestradiol production between days 2 and 
6 (p<0.01) (Figure 4.2.2).
No significant difference in oestradiol production was found between any of the 




Both insulin and IGF-I can stimulate each other's receptor with low affinity binding 
(Jones and Clemmons 1995). In the previous section of this chapter it was 
hypothesised that when follicles were cultured in media supplemented with a high 
dose of IGF-I (lug/ml HR IGF-I), the IGF-I receptors would have become 
overwhelmed with IGF-I. Therefore, under these conditions the IGF-I might have 
been able to mediate its actions via the insulin receptors, as well as the type I IGF 
receptor. Insulin receptor mRNA has been shown to be expressed in the oocyte and 
granulosa cells of bovine antral follicles (unpublished results from Armstrong, D.G.). 
This would explain the significant stimulatory effect on the growth of the early antral 
follicles in the size range 165-215^m, and the significant increase in oestradiol 
production seen in all size ranges of follicles.
The present study was set up to study the effects of IGF-I acting via only the IGF 
receptor, through blocking the insulin receptor with the use of an insulin receptor 
mouse monoclonal antibody. However, from the results it can be seen that the 
addition of the insulin receptor antibody had no significant effect on growth or 
oestradiol production, suggesting that the antibody may not have been able to get 
across the follicular wall. In addition, insulin has been shown in previous studies to 
exert various effects on ovarian cell types. Proliferation and differentiation of 
cultured human (Duleba et al. 1998) and porcine (Amsterdam et al. 1988; Barbieri et 
al. 1983) somatic cells have been stimulated in the presence of insulin. Furthermore, 
insulin has been shown to have direct effects on bovine ovarian function. It has been 
shown to stimulate granulosa cell proliferation (Gutierrez et al. 1997) and 
steroidogenesis (Gong et al. 1994; Gutierrez et al. 1997; Spicer et al. 1993), and 
these effects are influenced by the dose and size of follicle. Hence, by blocking 
insulin receptors, the beneficial effects of insulin were also being blocked, resulting 
in poor follicle growth and oestradiol production. Insulin appears to be crucial for 
normal bovine follicle growth at this stage, so by blocking its actions no conclusion 
can be reached on the effects of any other factors as the follicles cannot develop in 
the absence of insulin. This does not appear to be an appropriate way to analyse 
whether IGF-I is able to exert a stimulatory effect on follicle proliferation and
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differentiation via the IGF receptors alone at this particular stage of follicular 
development. A possible alternative way to address the question of whether IGF-I is 
mediating its actions via the insulin and IGF-I receptors would be to culture follicles 
in a high concentration of LR3 IGF-I. This would determine whether at this high 
dose there is the same stimulatory effect on follicle growth seen in follicles cultured 
in the presence of a high dose of recombinant IGF-I, bearing in mind that the 










Insulin-like growth factor binding proteins can regulate the availability of IGFs to 
their target cells by either inhibiting or potentiating their action (Giudice 1992). 
IGFBPs can sequester extracellular IGFs and hence reduce the number of 'free' IGFs 
available for specific cell surface receptors; this then inhibits any mitogenic actions 
of the IGFs. Two mechanisms by which facilitation of the IGF can be increased is by 
the activity of specific IGFBP proteases and changes in the expression of the IGFBPs 
(Giudice 1992). At present, mRNA encoding IGFBP-2 to -5 has been detected in 
bovine follicles (Armstrong and Webb 1997), and IGFBP-2, -4 and -5 mRNA have 
been found in the ovine follicle (Besnard et al. 1996a). IGFBP-2 mRNA has been 
found to be present in the granulosa cells and oocytes of bovine preantral and early 
antral follicles (Armstrong et al. 2002), as well as the granulosa cells of larger antral 
follicles (l-8mm) (Armstrong et al. 1998). Furthermore, immunoreactive IGFBP-2 
has been detected around granulosa cells from bovine follicles at the preantral stage 
(Armstrong et al 2002). There is a decrease in the concentration of IGFBP-2 in 
follicular fluid in cows (Armstrong et al. 1998) and sheep (Besnard et al. 1996a) 
during late follicular growth, which has been shown to be due to a loss of expression 
of mRNA encoding IGFBP-2 in granulosa cells in dominant follicles and proteolytic 
activity (Spicer et al. 2001). Likewise, the porcine ovary has been shown to express 
IGFBP-2, -3, -4 and -5 mRNA (Zhou et al. 1996), and - similar to cattle and sheep - 
IGFBP-2 mRNA and protein levels were also found to decline with an advance in 
follicle development (Samaras et al. 1993).
At various stages of follicle development the regulation of IGF-I bioavailability by 
IGFBPs is important for normal follicle and oocyte development. The identification 
of IGF-I binding in bovine preantral follicles (Wandji et al. 1992), coupled with the 
recent detection of expression of type I IGF receptor and IGFBP-2 mRNA from the 
preantral stage (Armstrong et al. 2002), suggests a role for the IGF system in early 
follicle development. Therefore, it is important to understand the mechanisms 
involved in regulating the expression of IGFBPs and hence the availability of IGF to 
its receptors at different stages of growth. Changes in the effects of IGF-I (Monniaux 
and Pisselet 1992), and the expression of IGFBPs from early to late follicle
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development (Monget et al. 1996), further supports the view that the need for IGF-I 
stimulation is dependent on the stage of follicle development.
This current study aimed to identify if IGF-I plays a role in regulating the expression 
of IGFBP-2 at different stages of follicle growth. In particular, the expression of 
IGFBP-2 in the oocyte and somatic cells during the crucial transition from late 
preantral to early antral stages was investigated.
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5.2 Materials and methods
5.2.1 Follicle isolation and culture
In Chapter 4 [experiment 2 (The effect of HRIGF-I in the presence or absence of the 
IGFBP regulatory mechanism)], follicles were cultured to determine the effect of 
IGF-I on early antral bovine follicular development. Once fixed and mounted on 
slides they underwent immunocyctochemistry for IGFBP-2. Briefly, early antral 
follicles in three size ranges (165(im-215|am, 216um -280um and 281um -380um) 
were isolated from bovine ovaries and cultured for 2, 4 or 6 days, as described in 
Chapter 2. Only follicles cultured for 6 days were used for immunocytochemistry for 
IGFBP-2.
5.2.2 Treatments
Culture medium (control) was prepared as described in 2.3.1. Human recombinant 
IGF-I (HR IGF-I), which does bind to IGFBPs, was purchased from Sigma 
Chemicals, Poole, UK. Two doses of HR IGF-I were used: a low dose of lOng/ml 
and a high dose of 1 (4,g/ml. The low dose represented a physiological dose that would 
be able to bind to the IGFBPs and would therefore be regulated by the level of 
IGFBPs present. The high dose, on the other hand, would swamp the IGFBPs 
present, allowing IGF-I to bypass any regulatory mechanism of the IGFBPs and 
hence bind freely to IGF receptors. Under these conditions it is also possible that the 
IGF-I may be able to bind to the insulin receptors, as well as the IGF receptors, to 
exert an action.
5.2.3 Detection of IGFBP-2 by immunocytochemistrv
Details of the procedure used have been described already by Armstrong et al (1998; 
2002). At the end of the culture period, follicles were fixed in 4% paraformaldehyde, 
embedded in paraffin wax and mounted on slides, as described in Chapter 2. Sections 
were dewaxed in xylene and rehydrated from ethanol to distilled water, and washed 
in PBS (2x5 minutes, Sigma Chemicals, Poole, UK). The expression of IGFBP-2 
was detected in follicles cultured for 6 days. Antigen retrieval was performed by 
placing sections (6|am) in 0.01M citrate buffer [2x5 minutes (600W)], and slides
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were left for 20 minutes at room temperature, before being washed in phosphate 
buffer solution (PBS, 2x5 minutes). Endogenous peroxidase was blocked by placing 
sections in 1% hydrogen peroxide for 10 minutes, followed by washing (2x5 minutes 
in PBS). The rabbii anti-bovine IGFBP-2 antiserum (Upstate Biotechnology 
Incorporated, Lake Placid, NY) was diluted 1:200 before use. After probing with 
primary antibody, the sections were washed and stained using goat anti-rabbit IgG 
labelled with horseradish peroxidase (1:100) (Sigma Chemicals, Poole, UK). 
Replacing primary antibody with normal rabbit serum, or saturating the primary 
antibody with antigen, was performed to detected non-specific binding. The section 
containing the oocyte nucleolus, or if this was absent, the largest cross-section of the 
oocyte was used for observations.
5.2.4 Detection of IGFBP-2 bv in situ hybridisation
At the end of the culture period, follicles were fixed in 4% paraformaldehyde, 
embedded in paraffin wax and mounted on slides, as described in Chapter 2. Samples 
were then taken to Roslin Institute were detection of IGFB-2 by in situ hybridisation 
was performed by Jerry Baxter, Karen Troup and Elaine McCullough. Details of the 
procedure used have been described already by Armstrong et al. (1998; 2002). The 
expression of IGFBP-2 was detected in follicles in all size ranges, cultured for 2, 4 
and 6 days. Sections (6|^m) were dehydrated, fixed and probed with 35S-labelled 
IGFBP-2 riboprobe. After the final high stringency wash, the sections were dipped in 
autoradiographic K2 photographic emulsion (Ilford Limited, Mobberley, Cheshire, 
UK) and exposed for 6 weeks at 4°C. Sections were developed (Kodak D-19, 
Edinburgh, UK) and fixed using Hypam fixer (Ilford Limited) before staining in 
haematoxylin and eosin. The sections were finally mounted in DPX mountant (R. A. 
Lamb, UK) before microscopic examination using both light- and dark-field 
illumination.
5.3 Image analysis
Details of the procedure used have been described already by Armstrong et al (1998). 
The intensity of the in situ hybridisation signal was analysed using an NUi-Image 
analysis system (NIH, Bethesda, MD). The number of graphic pixels occupied by
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silver grains (identified by a set grey threshold) within a defined area of the tissue 
section was counted and presented as a percentage of the total pixel number within 
the defined area. The section containing the oocyte nucleolus, or if this was absent, 
the largest cross-section of the oocyte was used for observations. Within each follicle 
the oocytes and three separate defined areas of granulosa cells were analysed. The 
hybridisation intensity, therefore, was the percentage of occupied pixels to total 
pixels within a defined area of the tissue. Background hybridisation intensity, 
measured with the sense RNA probes, was subtracted from the measurements 
obtained with the antisense probes to give the final hybridisation signal.
5.4 Statistical assessment
The data set was normally distributed in accordance with the Anderson-Darling test, 
variances were homogeneous and treatment groups were randomly assigned, 
therefore, a powerful parametric test could be used to analysis samples.
The intensity of staining for mRNA IGFBP-2 in granulosa cells was compared 
between days using one-way ANOVA. No significant difference was found between 
the day of culture within a treatment group; therefore, data for the three different 
culture days within each treatment group were grouped together. Differences in the 
intensity of mRNA IGFBP-2 staining in the granulosa cells and oocytes was 
investigated using one-way ANOVA.
The total number of granulosa cells showing staining and no staining for IGFBP-2 
protein was recorded for each follicle. The number of granulosa cells expressing 
IGFBP-2 protein was expressed as a percentage of the total granulosa cells present 
for each follicle. Mean percentage of granulosa cells showing expression of IGFBP-2 
protein was calculated for each treatment group and then compared between 
experimental groups using a one-way ANOVA.
The total number of follicles that exhibited staining for IGFBP-2 protein, and those 
showing no staining for IGFBP-2 protein in their granulosa cells or oocyte in each 
treatment group, was also recorded. The number of follicles showing staining for
149
Chapter 5
IGFBP-2 protein in their granulosa cells or oocytes was calculated as a percentage of 
the total number of follicles and displayed as bar charts. Percentages were analysed 
using a 2-proportion test. The 2-proportions test was chosen as each group was 
compared to one another and this method tests whether two binomial proportions are 





5.5.1 Effect of IGF-I on the level of expression of IGFBP-2 (mRNA) in 
qranulosa cells and oacvtes
Figure 5.1
mRNA IGFBP-2 expression in bovine follicles
Light-field illumination (a and c) and dark-field illumination of bovine ovarian follicles on day 6 of 
culture hybridised with antisense (a and b) and sense (c and d) riboprobes for IGFBP-2 detection. 
Intense staining was found in the granulosa cells and oocytes of follicles hybridized with antisense 
35S-IGFBP-2 riboprobe (b). No staining was found in follicles hybridized with sense 35S-IGFBP-2 
riboprobe (d).
mRNA IGFBP-2 was observed in the granulosa cells and oocytes of follicles on all 
days, in all treatment groups and in all size ranges (Figure 5.1).
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Chapter 5
No significant difference was found between the day of culture within a treatment 
group (Figure 5.2); therefore, data from the three different culture days within each 
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Chapter 5
The total number of separate defined areas of granulosa cells analysed in each size 
range for figures 5.2 and 5.3 is n= 54 for 165-215|am, n= 54 for 216-280^m and n= 
51 for 281-380jj,m. The total number of oocytes analysed in each size range is n= 18 
for 165-215(j.m, n= 184br 216-280^m and n= 17 for 281-380nm.
mRNA IGFBP-2 was observed in the granulosa cells and oocyte of follicles on all 
days, in all treatment groups and in all size ranges (Figure 5.1). Initial analysis 
showed that there was no significant difference in hybridisation intensity between 
days (Figure 5.2) or treatment groups (Figure 5.3). Therefore, the effect of IGF-I on 
IGFBP-2 protein production was investigated.
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5.5.2 Effect of IGF-I on the percentage of follicles expressing IGFBP-2 
(protein) in their granulosa cells
= 20.6 = 19.68
Figure 5.4
IGFBP-2 immunoreactivity in bovine follicles
Histological sections of bovine ovarian follicles on day 6 of culture after immunocytochemistry with 
(a) normal rabbit serum or (b) an antibody raised against bovine recombinant insulin-like growth 
factor binding protein-2 (IGFBP-2). la and Ib = oocyte, granulosa and theca cells; 2a and 2b = 
granulosa and theca cells.
Protein IGFBP-2 was observed in the granulosa cells and oocyte of follicles in all 
treatment groups and in all size ranges (Figure 5.4).
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165-215 216-280 281-380 
Follicle diameter size range (|im)
Figure 5.5
Effect of IGF-I on the percentage of granulosa cells expressing IGFBP-2 (protein) on
day 6 of culture
DayO = , Control = , IGF-I 10ng/ml = and IGF-I l|ag/ml =
Values are the mean percentage of granulosa cells showing staining for IGFBP-2 for each treatment 
group within each size range.
The total number of follicles in each size range for figures 5.5, 5.6 and 5.7 was n= 39 
for 165-215^im, n= 38 for 216-280|im and n= 31 for 281-380|im.
No significant difference was found between treatment groups in the mean 
percentage of granulosa cells showing staining for IGFBP-2 protein (Figure 5.5).
No significant different was found between treatment groups in the mean percentage 
of granulosa cells exhibiting staining for IGFBP-2 protein (Figure 5.5). Therefore, 
the actual total number of follicles showing expression for IGFBP-2 was calculated 






165-215 216-280 280-380 
Follicle diameter size range (u,m)
Figure 5.6
Effect of IGF-I on the percentage of follicles expressing IGFBP-2 (protein) in their
granulosa cells on day 6 of culture
. Control = IDay 0 = [ .IGF-I I0ng/ml = , IGF-I lug/ml =
The total number of follicles in each size range is n= 39 for 165-215um, n- 38 for 216-280u.m and n=
31for281-380|am.
Values are the mean percentage of follicles showing staining for IGFBP-2 in their granulosa cells for
each treatment group within each size range.
No significant differences in the percentage of follicles expressing IGFBP-2 in their 
granulosa cells were found in the smallest size range of follicles (165-215(im). 
However, a significant decrease in IGFBP-2 expression was found in medium 
follicles cultured in l|ig/ml IGF-I compared to the level of expression seen in the 
Day 0 follicles (p<0.05). Furthermore, in the largest size range (281-380|im), there 
was a significant decrease in the number of follicles expressing IGFBP-2 in the 
control and lOng/ml IGF-I treatment groups compared to that seen in the Day 0 
experimental group (p<0.05). Follicles cultured with lug/ml IGF-I were found to 
maintain the level of expression seen in the Day 0 follicles, and therefore had a 
significantly higher percentage of follicles expressing IGFBP-2 than those seen in the 
control and lOng/ml IGF-I treatment groups (p<0.05) (Figure 5.6).
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5.5.3 Effect of IGF-I on the percentage of follicles expressing IGFBP-2 
(protein) in their oocvtes
100 T
a
165-215 216-280 280-380 
Follicle diameter size range (|im)
Figure 5.7
Effect of IGF-I on the percentage of follicles expressing IGFBP-2 (protein) in their
oocytes on day 6 of culture
, IGF-I 10ng/ml = _DayO = , Control = , IGF-I lug/ml =
'n' numbers are the same as in Figure 5.3. Values are the mean percentage of follicles showing 
staining for IGFBP-2 in their oocytes for each treatment group within each size range.
No significant difference was found between treatment groups in the percentage of 
follicles expressing IGFBP-2 in their oocytes in follicle groups with a small and 
medium size range (165-215(im and 216-280jj.ni). However, a significant decrease in 
IGFBP-2 expression was found in the largest size range (281-380(im) of follicles 










246nm ± 3.26 313um ± 5.2
% of granulosa cells 
expressing IGFBP-2
% of follicles expressing 
IGFBP-2 in their granulosa 
cells
% of follicles expressing 
IGFBP-2 in their oocytes
No effect No effect
No effect J, when cultured with 
lUg/ml HR IGF-I
No effect No effect
No effect
-I when cultured with 
control or 10 ng/ml 
HR IGF-I
<!• when cultured with 
control or lOng/ml 
HR IGF-I
Figure 5.8
Summary of the effects of human recombinant IGF-I on IGFBP-2 (protein) expression 




Previous work has outlined the involvement of IGFBP-2 in the regulation of IGF-I 
bioavailability (Armstrong et al. 1998; Armstrong et al. 2002; Monget et al. 2002; 
Perks and Wathes 1996; Yuan et al. 1998). It has been hypothesised that IGFBP-2 
present in the early stages of follicle growth will bind any IGF arriving from the 
circulation or adjacent antral follicles and regulate its access to the type I IGF 
receptors in the oocyte and granulosa cells (Armstrong et al. 2002). This study has 
confirmed that IGFBP-2 (mRNA and protein) is expressed in the oocyte and 
granulosa cells of early antral follicles. Furthermore, IGF-I has been identified as a 
growth factor that plays a role in controlling the expression of IGFBP-2, and this 
regulatory effect appears to be dependent on the stage of follicle development.
Armstrong et al. (1998) showed that in vitro, FSH strongly inhibits expression of 
IGFBP-2 mRNA by bovine granulosa cells taken from antral follicles (4-8mm in 
diameter). Similarly, FSH was shown to strongly decrease the expression of 
IGFBP-4 and -5 by rat granulosa cells (Liu et al. 1993). By contrast, FSH was found 
to have no effect on IGFBP-2 production in ovine granulosa cells (Armstrong et al. 
1996). Follicles can grow to the early antral stage in the absence of gonadotrophins 
(Aworwi et al 1984; Gong et al. 1996), and are not dependent upon gonadotrophin 
control until later in antral development. Although there is some evidence to suggest 
that FSH might have a role in the rate of preantral development in sheep (Campbell 
et al. 2004), it seems unlikely that FSH would be involved in playing a crucial role 
during these early stages of development.
The correct regulation of IGFBPs during follicle development is essential to ensure 
that the follicle is not under or over exposed to circulating IGFs. IGFBP expression 
in larger antral follicles than used in the current study have been found to be 
influenced by the presence of various hormones and growth factors (Chamberlain 
and Spicer 2001; Sakal et al. 1992; Voge et al. 2004). FSH in the presence or 
absence of insulin was found to increase IGFBP-2 mRNA but not change IGFBP-2, 
-4 or -5 mRNA levels in granulosa cells of antral follicle 1-5 mm in diameter. 
Furthermore, oestradiol was found to increase IGFBP-2 mRNA in the presence of
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insulin, and LH increased IGFBP-3 mRNA levels. In larger follicles (7-9 mm) 
insulin was found to increase IGFBP-2 gene expression, while oestradiol decreased 
IGFBP-5 mRNA levels (Voge et al. 2004). In a similar study, the production of 
IGFBP-2 and -5 by granulosa cells was inhibited by insulin, with EGF and bFGF 
further enhancing insulin's inhibitory actions (Chamberlain and Spicer 2001). These 
results indicate that the expression of IGFBPs is differentially regulated by various 
stimuli, and hence allows different levels of regulation for the bioavailability of 
IGFs. IGF itself has been shown to play a role in the control of ovine granulosa cell 
IGFBP-2 production, where both FSH and IGF-I were necessary for maximum 
production of IGFBP-2 (Armstrong et al. 1996). Grimes and Hammond (1992) 
showed that IGF-I in a dose-dependent manner significantly stimulated the 
production of IGFBP-2 and -3 in granulosa cells taken from 4-6 mm diameter 
porcine follicles. Furthermore, the synthetic analogue, LR3-IGF-I, which has a low 
affinity for IGFBPs, was shown to have a significantly greater potency in stimulating 
the production of these IGFBPs than IGF-I. These results suggest that IGFBP 
production is regulated via the type I IGF-I receptor, and that an increase in IGF 
activity stimulates the production of IGFBPs, which in turn reduces the 
bioavailability of the IGFs. The results found in this current study (summarised in 
Figure 5.8) support the findings that IGF-I can stimulate IGFBP-2 expression in a 
dose-dependent manner. It was found that the percentage of follicles expressing 
IGFBP-2 in their granulosa cells in the largest size group decreased when IGF-I was 
absent or the concentration present was low. By contrast, when the follicles were 
cultured in a high concentration of IGF-I the high level of expression of IGFBP-2 
found in the Day 0 follicles was maintained. Oestradiol in the presence of insulin 
has been shown previously to increase IGFBP-2 mRNA expression in granulosa cells 
of antral follicles (l-5mm in diameter) (Voge et al. 2004), and interestingly in the 
present study there was found to be a significant increase in oestradiol production in 
the follicles cultured in the high dose of IGF-I (see Chapter 4 results), which also 
exhibited a high level of IGFBP-2 expression. However, it is unclear whether the 
increase in oestradiol production in the present study was directly responsible for the 
increase in IGFBP-2 expression. The results presented here suggest that at this stage 
in development the granulosa cells have differentiated enough to be able to respond
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to the action of IGF-I by adjusting the expression of IGFBP-2, possibly by a negative 
feedback mechanism. Furthermore, the oocyte appears to have developed to a stage 
where it can also modulate the expression of IGFBP-2 to regulate IGF 
bioavailability.
For the ovarian follicle to develop properly a complex set of reciprocal interactions 
between the oocyte and granulosa cells is required. Recent evidence has shown that 
the influence of the oocyte on granulosa cell changes and vice versa; it alters with the 
progression of their development (Latham et al. 2004). In vivo (Armstrong et al. 
2001) and in vitro (McCaffery et al. 2000) studies have shown that inappropriate 
exposure of the oocyte to IGF-I within preantral follicles is detrimental to oocyte 
development during early follicle growth. However, in the present study, the 
expression of IGFBP-2 in follicles in the size range 165-215um was found not to 
respond to the presence of IGF. This implies that the follicles are still at an immature 
stage of development, where the oocyte has not yet advanced and the granulosa cells 
have not differentiated to a stage of growth where a mechanism of regulation for 
IGFBP-2 has developed. However, when a high concentration of IGF-I was present, 
follicles in the size range 216-280pim were able to respond to IGF-I by modulating 
the expression of IGFBP-2. It could be hypothesised that at this high concentration, 
IGF-I would not be regulated as it would be able to bypass the IGFBPs and thus have 
a direct action on the follicle. This inappropriate exposure of the follicle to IGF-I 
may allow the granulosa cells to accelerate in their development to a stage where 
they become differentiated enough to respond to IGF-I by modulating the expression 
of IGFBP-2. Conversely, the oocyte remains unaffected by this high concentration, 
suggesting that at this stage of growth the actions of IGF-I on granulosa cells and the 
oocyte are independent of each other, and are instead influenced by the 
developmental stage and size of the follicle.
In conclusion, this work has shown that IGF-I can play a role in regulating its own 
bioavailability by influencing the expression of IGFBP-2. It is now clear that the 
biological actions of IGF depend in part on the ability of specific proteases to break 
down the IGF/IGFBP complex and/or the level of expression of the IGFBPs (Giudice
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1992). The results from this study suggest that IGF-I may regulate the expression of 
IGFBP-2 through a negative feedback mechanism, which again is stage dependent. 
The control of local growth factors by regulatory mechanisms needs to be more fully 
investigated, as it appears to be key to developing an in vitro culture system that will 
accelerate follicle development without causing precocious differentiation to occur. 
The culture medium used in this system was not supplemented with FSH, as IGFs are 
well known to work in synergy with gonadotrophins to promote follicular 
development (Spicer et al 1993; Zhao et al. 2001) and this study wanted to solely 










The bioavailability of IGFs is regulated by a family of IGF binding proteins 
(IGFBPs) that bind IGF with higher affinity than the IGF-I and -II receptors. Hence, 
effects of IGF can be regulated at the level of the target cells (Jones and Clemmons
1995). The IGFBP family consists of at least six structurally related proteins 
(IGFBP-1 to -6) with high but different affinities for IGF-I and IGF-II (Jones and 
Clemmons 1995), and a number of IGFBP-related proteins with lower affinities for 
IGFs (Kirn et al. 1997; Nicholas et al. 2002). The affinity of IGFBPs for IGFs is 
regulated by a number of post-translational modifications, including 
phosphorylation, glycosylation and proteolytic cleavage (Firth 1998).
Follicular growth is associated with changes in IGFBP concentrations more than with 
changes in the IGF-I and -II ligands (Spicer and Echternkamp 1995; Stewart et al.
1996). At specific developmental stages during the growth of the follicle the relative 
ratio of the IGFs to IGFBPs varies, allowing cell-specific growth promoting effects 
of the IGFs. Proteases are enzymes that catalyse the breakdown of peptide bonds by 
the process of proteolysis, and the proteolytic cleavage (degradation of the 
IGF/IGFBP complex) of IGFBPs by proteases generally results in reduced affinity of 
the fragments for IGFs (Cwyfan-Hughes et al. 1997; Rajaram et al. 1997). Members 
of several classes of proteases have shown the ability to degrade IGFBPs, including 
kallikreins, cathepsins, PAPP-A and matrix metalloproteinases (Firth and Baxter 
2002; Rajah et al. 1995). Proteolysis of IGFBPs has been detected in follicular fluid 
from humans (Chandrasekher et al. 1995; Cwyfan-Hughes et al 1997), cattle (Rivera 
et al. 2001; Spicer et al. 2001), ewes (Besnard et al. 1996b; 1997; Mazerbourg et al. 
1999), mares (Bridges et al. 2002) and pigs (Besnard et al. 1997), and the amounts 
and activity of these enzymes change during follicle development. Expression of the 
mRNAs encoding IGFBP-2 to -5 have been found in bovine follicles and expression 
of IGFBP-2, -4 and -5 in ovine follicles (Webb et al. 1999). In the cow (Roberts and 
Echternkamp 2003) and in the ewe (Besnard et al. 1996a; Monget et al. 1993) 
follicular growth is characterised by an increase in IGFBP-3 and a decrease in 
IGFBP-2, -4 and -5 levels. By contrast, follicular atresia is associated with a slight 
decrease in IGFBP-3 levels in the ewe (Monget et al. 1993) and a large increase in
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IGFBP-2, -4 and -5 in both the ewe and heifer (Monget et al. 1993; Roberts and 
Echternkamp 2003).
The decrease in IGFBP-2 concentration in follicular fluid in cows (Armstrong et al. 
1998) and sheep (Besnard et al. 1996a) during follicular growth has been shown to 
be due to a loss of expression of mRNA encoding IGFBP-2 in granulosa cells in 
dominant follicles (Armstrong et al. 1998). However, recent data has confirmed that 
the decrease in IGFBP-2 is also partly due to an increase in IGFBP-2 proteolytic 
degradation (Besnard et al. 1996b; Monget et al. 2003; Spicer et al. 2001). This in 
turn would increase the available 'free' IGF and hence increase FSH responsiveness 
of the granulosa cells. In contrast to the expression of the mRNA encoding IGFBP-2 
in granulosa cells, the expression of mRNA encoding IGFBP-4 in thecal tissue does 
not change during follicular growth (Armstrong et al. 1998; Besnard et al. 1996a). 
The decrease in IGFBP-4 concentration in follicular fluid during the development of 
the follicle is due entirely to a corresponding increase in the activity of a specific 
IGFBP-4 protease (Besnard et al. 1996a). Indeed, the finding that IGFBP-4 
proteolytic activity is higher in dominant, oestrogen-active follicles than in 
subordinate follicles of the same cohort suggests that the IGFBP-4 protease plays a 
role in the establishment of ovarian follicular dominance in cattle (Rivera et al. 
2001).
During follicle development, IGFBP-2 and type I IGF receptor have been detected in 
granulosa cells and oocytes of bovine preantral (Armstrong et al. 2000; 2002) and 
antral follicles (Armstrong et al. 1998; 2000, see Chapter 5 results). Furthermore, the 
oocyte, cumulus and mural granulosa cells of preovulatory follicles have also been 
shown to express IGFBP-2 and type I IGF receptor (Nuttinck et al. 2004), implying 
that a fully functional IGF system is present throughout the majority of the bovine 
follicular growth phase. Evidence of a small, yet significant, amount of IGFBP-2 
proteolytic activity in bovine subordinate (>1 mm in diameter) and preovulatory 
follicles was confirmed by the appearance of a 12-kDa breakdown product of 125I- 
IGFBP-2 (Spicer et al. 2001). It was found that large dominant follicles had a 
significantly lower IGFBP-2 proteolytic activity than the subordinate small and large
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follicles (Spicer et al 2001). Furthermore, proteolysis of 125I-labelled IGFBP-2 was 
negatively correlated with follicular fluid oestradiol and positively correlated with 
follicular fluid levels of IGFBP-2 (Spicer 2004). IGFBP-2 proteolytic activity during 
follicle growth has also been detected in horses (Bridges et al. 2002), sheep (Besnard 
et al. 1996b) and pigs (Besnard et al. 1997). However, in contrast to cattle, there is a 
small increase in IGFBP-2 proteolytic activity during follicle growth in sheep 
(Besnard et al. 1996b) and pigs (Besnard et al. 1997), but no change during follicle 
growth in horses (Bridges et al. 2002). Recently, Pregnancy-Associated Plasma 
Protein-A (PAPP-A), which is known to be a IGFBP-4 protease in a variety of 
species (human: Conover et al. 2001; ovine, bovine, porcine and equine: Mazerbourg 
et al. 2001), has now been identified as a protease present in bovine, equine and 
porcine follicular fluid capable of cleaving IGFBP-2 (Gerard et al. 2004; Monget et 
al. 2003).
FSH in human (Adachi et al. 1995) and rat (Liu et al. 1993; Fielder et al. 1993) 
granulosa cell cultures has been shown to induce proteolysis, while IGFs have been 
found to block FSH-induced proteolysis of IGFBP-5 in cultured rat granulosa cells 
(Fielder et al. 1993) and to block IGFBP-3 proteolytic degradation in porcine 
granulosa cell cultures (Grimes and Hammond 1994). The mechanism by which IGF 
inhibits protease activity in these culture systems is unclear. However, mediation by 
IGF receptors is unlikely as antagonism of receptor action was found not to alter 
intrinsic degradation of IGFBP-3 in porcine granulosa cells. Furthermore, IGF-I 
inhibited degradation in cell-free conditioned medium, which suggests direct 
stabilisation of IGFBP-3 via binding of IGFs, whilst LR3 IGF-I attenuated IGFBP-3 
degradation even though it has a low affinity for IGFBPs. IGFs may, therefore, 
inhibit proteases directly (Grimes and Hammond 1994). Contrary to these results, 
data from human granulosa cell cultures shows that binding of IGF to IGFBP-4 
actually increases the susceptibility of IGFBP-4 to proteolysis (Iwashita et al. 1998) 
and similarly, incubation of IGF-I and follicular fluid from bovine, porcine and 
equine preovulatory follicles enhances IGFBP-2 (Gerard et al. 2004; Monget et al. 
2003) and IGFBP-4 (Mazerbourg et al. 2000) degradation.
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Oocytes have been shown recently to play a role in regulating and controlling their 
own development. Indeed, oocytes may secrete many proteins during their 
development whose functions, at the present time, remain unknown (Eppig et al. 
2002). The identification and characterisation of oocyte-secreted factors is crucial to 
resolving the mechanisms by which the oocyte can orchestrate follicular 
development. The presence of mRNA encoding IGF receptors and IGFBP-2 in the 
granulosa cells and oocyte of bovine follicles from the preantral stage and onwards 
highlights the importance of the IGF system throughout follicular development 
(Armstrong et al. 1998; 2000; 2002; Nuttinck et al. 2004, see Chapter 5 results). The 
production of specific IGFBP proteases by the oocyte and/or granulosa cells would 
provide a regulatory mechanism whereby the oocyte and/or granulosa cells can 
regulate their own exposure to IGFs. Furthermore, recent studies in cattle have 
demonstrated that the oocyte can secrete paracrine growth factors that can interact 
with the surrounding cumulus cells to modulate their gonadotrophin and IGF- 
stimulated steroidogenesis (Glister et al. 2003; Li et al. 2000).
IGF-I or IGF-II
(From C'fcuWion or larger fofcctes)
IGFBP Protease




Diagrammatic representation of hypothetical mechanism by which bovine oocytes 




Previous studies have shown that preovulatory follicular fluid contains proteases 
capable of degrading IGFBP-2 (Spicer et al. 2001; Bridges et al. 2002; Besnard et al. 
1996b; Besnard et al. 1997); however the cell type producing these proteases is 
unknown. With this knowledge, the present study hypothesised that the bovine 
oocyte, cumulus and/or mural granulosa cells were capable of secreting IGFBP-2 
proteases at specific stages of development to increase IGF bioavailability, and hence 
IGF actions. This regulatory mechanism would allow the oocyte and granulosa cells 
to regulate their own exposure to IGFs (Figure 6.1). Therefore, the aim of this work 
was to identify the occurrence of IGFBP-2 proteolysis as a result of the incubation of 
intact IGFBP-2 with different bovine follicular compartments. Furthermore, the 




6.2 Materials and methods
6.2.1 Collection of follicular fluid, oocvte-cumulus complexes, denuded 
oocvtes and mural aranulosa cells
Bovine follicular fluid, oocyte-cumulus complexes, denuded oocytes and granulosa 
cells were obtained, as described in Chapter 2.
6.2.2 Production of concentrated conditioned medium
To rule out the possibility that a dilution effect was occurring because bovine oocyte- 
cumulus complexes and denuded oocytes were only producing proteases capable of 
cleaving IGFBP-2 in very low concentrations, xlO concentrated samples of oocyte- 
cumulus complex, denuded oocyte and mural granulosa cell conditioned media were 
prepared before being incubated with intact IGFBP-2. Oocyte-cumulus complex (2.5 
oocytes/jjl), denuded oocyte (2.5 oocytes/(j,l) and granulosa cell concentrated 
conditioned media were obtained by collection of lOOul of conditioned media for 
each treatment group, which was lyophilised and then reconstituted in lOjal dlr^O to 
give a xlO concentrate.
6.2.3 Measurement of IGFBP-2 cleavage
IGFBP-2 (31 kDa) (Ing/ml) (GroPep Limited, Adelaide, Australia) was incubated 
for 20 hours with oocyte-cumulus complex (2.5 oocytes/jal), denuded oocyte (2.5 
oocytes/fil), granulosa cells (6,900/ul) (measured using Improved Neubauer 
haemocytometer, Hawksley, England) or concentrated conditioned media. Intact 
IGFBP-2 alone and follicular fluid (previously shown to cleave IGFBP-2 (Spicer et 
al. 2001)) cultured with intact IGFBP-2, were used as negative and positive controls 
respectively. To investigate if FSH and/or IGF-I had the ability to enhance or inhibit 
the degradation of IGFBP-2, FSH (300mIU/ml) (Puregon, Organon) or human 
recombinant IGF-I (lOng/ml) (Sigma Chemicals, Poole, UK) were incubated with 
the IGFBP-2 and conditioned media. Proteolytic activity was analysed by 




6.3.1 Detection of proteolvsis of IGFBP-2 bv oocvte-cumulus complexes, 
denuded oocvtes and mural aranulosa cells
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Figure 6.2
Representative immunoblot measuring IGFBP-2 proteolytic activity of bovine oocytes 
and granulosa cells
Lanes 1-3 and 5 are samples containing oocyte-cumulus complexes, denuded oocytes, mural 
granulosa cells and bovine follicular fluid respectively, which have been incubated with IGFBP-2. 
Lane 4 contains intact IGFBP-2.
Several breakdown products of IGFBP-2 - of approximately 21 kDa, 15 kDa and 14 
kDa, as well as 21 kDa and 15-kDa - were identified from the incubation of mural 
granulosa cells and bovine follicular fluid (positive control) with IGFBP-2 
respectively. No breakdown fragments were detected in the lane containing intact 
IGFBP-2 alone (negative control). In both the mural granulosa cell and follicular 
fluid samples the major breakdown product appeared to be at approximately 21 kDa. 
Incubation of IGFBP-2 with oocyte-cumulus complexes and denuded oocytes 















Representative immunoblot measuring IGFBP-2 proteolytic activity of bovine oocytes 
and granulosa cells in the presence of FSH or IGF-I
Lanes 1-3 are samples containing oocyte-cumulus complexes, denuded oocytes and mural granulosa 
cells respectively, which have been incubated with IGFBP-2 in the presence of FSH. Lanes 4-6 are 
samples containing oocyte-cumulus complexes, denuded oocytes and mural granulosa cells 
respectively, which have been incubated with IGFBP-2 in the presence of IGF-I. Lane 7 contains 
granulosa cells incubated with IGFBP-2.
Cleavage of IGFBP-2 was again observed after incubation of mural granulosa cells 
alone, and was also observed in the presence of FSH or IGF-I. Intact IGFBP-2 was 
found to migrate again at approximately 21 kDa and 14 kDa, with 21 kDa being the 
major breakdown product. The presence of FSH or IGF-I did not appear to inhibit or 
enhance proteolysis of IGFBP-2, brought about by the incubation of intact IGFBP-2 
with mural granulosa cells. Oocyte-cumulus complexes and denuded oocytes 
incubated with intact IGFBP-2 in the presence of FSH or IGF-I failed to result in any 
proteolysis of IGFBP-2 (Figure 6.3).
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Representative immunoblot measuring IGFBP-2 proteolytic activity of bovine oocyte 
and granulosa cell concentrated conditioned media alone, or in the presence of IGF-I
Lanes 1-3 are samples containing oocyte-cumulus complex, denuded oocyte and mural granulosa cell 
concentrated conditioned media respectively, which have been incubated with IGFBP-2. Lanes 4 and 
6 are denuded oocytes and denuded oocyte concentrated conditioned media respectively, which have 
been incubated with IGFBP-2 in the presence of IGF-I. Lanes 5 and 7 are samples containing oocyte- 
cumulus complexes and oocyte-cumulus complex concentrated conditioned media respectively, which 
have been incubated with IGFBP-2 in the presence of IGF-I.
To identify if bovine oocyte-cumulus complexes and denuded oocytes were 
producing proteases capable of cleaving IGFBP-2, but in very low concentrations, 
xlO concentrated samples of oocyte-cumulus complex (see section 6.2.2), denuded 
oocyte and mural granulosa cell conditioned media were incubated with IGFBP-2. 
Mural granulosa cell concentrated conditioned media was found to cleave IGFBP-2 
with a breakdown product of approximately 21 kDa. However, intact IGFBP-2 was 
not found to be cleaved by a 20 hour incubation with oocyte-cumulus complex and 
denuded oocyte concentrated conditioned media; furthermore, the presence of IGF-I 
did not enhance proteolysis of IGFBP-2 (Figure 6.4).
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Representative ligand blot measuring IGFBP-2 proteolytic activity of bovine oocytes
and granulosa cells
Lanes 1, 4 and 7 are samples containing mural granulosa cells incubated with intact IGFBP-2 alone or 
in the presence of IGF-I or FSH respectively. Lanes 2, 5 and 8 are samples containing denuded 
oocytes incubated with intact IGFBP-2 alone or in the presence of IGF-I or FSH respectively. Lanes 
3, 6 and 9 are samples containing oocyte-cumulus complexes incubated with intact IGFBP-2 alone or 
in the presence of IGF-I or FSH respectively.
Western ligand blotting with biotinylated IGF-II revealed one band of 31 kDa, which 
corresponds to the intact IGFBP-2 added to the samples. One possible proteolytic 
fragment was observed in samples containing oocyte-cumulus complexes incubated 
in the presence of IGF-I and mural granulosa cells incubated in the presence of FSH. 
However, this result was very faint and not consistent, so this method does not 
appear to be ideal for detection of proteolytic fragments resulting from the 




Evidence for proteolysis of IGFBP-2 has been detected previously in bovine (Monget 
et al. 2003; Spicer et al. 2001), ovine (Besnard et al. 1996b), porcine (Besnard et al. 
1997; Monget et al. 2003) and equine (Bridges et al. 2002; Gerard et al. 2004) 
follicular fluid with the use of a combination of immunoblotting and western ligand 
blotting techniques. However, the exact location of the production of protease(s) 
capable of degrading IGFBP-2 remains unknown. The findings from the present 
study, consistent with previous studies, revealed that bovine follicular fluid was 
capable of cleaving IGFBP-2 (Spicer et al. 2001; Monget et al. 2003). Furthermore, 
bovine mural granulosa cells were shown to produce a protease, soluble in culture 
medium, which degraded exogenously added IGFBP-2, indicated by the production 
of low molecular weight fragments. The incubation of oocyte cumulus complexes 
and denuded oocytes with intact IGFBP-2 did not show any proteolysis of IGFBP-2, 
indicating that the protease(s) is mainly produced by mural granulosa cells. The 
addition of recombinant IGF-I or FSH had no effect in terms of enhancing or 
inhibiting the degradation of IGFBP-2 in any of the treatment groups.
Proteolytic activity for IGFBP-2 and -3 has been detected in culture medium 
conditioned with human theca and stroma (Mason et al. 1996). In the present study, 
the addition of FSH or IGF-I was not found to make IGFBP-2 more susceptible to 
cleavage by oocyte cumulus complexes or denuded oocytes. Furthermore, the level 
of proteolysis observed by mural granulosa cells after the addition of FSH or IGF-I 
did not appear to significantly alter when compared to the degree of proteolytic 
degradation caused by mural granulosa cells incubated in their absence. Unlike the 
current study, a variety of factors have previously been shown to have a role in 
modulating IGFBP proteolysis. In rats, treatment with pregnant mare serum 
gonadotrophin (PMSG) was shown to markedly increase the expression of the 
IGFBP-4 protease PAPP-A in mural granulosa cells, while FSH was found to 
stimulate PAPP-A expression in mural granulosa cells, as well as switching on 
expression of PAPP-A in cumulus granulosa cells. Interestingly, this FSH induced 
stimulation of expression of PAPP-A was inhibited in the presence of oocytes and 
the oocyte secreted factor BMP-15 (Matsui et al. 2004). FSH and IGF-I have both
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been implicated in several species as playing a role in either enhancing or inhibiting 
IGFBP degradation (Adachi et al. 1995; Fielder et al. 1993; Gerard et al. 2004; 
Grimes and Hammond 1994; Iwashita et al. 1998; Liu et al. 1993; Mazerbourg et al. 
2000; Monget et al. 2003). Studies using bovine and porcine preovulatory follicular 
fluid have shown that they were only capable of inducing a partial proteolytic 
degradation of exogenous IGFBP-2. However, this degradation was enhanced in the 
presence of excess IGF-II in a dose-dependent manner (Monget et al. 2003), 
suggesting that, like IGFBP-4 (Mazerbourg et al. 2000), IGFBP-2 might undergo a 
conformational change after binding to IGFs that make it more susceptible to 
degradation (Gockerman and Clemmons 1995). Moreover, the addition of LR3-IGF- 
I, which does not bind to IGFBPs, was less efficient than IGF-I or IGF-II at 
enhancing cleavage of IGFBP-2 (Monget et al. 2003).
Characterisation of specific IGFBP proteases will be beneficial to developing in vitro 
culture techniques, as it will allow us to tract follicle development and they may act 
as markers of follicle health. Identification of the protease PAPP-A in human ovaries 
by in situ hybridisation revealed that preantral and atretic antral follicles have very 
low levels of detection, while healthy antral to preovulatory follicles displayed an 
intense PAPP-A signal. This signal was restricted to the granulosa cells, and was also 
present in healthy corpora lutea (Hourvitz et al. 2000). By measuring IGFBP-4 
protease activity with PAPP-A antibodies the secretion of PAPP-A has been detected 
from cultured human ovarian granulosa cells. However, PAPP-A IGFBP-4 protease 
activity is barely detectable in granulosa cell conditioned media until follicles are 
more than 9mm in diameter, which is coincident with dominant follicle selection in 
the human ovary. Additionally, secretion of PAPP-A was found from luteinising 
granulosa cells (Conover et al. 2001). IGFBP-2 and PAPP-A mRNA have been 
shown to be expressed in granulosa cells in sheep (Besnard et al. 1997; Mazerbourg 
et al. 2003) and cattle (Armstrong et al. 1998; Mazerbourg et al. 2001), with PAPP- 
A mRNA expression being highest in granulosa cells from fully differentiated 
follicles when compared to immature and atretic follicles (Mazerbourg et al. 2001). 
In addition, PAPP-A has been highlighted as a protease found in preovulatory bovine 
follicular fluid that is capable of cleaving IGFBP-2, with an increase in heparin-
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binding fragments from degraded IGFBP-5 possibly blocking this PAPP-A cleavage 
of IGFBP-2 by direct interaction with PAPP-A rather than IGFBP-2 (Monget et al. 
2003). Interestingly, even though PAPP-A expression is highest in fully 
differentiated bovine follicles (Mazerbourg et al. 2001), large dominant bovine 
follicles were found to have a lower IGFBP-2 proteolytic activity than subordinate 
follicles (Spicer et al. 2001). These results support the view that, other than the direct 
cleavage of IGFBP-2 by PAPP-A, various other proteases - such as kallikreins 
(Holland et al. 2001; Rehault et al. 2001) and/or other mechanisms - are involved in 
the loss of IGFBP-2 expression during bovine follicle development (Spicer 2004).
The intrafollicular cleavage of IGFBPs directly participates in the increase in 
bioavailability of IGFs that might further stimulate granulosa cell proliferation and 
steroidogenesis (Monniaux and Pisselet 1992). Proteolysis of human IGFBP-3 
generates two types of fragments with different activities. One has a weak affinity for 
IGF-I and is a weak antagonist of IGF action; the other lacks affinity for IGFs but 
inhibits IGF-stimulated mitogenesis, thus acting via a mechanism independent of the 
IGFs (Lalou et al. 1996). It is, therefore, possible that IGFBP-2 proteolytic fragments 
have IGF-independent effects on follicular cells. Furthermore, it has recently been 
demonstrated that levels of one IGFBP can have direct effects on the level of other 
IGFBPs (Cwyfan-Hughes et al. 1997; Mazerbourg et al. 1999; 2000). The addition 
of exogenous IGFBP-2 to follicular fluid from ovine, bovine, porcine and equine 
preovulatory follicles was able to inhibit IGFBP-4 degradation, suggesting that 
alterations in intrafollicular IGFBP-2 levels, due to changes in mRNA expression 
and proteolytic degradation, are involved in the regulation of intrafollicular IGFBP-4 
levels (Mazerbourg et al. 1999; 2000).
Overall, this data shows that in the developing bovine antral follicle, mural granulosa 
cells but not oocytes and cumulus granulosa cells have the ability to produce 
proteases capable of cleaving IGFBP-2. This data clearly demonstrates yet another 
mechanism by which IGF bioavailability can be regulated, and hence aids in 
modulating the specific actions of IGFs. Differences in the level of mRNA and 
protein of IGFBP-2 have been studied in Chapter 5; however, by studying the
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production of proteases the actual bioavailability and processes involved in 
regulating the access of IGFs to the follicle can be revealed. Therefore, future 
research should focus on further characterisation and regulation of specific proteases 
and elucidation of thie production and their spatial and temporal expression 
throughout ovarian follicle development.
The original hypothesis behind this study was that the oocyte was capable of 
producing proteases that would cleave IGFBP-2 at specific developmental stages, 
thereby increasing IGF bioavailability and hence IGF receptor mediated effects upon 
the developing follicle. This would provide a stage dependent putative mechanism 
whereby the oocyte can regulate its exposure - as well as the surrounding granulosa 
cells - to IGFs and thus control its own development as well as the early stages of 
granulosa cell differentiation and proliferation. Previous studies and work carried out 
for this thesis support this view, as IGF-I was not found to play an important role 
during primordial follicle initiation or early follicle development (see Chapter 3 
results). The IGF receptor has been shown to be present from the preantral stage in 
bovine follicles (Armstrong et al. 2000; Armstrong et al. 2002) and has been shown 
to have a stimulatory role in follicle development (Gutierrez et al. 2000; Itoh et al. 
2002). However, the finding that overexposure of preantral follicle oocytes to IGF-I 
had a negative effect on their health highlighted the importance of the correct 
regulation of IGF bioavailability. As the follicle develops to the antral stage it has 
been shown to be able to respond to the presence of IGF-I in a stage dependent 
manner. Granulosa cells were shown to proliferate and differentiate, IGF-I was found 
to improve oocyte health in the more mature antral follicles studied, and the 
expression of IGFBP-2 altered to either increase or decrease IGF bioavailability in 
response to the level of 'free' IGF available to the follicle (see Chapters 4 and 5). 
Although the oocyte was not found to produce protease(s) capable of cleaving 
IGFBP-2, there are limitations to this current study as the proteolytic activity of 
oocytes and granulosa cells from only antral follicles was investigated. Effects of the 
oocyte and granulosa cells can be stage dependent (Latham et al. 2004), so a future 
study into the production of proteases from oocytes and granulosa cells at specific 
developmental stages would give a fuller understanding of the mechanisms
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regulating IGF bioavailability. The use of 125I-labelled IGFBP-2 would account for 
problems associated with ligands not being able to bind sufficiently to the IGFBP 
fragments and possible cross-reactive and non-specific binding of the antibodies 
used. Additionally, if ,the exact protease is identified, then mRNA levels of this 
protease could be measured from the oocyte and/or granulosa cells collected from 
varying stages of follicular development.
mRNA for the protease PAPP-A has been shown to be expressed in the granulosa 
cells of bovine follicles, with expression being highest in granulosa cells from bovine 
fully differentiated follicles in comparison with immature and atretic follicles 
(Mazerbourg et al. 2001). Furthermore, PAPP-A has been highlighted as a protease 
found in preovulatory bovine follicular fluid that is capable of cleaving IGFBP-2 
(Monget et al. 2003). It could therefore be hypothesised that the protease being 
produced by the granulosa cells is PAPP-A. However, to prove this the ability of a 
PAPP-A antibody to immunoneutralise the proteolysis of intact IGFBP-2 could be 
tested by supplementation of the PAPP-A antibody to the incubation culture medium. 
Moreover, the addition of protease inhibitors that inhibit different types of proteases 
- such as serine, cysteine or matrix metalloproteinases - would rule out the possible 








The development of in vitro systems to support the growth and development of 
follicles from domestic species would be advantageous as they provide an excellent 
model for investigating the long-term culture of immature follicles. The complete 
development of oocytes in vitro from the primordial follicle stage through to the 
production of live young has only ever been achieved in rodents (Eppig and O'Brien 
1996; O'Brien et al. 2003). To date, there has been little success in applying these 
techniques to humans and domestic animals that have follicles that require a long 
growth period. In recent years it has become clear that local control of follicular 
development by growth factors plays a crucial role in the regulation of follicle 
development and oocyte maturation. The insulin-like growth factor system is one of 
the local control families that have been found to play a key role in regulating 
follicular growth, and a fuller understanding of the mechanisms involved in the 
regulation of IGF could improve in vitro culture systems.
The aims of this thesis were to (1) investigate the effects of IGF-I on early bovine 
oocyte and somatic cell development and health using a defined serum-free culture 
system, (2) analyse temporal and spatial differences in IGFBPs expression at 
different stages of follicle development, as a mechanism to regulate IGF 
bioavailability and (3) identify the proteolytic activity of different bovine follicular 
compartments. The research carried out in this study has revealed that IGF-I can 
have a direct action on the developing follicle, and that the follicle is capable of 
regulating its own exposure to IGFs by modulating IGFBP expression. Furthermore, 
these effects are both dose and stage dependent, hi addition, the secretion of 
proteases capable of degrading IGFBP-2 was detected in granulosa cell conditioned 
medium but not oocyte conditioned medium.
The gradual initiation of growth of ovarian follicles from the primordial pool is a 
process that is poorly understood. In Chapter 3 the effect of IGF-I on primordial 
initiation and early follicle growth and oocyte health, in the presence or absence of 
androgen, was investigated. Previous studies have shown androgen receptors to be 
detected in bovine follicles (Hampton et al. 2004), and work in this thesis confirmed
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the presence of androgen receptor immunoreactivity in granulosa cells and oocytes of 
preantral and antral bovine follicles. In addition, androgen has been shown in 
previous studies on primate ovaries to promote primordial follicle initiation and 
increase IGF-I and IGF-I receptors gene expression (Vendola et al. 1999a; 1999b). 
Taken together, these results imply that androgens may play a role in early follicle 
growth and that the actions of IGF-I through its receptor may be influenced by the 
presence of androgens. The current data, in agreement with previous studies (Derrar 
et al. 2000; Kezele et al. 2002b), found no effects of IGF-I on primordial follicle 
initiation or activated follicle growth. Supplementation of the culture medium with 
androstenedione, either on its own or in combination with IGF-I, also failed to affect 
follicle activation and growth. IGF-I that was not regulated by IGFBPs was found to 
have a negative effect on the oocyte health of follicles cultured for six days. This 
suggests that during the early stages of follicle development, as seen in follicles at 
the preantral stages of development (McCaffery et al. 2000), the regulation of the 
bioavailability of IGF is crucial to maintain the health of the oocyte. This result was 
not altered by the supplementation of the culture medium with androstenedione, 
suggesting that the actions of IGF-I through its receptor are not influenced, at this 
stage in bovine follicle development, by the presence of androgens. In summary, this 
data shows that in the developing bovine follicle IGF-I was not found to play an 
important role during primordial follicle initiation or early follicle development. 
However, as this and other studies have shown the culture of cortical strips causes 
wholesale activation of follicles (Braw-Tal and Yossefi 1997; Derrar et al. 2000; 
Wandji et al. 1996, see Chapter 3 results). This activation does not appear to be 
normal and is probably as a result of the overstimulation by the inappropriate culture 
conditions. Due to this fact, the use of the CAM culture system, which has been 
shown not to cause mass initiation of primordial follicles (Cushman et al. 2002), may 
prove to be a more useful technique in identifying factors that influence primordial 
follicle activation and early follicle growth.
The precise role of the IGF system in the regulation of bovine oocyte and follicle 
development throughout follicle growth is now becoming more fully understood 
(Derrar et al. 2000; Itoh et al 2002; Lorenzo et al. 1994; McCaffery et al. 2000).
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IGF-I has been shown to be essential for follicle development past the late preantral 
stage (Baker et al. 1996), to stimulate both proliferation and differentiation of 
somatic cells (Spicer et al. 1993; Stewart et al. 1995), to act as a follicle survival 
factor (Louhio et al. 2000), to stimulate follicle development (Gutierrez et al. 2000; 
Itoh et al. 2002) and to enhance nuclear maturation of oocytes (Lorenzo et al. 1994). 
However, the regulation of IGF bioavailability appears to be as important as its 
presence, as previous culture of bovine preantral follicles has shown that while IGF-I 
had a positive effect on follicle growth, a negative effect was observed on oocyte size 
and granulosa differentiation (McCaffery et al. 2000). In the present study (Chapter 
4), human recombinant IGF-I, when not regulated (l|j,g/ml), was found to 
significantly stimulate follicle proliferation in the early stages of antral development, 
and differentiation at all developmental stages investigated, as exhibited by 
oestradiol production. Furthermore, these effects were found to occur in a dose and 
stage dependent manner. Interestingly, LR3 IGF-I, even though it is not regulated by 
IGFBPs, did not stimulate follicle differentiation or proliferation, indicating that the 
high dose of recombinant IGF-I may have been acting via the insulin receptors as 
well as the IGF receptors. Moreover, in the most mature antral follicles studied, 
oocyte health was found to improve by the presence of human recombinant IGF-I. 
The results emphasise the continual changes in the requirements of the developing 
follicle and the mechanisms regulating the IGF system throughout follicular 
development. Follicular growth is regulated by the interaction of many different 
factors. One of the main roles of IGFs is to work in synergy with FSH to regulate 
follicle development, hence, future studies investigating the interaction of IGFs and 
FSH during antral growth would provide a more comprehensive understanding of 
how these factor may work together in vivo. Furthermore, IGF-II has been shown to 
be the principal intrafollicular IGF ligand in cattle (Armstrong et al. 2000), hence, 
investigation into it actions and identification of expression patterns of the type II 
IGF receptor would be beneficial.
The biological actions of IGF depend in part on the ability of specific proteases to 
break down the IGF/IGFBP complex and/or the level of expression of the IGFBPs 
(Giudice 1992). In Chapter 5 it was shown that IGF-I could exert an influence on the
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regulation of its own bioavailability, by influencing the expression of IGFBP-2 in the 
oocyte and granulosa cells. The results suggest that IGF-I may regulate the 
expression of IGFBP-2 through a negative feedback mechanism, which again is dose 
and stage dependent. In the present study there was found to be a significant increase 
in oestradiol production in the follicles cultured in the high dose of IGF-I (see 
Chapter 4 results), which also exhibited a high level of IGFBP-2 expression. 
Oestradiol in the presence of insulin has been shown previously to increase IGFBP-2 
mRNA expression in granulosa cells of antral follicles (l-5mm in diameter) (Voge et 
al. 2004). Hence further work on the regulation of IGFBPs by growth factors 
working alone or in synergy with gonadotrophins or steroids will give a further 
understanding of the relative bioavailability of IGF present at different follicular 
development stages.
In addition to the level of expression of IGFBPs, the release of specific IGFBP 
proteases at specific stages of development is yet another mechanism that plays an 
important role in modulating IGF bioavailability (Spicer et al. 2001; 2004). Chapter 
6 explored the proteolytic activity of oocytes and granulosa cells from large antral 
follicles by incubating them in the presence of intact IGFBP-2 and then identifying 
the presence of proteolytic fragments brought about by the cleavage of IGFBP-2. 
Mural granulosa cells but not oocytes or cumulus granulosa cells were found to 
secrete proteases capable of degrading IGFBP-2. Cleavage of IGFBPs has been 
shown to be enhanced or inhibited by the presence of IGF-I (Fielder et al. 1993; 
Grimes and Hammond 1994) and/or FSH (Adachi et al. 1995; Liu et al. 1993; 
Fielder et al. 1993). However, in the present study, the addition of FSH or IGF-I was 
not found to make IGFBP-2 more susceptible to cleavage by incubation with oocytes 
or granulosa cells when compared to the degree of proteolytic degradation caused in 
their absence. The hypothesis that the oocyte and/or granulosa cells were capable of 
producing proteases that would cleave IGFBP-2 at specific developmental stages, 
thereby increasing IGF bioavailability and hence IGF receptor mediated effects upon 
the developing follicle; provides a stage dependent putative mechanism whereby the 
oocyte and/or granulosa cells can regulate their own exposure to IGFs and thus 
control their own development as well as the early stages of granulosa cell
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differentiation and proliferation. Oocyte were not found to produce a protease(s) 
capable of cleaving IGFBP-2 which does not seems surprising as the production of a 
protease from the oocyte may be potentially very damaging if it were to be activated 
at an inappropriate time. The concentration of IGFBP-2 in bovine follicular fluid is 
much higher than that of IGFBP-4 and -5 (Spicer and Echternkamp 1995), and 
furthermore IGFBP-2 has been shown to be bound up in granulosa cells, hence, a 
protease capable of cleaving IGFBP-2 would have to be strictly regulated to ensure 
the release and hence increase in IGFs bioavailability occurs in a regulated fashion. It 
seems much more likely that the oocyte may stimulate the granulosa cells to start 
producing a protease capable of cleaving IGFBP-2. Effects of the oocyte and 
granulosa cells can be stage dependent (Latham et al. 2004), so a future study into 
the production of proteases from oocytes and granulosa cells at specific 
developmental stages would give a fuller understanding of the mechanisms 
regulating IGF bioavailability. The addition of protease inhibitors that inhibit 
different types of proteases - such as serine, cysteine or matrix metalloproteinases - 
or the addition of specific protease antibodies would allow the exact protease(s) to be 
identified. Additionally, if the exact protease is identified, then mRNA levels of this 
protease could be measured from the oocyte and/or granulosa cells collected from 
varying stages of follicular development. Further work identifying the developmental 
stages when specific proteases that degrade IGFBPs are being produced would allow 
us to monitor follicular development during long-term culture, as they may act as 
markers of follicular health and thus follicle viability.
Overall, these experiments highlight the importance of the IGF system in the early 
stages of oocyte and follicle growth, and emphasise the need for regulatory 
mechanisms, such as the IGFBPs, to be maintained during in vitro follicle culture. 
The results presented here draw attention to the need for future in vitro work to focus 
on investigations into the regulation of ovarian follicle development, as these are 
essential to our understanding of how the oocyte gains full developmental 
competence. It is still unclear how paracrine factors co-ordinate follicle and oocyte 
development, especially during the early stages of growth. Locally produced growth 
factors are usually secreted via the constitutive secretary pathway and stored in
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extracellular depots where they are unable to interact with their receptors. Therefore, 
the complex mechanisms regulating the release or activation of growth factors that 
are associated with the ECM, attached to cell surfaces, or sequestered by 
carrier/binding proteins, is vital to elucidate the regulation of the bioavailability of 
these important factors during follicle development. Furthermore, the identification 
of good developmental markers, such as the production of proteases at specific 
developmental stages, is needed to enable advancement in the development of an in 
vitro culture system that will accelerate follicle development without causing 




Bovine and primate ovaries have many similarities that make the cow an excellent 
model for humans. Bovine ovaries are also an important model in themselves 
because of their agricultural importance. The ultimate goal of studies on follicle 
growth in vitro is to develop conditions that will sustain follicular development to the 
stage where the oocyte is capable of meiotic maturation, fertilisation and normal 
development.
The use of serum-free cultures as a way to improve our understanding of how growth 
factor systems are regulated during follicle development has provided a wealth of 
knowledge in recent years. The aim of this thesis was to use these culture techniques 
to provide insights into how the complex IGF system is regulated throughout 
follicular growth. This research has highlighted the stage and dose dependent actions 
of IGF-I on both follicle proliferation and differentiation, as well as oocyte health. In 
addition, the regulation of IGF bioavailability by IGFBPs has been shown to be 
governed, in part firstly, by the level of expression that can be modulated by the 
presence of IGFs and follicle developmental stage; and secondly, the production of 
specific IGFBP proteases by specific cell types. Further investigation into how the 
IGF system interacts with gonadotrophins and other local growth factors will give a 
broader understanding of the multifactorial regulatory mechanisms governing follicle 
development.
Culture systems are of great importance as they not only provide an environment for 
in vitro growth of follicles but are also an invaluable tool for further research into 
processes governing follicular development. Only with continued research into the 
precise regulatory events of growth factor systems, such as the IGF system, will a 
fuller understanding of the complex processes involved in normal follicle 
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